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Developing immature follicles either from fresh or cryopreserved ovarian tissue to 
attain competent and fertilisable oocytes could provide an option for some patients 
undergoing fertility preservation to avoid the risk of ovarian micro-metastases 
following ovarian tissue transplantation. The first stage of an in vitro growth system 
(IVG) is activation of primordial follicles. Regulation of this process is critical as 
uncontrolled and precocious growth initiation of primordial follicles during in vitro 
activation (IVA) has been a major concern. A delicate balance between inhibitory and 
stimulatory signals is required to achieve activation but this can also be regulated by 
manipulating key signalling pathways associated with follicle activation.  
 
Phosphatase and tensin homolog of chromosome 10 (PTEN), expressed by the oocyte, 
is a negative regulator of the Phosphoinositide 3-kinase (PI3K) pathway and has been 
utilised to initiate primordial follicle growth both in vivo and in vitro in a range of 
species. Pregnancies have been achieved after grafting small ovarian cortical 
fragments exposed to PI3K/protein kinase B (Akt) activators to reinitiate the growth 
of residual follicles in the ovarian tissue of premature ovarian insufficiency (POI) 
patients. However, activating growth in this way may be damaging to the ovarian 
follicles. PTEN also has a role in maintaining genomic integrity. Its effects on DNA 
double strand breaks (DSBs) repair capacity has been debatable. Notably, unrepaired 
DNA damage is related to ovarian ageing. Meiotic errors are also more likely, leading 
to chromosomal abnormalities and impacting on oocyte quality. Therefore, we 
hypothesised that inhibiting PTEN to increase the activation of primordial follicles 
could result in increased DNA damage and compromised DNA repair capacity in 




preantral follicles selected for culture. The overall aim of this thesis was to determine 
the collective effects of PI3K/PTEN/Akt/mammalian target of rapamycin (mTOR) 
modulation pathway, either by inhibiting or activating the signals, on primordial 
follicle activation and DNA damage response (DDR) of bovine ovarian follicles in 
vitro.  
 
These experiments demonstrated that short-term incubation of ovarian cortex with low 
(1PM) and high dose (10PM) dipotassium bisperoxo (5-hydroxypyridine-2-carboxyl) 
oxovanadate (V) (bpv(HOpic)), a PTEN inhibitor, increased primordial follicle 
activation but resulted in a reduction in the proportion of morphologically healthy 
follicles in the high dose group. In parallel, DNA damage increased with limited DNA 
repair function. This was observed both in low and high dose. The mTOR signalling 
pathway is a master regulator of cell growth and metabolism and its inhibition 
attenuates follicle growth activation. In the second part, the potential benefit of 
inhibiting PI3K/Akt/mTOR signalling on the regulation of in vitro follicular activation 
was investigated. The addition of a low dose rapamycin to bpv(HOpic) or rapamycin 
on its own reduced DNA damage and improved DNA repair capacity of the oocytes. 
In the last part, experiments were extended to isolated preantral follicles. None of the 
treatments had an effect on promoting isolated follicle growth and survival. Although 
DNA repair protein ataxia telangiectasia mutated (ATM) was significantly 
upregulated in the presence of rapamycin, it appeared that cumulative effects of 
increased gamma H2A histone family member X (JH2AX) and upregulation of ATM 




Altogether, these data provide unimproved understanding into the regulation of the 
follicular activation and its relation with DDR, highlighting the significance of getting 
closer to physiological conditions to maintain follicle integrity. This may be a 
promising strategy for the derivation of mature oocytes in vitro. However, further 



















Lay Summary  
Recent advances in cancer treatment including the improvement of chemotherapeutic 
regimens have led to increased survival of younger patients. This has resulted in 
greater consideration of future fertility and therefore an increased demand for fertility 
preservation prior to potentially damaging treatments. Cryo-preservation of ovarian 
material is now offered to young female cancer patients for subsequent ovarian tissue 
transplantation. Unfortunately, in certain cases, this method is not applicable due to 
the risk of transferring malignant cells during transplantation. Developing immature 
eggs (oocytes) either from fresh or cryopreserved ovarian tissue outside the body (i.e. 
entirely in vitro) to obtain mature eggs that could be fertilised would avoid this risk. 
The first stage in achieving a complete IVG system is activation of primordial follicles 
that contain the most immature eggs.  
 
Primordial follicles are in a resting state within the ovary until they receive appropriate 
signals to initiate their growth initiation. Fragments of ovary containing primordial 
follicles can be cultured and this leads to activation of follicles and growth to 
developing follicles. However, the activation of these follicles is under control by the 
fine balance between inhibitory and stimulatory signals. PTEN is a factor known to 
have a major role in primordial follicle activation. Inhibition of PTEN will activate 
another signalling pathway called Akt that can increase the activation of immature 
eggs. These factors have been used to activate primordial follicle in range of species 
and has been applied clinically to reinitiate the growth of follicles in patients with very 
few follicles in their ovaries, and pregnancies have been achieved. A specific drug 
designed to stimulate Akt was used to incubate the tissue fragments prior to 




also involved in cancer cell growth. Its activation may also affect DNA damage and 
its repair. In this study, the effects of these factors on DNA damage and DNA repair 
capacity of ovarian follicles have been studied using cow ovaries as a model for 
human.  
 
This study has demonstrated that PTEN inhibition leads to increased primordial 
follicle activation, but also increases DNA damage and suppresses DNA repair 
capacity of cow ovarian follicle in vitro. As increasing the activation is associated with 
compromised DDR, it was hypothesised that decreasing the growth rate may improve 
DDR and prevent uncontrolled activation. This was tested by using a specific 
substance, mTOR inhibition that can slow the rate of activation. It was found that 
mTOR inhibition reduced DNA damage and improved DNA repair capacity of the 
follicles in vitro. To further analyse treatment effects on subsequent follicle growth, 
growing follicles were isolated from the fragments exposed to the treatments. 
However, no effect of treatments on follicle health, the number of antral follicles, 
expression of follicular health markers such as growth differentiation factor 9 (GDF9), 
connexin43 (Cx43) and laminin in isolated growing follicles cultured individually for 
another 6 to 8 days. Further analysis showed a reduction in expression of ATM and 
Rad51 in the PTEN inhibition group. These findings will help to improve and develop 
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1. Literature Review 
A part of this chapter has been published as a review in Cells 2020, 9(1), 
200; https://doi.org/10.3390/cells9010200.  
1.1. Introduction 
Cryopreservation of ovarian cortex prior to gonadotoxic treatments is used to preserve 
reproductive function and fertility of woman with cancer. Development of ovarian 
cryopreservation and subsequent transplantation has now resulted in the birth of almost 
200 babies. However, in many cases, there is a risk of reintroducing malignant micro-
metastases by transplanting the ovarian tissue, and this may lead to cancer recurrence 
(Dolmans et al., 2013, Dolmans and Masciangelo, 2018).  
 
The probability of reintroducing malignant cells is influenced by the stage and type of 
cancer with the risk of ovarian micro metastasis in leukaemia cancer patients being 
estimated as greater than 50% (Dolmans et al., 2010) whilst the risk of ovarian 
metastasis in low-stage breast cancer and lymphoma is estimated as 0% (Meirow et 
al., 1998, Rosendahl et al., 2011). The risk tends to be variable across studies in 
cervical cancer patients, ranging from 0 to 14.3% (reviewed by (Bastings et al., 
2013)).These data highlight the potential risk of ovarian transplantation for certain 
patients and emphasise the need to develop  in vitro systems (IVG and IVM) that could 
significantly improve reproductive outcomes for young female cancer survivors. In 
fact, it has recently been reported that the first live birth has been achieved  using 
vitrification of oocytes from a female cancer survivor matured in vitro (IVM) 
(Grynberg et al., 2020). 
 
To avoid the risk of ovarian micro-metastases but still utilise the ovarian tissue, 




obtain mature oocytes are being developed as a solution to avoid the risk of ovarian 
micro-metastases after ovarian tissue transplantation (Barnes et al., 1996, Gosden, 
2000, Telfer et al., 2008, Telfer and McLaughlin, 2012, Telfer and Zelinski, 2013, 
Thomas et al., 2003a, Thomas et al., 2003b). The primary focus in developing the IVG 
systems is increasing the number of developmentally competent oocytes (Telfer and 
McLaughlin, 2012). The first stage in this process is to activate and grow the most 
immature stage of follicle development (primordial follicles) contained within the 
tissue. To date, growth and maturation of primordial follicles entirely in vitro to 
produce developmentally competent oocytes capable of being fertilised and resulting 
in the birth of healthy offspring has only been achieved in mice (Eppig and O'Brien, 
1996, O'Brien et al., 2003).  
 
Success in mouse models has led to the development of methods to support the growth 
of ovarian follicles in vitro starting from the early stages of follicle development in 
large mammals and human (Brito et al., 2014, Hovatta et al., 1997, Hovatta et al., 
1999, Picton and Gosden, 2000, Telfer and McLaughlin, 2012, Xiao et al., 2015). 
Developing an optimal environment in vitro that supports follicular growth and 
survival is complex and challenging (Galloway et al., 2000, McGee and Hsueh, 2000). 
It is now clear that in vitro follicle development from primordial stages requires a 
multistep culture system to initiate primordial follicle growth, preantral to antral 
follicle development and subsequently oocyte in vitro maturation (Telfer and 
McLaughlin, 2012, Telfer and Zelinski, 2013). Meiotically mature human oocytes 
derived from immature ovarian follicle grown in a multistep culture system has been 




to optimise in vitro growth systems, it is crucial to have a greater understanding of the 
mechanisms regulating the activation of primordial follicles. 
 
Activation of follicle growth is regulated by a combination of inhibitory, stimulatory 
and maintenance factors (Zhang and Liu, 2015). The PI3K/Akt signalling pathway 
within the oocyte has been shown to be a key regulator of primordial follicle activation. 
This system is a key signalling pathway in the regulation of primordial follicle growth 
and differentiation. Inhibition of PTEN, a major regulator of the PI3K pathway, has 
been widely used either in vivo (knockout mouse studies) or in vitro studies (use of a 
pharmacological inhibitor of PTEN) to induce primordial follicle activation in range 
of species (Adhikari et al., 2012, Fan et al., 2008, Jagarlamudi et al., 2009, Reddy et 
al., 2008). Pregnancy has been achieved after transplanted small ovarian cortical 
fragments exposed to pharmacological inhibitors of PTEN (Suzuki et al., 2015). 
However, this method may be damaging to follicular growth and survival (Lerer-
Serfaty et al., 2013, McLaughlin et al., 2014) implying that further investigation is 
required to fully understand the impact and implications of follicle activation using 
pharmacological approaches involving this pathway. Looking at its effects on the stage 
before the apoptosis occurs which is DDR is a major focus of this thesis using the 
bovine system as a model for human oocyte development. A thorough understanding 
of the impact of different culture conditions on DDR will be beneficial to optimise 
oocyte quality produced by a multistep culture system. 
 
1.2. Primordial Follicle Formation and the Ovarian Reserve 
Fetal life is a critical period of primordial follicle assembly as it has direct implications 
to determine female reproductive lifespan (Geber et al., 2012). During embryogenesis, 




separation, migration and colonisation. In the human, these processes are completed 
at the end of 5 weeks of embryogenesis when the PGCs reach and settle in the genital 
ridge from the yolk sac through the dorsal mesentery of the hindgut to become oogonia 
(Faddy et al., 1992, Mollgard et al., 2010).  
 
In other mammalian species, such as mice, PGCs have migrated to the genital ridge 
around ten days after conception. In the bovine, the genital ridge does not appear until 
28-32 days of gestation and migration occurs around day 30 to 64 of pregnancy. In the 
genital ridge, the germ cells multiply and form oogonia. At 12 weeks of gestation, 
most of the germ cells are connected by intercellular bridges and appear as a nest/cyst 
of oogonia. Some oogonia start to enter meiosis and progress to diplotene stage of the 
first meiotic prophase and are referred to as primary oocytes (Bendsen et al., 2006, Le 
Bouffant et al., 2010). The high activity of germ cell proliferation at this stage is in 
line with the high somatic cell proliferation rate in the coelomic surface epithelium 
and blastemal cords that arise from regions within the ovaries. This intense 
proliferation can cause oocytes to be pushed to the cortical area of the ovary, included 
in the superficial epithelium or spread freely on the surface of the ovary, from which 
some may be lost (Motta et al., 1986). It is estimated that the number of oogonia 
reaches a peak at five months of gestational age (Baker, 1963). Between 17 and 24 
weeks of gestation, most oogonia have transformed into oocytes. During cyst 
breakdown, most of the oocytes experience apoptosis with just one third surviving. 
Pre-granulosa cells originated from the mesenchyme of the genital ridge establishes 
connections and surround these germ cells and ultimately form the primordial follicle 
pool (Pepling and Spradling, 2001, Pepling, 2012, Picton et al., 1998, Wang et al., 




of ovulation (Picton et al., 1998). 
 
At birth, a pair of normal female human ovaries contains a finite stock of only 600,000 
– 1,000,000 follicles (Baker, 1963). By the onset of puberty, the number of primordial 
follicles drops drastically with only approximately 500,000 follicles being present. 
Throughout life, approximately 400 - 600 oocytes will be released through ovulation 
(Wallace and Kelsey, 2010), whilst the remaining follicles undergo degeneration 
(atresia). The pool of primordial follicle serves as the source of growing follicles 
throughout the female’s reproductive life span and will progressively dwindle with age 
leading to decreased ovarian reserve and ultimately reproductive senescence (Faddy 
and Gosden, 1995) (Fig 1.1). At the age of 50, a woman’s primordial follicle pool will 
almost be exhausted, when there are only roughly 1000 follicles present in the ovary 









the genital ridge, germ cells will proliferate massively, and oogonia are formed. Most of the oogonia 
and germ cells undergo apoptosis during the process. The oogonia that survived the apoptosis are then 
encircled by pre-granulosa cells and transformed into primordial follicles. A small number of the 
follicles will be initiated to develop to growing follicles. The selected follicles then mature and ovulate 
in response to the pre-ovulatory gonadotrophin surge. Following repeated cycles of recruitment, atresia, 
or ovulation, the follicle reserve is depleted with increasing age leading to menopause. dpc= days post 
coitum (Adapted from (Kaipia and Hsueh, 1997, Monniaux et al., 2014). 
 
It is generally accepted that no new primordial follicles are formed postnatally 
(Hirshfield, 1991, Mandl and Zuckerman, 1951) but this idea has been challenged by 
the fact that reestablishment of the primordial follicle pool was observed following 
genotoxic drug treatment in mice (Johnson et al., 2004). These results have been 
controversial (Eggan et al., 2006, Gong et al., 2010, Gosden, 2004, Johnson et al., 
2005, Pacchiarotti et al., 2010, Telfer et al., 2005, Woods et al., 2013, Zhang et al., 
2008, Zou et al., 2009). Some studies have identified the existence of putative oogonial 
stem cells in postnatal mammalian ovaries (Pan et al., 2016), with cells that have 
characteristics of germline stem cells being isolated from adult human ovaries (Woods 
et al., 2012; Clarkson et al., 2018). However, there is still no evidence to conclusively 
show that these cells contribute to the ovarian reserve by forming new oocytes under 
normal physiological conditions. 
 
Primordial follicles are quiescent, and the transition to the growing (primary) stage 
only occurs if they receive the appropriate signals. The number of primordial follicles 
activated at any given time is variable within different mammalian species (Elvin and 
Matzuk, 1998, Jagarlamudi et al., 2010, Matzuk et al., 2002). The exact mechanism 
of primordial follicle activation is not entirely understood (Jagarlamudi et al., 2010). 




after birth, followed by primordial to primary follicle transition immediately 
thereafter. Around 15 days postpartum, the first group of antral follicles is established. 
Whereas in primates and most domesticated animals, this transition has started during 
fetal life and is a prolonged and asynchronous process whereby some follicles are 
gradually initiated to grow before other primordial follicles are formed (Fortune et al., 
2000, Fortune, 2003, Gougeon, 1996).  
1.3. The General Concept of Mammalian Folliculogenesis 
Folliculogenesis is the process in which primordial follicles develop into primary, 
secondary and antral stage follicles that can generate mature and fertilisable oocytes 
(Hernandez Gifford, 2015, Khan et al., 2016). Folliculogenesis involves two principal 
phases, which are gonadotrophin independent and gonadotrophin dependent (Aerts 
and Bols, 2010, Edson et al., 2009, Fortune, 1994, Hirshfield, 1991, Hummitzsch et 
al., 2013b).  
 
During folliculogenesis, the maturation of ovarian follicle involves several sequential 
stages, namely: initiation of primordial follicle growth, selection, ovulation and 
luteinisation. In initial recruitment, primordial follicles are recruited from the 
primordial follicle pool for further growth. Initial recruitment is a continuous process 
that initiates after primordial follicle assembly before the onset of puberty. Oocyte 
growth is the main characteristic of the growing follicles after this stage, though the 
oocyte remain arrested in the diplotene stage of prophase I. Follicles not recruited 
remain quiescent (Hsueh et al., 2015, McGee and Hsueh, 2000). Once recruited, the 
activated primordial follicles develop into primary, secondary, and ultimately antral 




hypothalamic-pituitary-ovarian axis, but also several intra-ovarian and paracrine 
factors that affect the follicular development in a stage-specific manner (Richards and 
Pangas, 2010). 
 
The first phase of follicle growth i.e. from primordial to preantral stages can take 
several weeks in humans and cows, during which the follicle increases in size from 
30-50 μm (primordial follicles) to 100 - 200 μm (preantral follicles). The earliest phase 
of follicle development up to the preantral stage can occur independently of 
gonadotrophic hormones. These early stages are acutely dependent upon the 
bidirectional interaction between germ cells and surrounding somatic cells (McGee 
and Hsueh, 2000). It has been reported that follicle stimulating hormone (FSH) 
receptors (FSHR) are not present in primordial follicles until they enter the growth 
phase, as their expression may be induced during the primordial to primary stage 
transition (Oktay et al., 1997). This may suggest that the role of FSH in primordial 
follicle growth initiation may not be essential. Nevertheless, it does not preclude the 
possibility of its direct effects on primary follicles onward or an indirect effect 
mediated by factors released by larger follicles or ovarian stromal cells (Silva et al., 
2004). Although FSH is not crucial for primordial follicle activation in bovine ovaries, 
it promotes the growth of primary and secondary follicles in humans (Abir et al., 1997) 
and cows (Wandji et al., 1996a).  
 
Preantral to early antral follicle is often regarded as gonadotrophin sensitive stage. 
FSHR is present at this stage and the follicle is responsive to gonadotrophin hormones. 
At this stage granulosa and theca cells have become responsive to gonadotrophin 




2007). Studies utilising FSH deficient mice (Abel et al., 2000) and women lacking 
gonadotrophins (Goldenberg et al., 1976) have demonstrated that follicle development 
can occur to the multilaminar stage in the absence of gonadotrophins (Kumar et al., 
1997). Whilst early follicle development can occur independently of FSH, the FSHR 
is present in granulosa cells of early preantral follicles and their growth may be 
enhanced by FSH (Oktay et al., 1997). In a study utilising human ovarian tissue 
transplanted to hypogonadal mice, it was observed that follicles transplanted with two 
layers of granulosa cells did not form antral cavities in the absence of FSH. This data 
may infer that FSH is crucial for follicular growth beyond two granulosa cell layers, 
although growth activation is gonadotrophin independent (Oktay et al., 1998). In 
addition, there is growing evidence to suggest that a low dose FSH is favourable to 
support preantral follicle growth and survival in bovine and human in vitro culture 
systems (McLaughlin and Telfer, 2010, McLaughlin et al., 2018, Ribeiro et al., 2015). 
While follicle development from antral stage onward is completely dependent on the 
presence of gonadotrophins (Abir et al., 2006). This stage depends on the circulating 
levels of FSH and luteinising hormone (Hummitzsch et al.) as the follicles become 
more sensitive to these hormones (Richards and Pangas, 2010). FSH regulates 
granulosa cell proliferation by binding to and activating the FSHR, which is located in 
granulosa cells. The interaction of FSH with its G protein-coupled receptor (GPCR) 
triggers the canonical intracellular signalling pathway activating adenylate cyclase-
mediated cyclic adenosine monophosphate (cAMP) production and the protein kinase 
A (PKA) signalling pathway. These events have been reported as the main mechanism 
of FSH action in granulosa cells. However, it is increasingly evident that FSHR is also 




Glycogen synthase kinase 3β (GSK3β), serum and serum-and glucocorticoid-induced 
kinase (SGK), and p38 mitogen-activated protein kinase (p38MAPK) (Gonzalez-
Robayna et al., 2000, Wayne et al., 2007). Extracellular signal-regulated kinase (ERK) 
is an alternate pathway of FSH stimulation that allows robust mTOR activity upon 
TSC2 phosphorylation (Kayampilly and Menon, 2007, Manning et al., 2002, Tee et 
al., 2002), thereby enhancing granulosa cell proliferation (Kayampilly and Menon, 
2007). 
Increasing luteinising hormone (LH) level at this stage promotes follicular growth and 
steroidogenesis. An increase in estradiol production, triggered by FSH in granulosa 
cells, is essential for further follicle development at this stage (Findlay et al., 2019). 
After the onset of puberty, a few preantral follicles will reach the preovulatory stage 
under cyclic gonadotrophin stimulation (Richards, 1980, Zeleznik, 2001). 
Preovulatory follicles are the major source of the cyclic estradiol secretion. In response 
to the preovulatory gonadotrophin surge, the dominant Graafian follicle ovulates to 
release the mature oocyte, whereas the remaining somatic cells transform into the 
corpus luteum (Hsueh et al., 2015, McGee and Hsueh, 2000) (Figure 1.3). 
 
1.3.1. Primordial Follicle Initiation and Growth: Sequence of Events 
Involved 
In general, primordial follicle growth initiation can be distinguished by two phases, 
firstly the transformation of the pre-granulosa cells to a cuboidal shape, and then 
increasing numbers of granulosa cells which coincides with the rapid rise in oocyte 
size. Granulosa cell proliferation during these events involves a “rounding up” of cells 




activation occurs only in a small number of follicles each day and is independent of 
gonadotrophic hormones (Peters et al., 1973). The timing of primordial follicle growth 
initiation varies between species. In human and sheep, it occurs when the oocytes are 
completely enclosed by approximately 15 cuboidal granulosa cells, and 40 cuboidal 
cells in bovine (reviewed by (Picton and Gosden, 2000)) (Figure 1.2). 
 
Figure 1.2. Histological sections of haematoxylin and eosin (H & E) staining showing bovine and 
human ovarian follicle development. (A) Non-growing bovine ovarian follicles are prolate in shape 
with granulosa cells cluster (black arrow) at opposite poles of the follicle’s long axis, (B) Bovine 
primary follicles indicated by oocyte surrounded by cuboidal granulosa cells, (C) Multilayer secondary 
bovine ovarian follicles, (D) Primordial and transitory (red arrow) human ovarian follicles, (E) A human 
primary follicle and (F) A human secondary follicle (ovaries from transgender patients). Scale bar = 20 
Pm. 
 
1.3.1.1. The Role of Follicular Microenvironment, Autocrine and 
Paracrine Signals in Primordial Follicle Activation 
Primordial to primary follicle transition involves multiple pathways that serve as the 




follicle initiation depends on the response of each cell of the follicle to the activation 
or inhibition signals. The follicular microenvironment influencing pre-granulosa cell 
activation remains undetermined. However, a number of autocrine and paracrine 
signals derived from the follicular microenvironment other than oocytes and granulosa 
cells, including the stromal compartment, have been identified and implicated as being 
positive or negative regulators. Chemo-attractive cytokine stromal-derived factor-1 
(SDF1) and its receptor C-X-C chemokine receptor type 4 (CXCR4) are known to be 
implicated in primordial germ cell formation and are also recognised recently as a 
negative regulator of the oocyte development at the early stage in neonatal mouse 
ovary (Holt et al., 2006).  
 
The role of locally acting growth factors is now widely understood to be essential in 
regulating primordial follicle activation. KIT ligand (KL) or stem cell factor (SCF), 
secreted by immature granulosa cells, is known to promote primordial follicle growth 
in mouse and rat ovaries (Parrott and Skinner, 1999, Reddy et al., 2005) and pieces of 
monkey ovarian cortex (Gougeon and Busso, 2000). SCF has been confirmed to 
regulate theca cell growth and subsequent production of theca cell factors including 
transforming growth factor-D, keratinocyte growth factor (KGF), hepatocyte growth 
factor (HGF) and transforming growth factor E (TGFE). Several growth factors 
including basic fibroblast growth factor (bFGF), platelet-derived growth factor 
(PDGF), KGF and connective tissue growth factor (CTGF) produced predominantly 
by oocytes and by all cells at a reduced rate have also been shown to activate 
primordial follicle initiation (Kezele et al., 2005, Nilsson et al., 2001, Nilsson et al., 





Studies conducted in rodents have supported the role of insulin-like growth factor 
(IGF) (Thomas et al., 2007) and TGFE superfamily members to promote primordial 
follicle growth. Bone morphogenetic factor 7 (BMP7) produced in stromal and theca 
cells, increases the number of growing follicle leading to primordial follicle pool 
depletion in rat (Lee et al., 2001, Lee et al., 2004). Similarly, bone morphogenetic 
factor 4 (BMP4) has been identified to increase the proportion of growing follicles in 
rat (Nilsson and Skinner, 2003). In addition, the microenvironment of primordial 
follicles including nutrition, reactive oxygen species (ROS), antioxidant and 
appropriate oxygen and energy support has been demonstrated to have a role in 
determining the fate of the follicle (Laplante and Sabatini, 2012, Praxedes et al., 2018). 
It is an intriguing observation that total protein consumption may profoundly affect 
fertility performance, probably attributed to a functional relationship between amino 
acids and the mTOR activity. It has been reported that low protein diet attenuates 
primordial follicle activation in mice (Zhuo et al., 2019). Insulin at low concentration 
has also been reported as an endocrine factor to support the coordination of primordial 
follicle activation by acting at the insulin receptor with the oocyte as the site of action 





Figure 1.3. Folliculogenesis and factors involved in primordial follicle activation. The initiation 
phase is marked by the transformation of the flattened pre-granulosa cells surrounding the oocyte into 
cuboidal cells. Once recruited, the activated primordial follicles develop into primary, secondary, and 
ultimately antral follicles. In the earliest stage, the follicles grow in an FSH-independent fashion. 
Preantral stage is often regarded as a gonadotrophin independent stage, but FSHR is present at this stage 
and the follicle is responsive to gonadotrophin hormones, thus it can be more accurately regarded as 
being ‘gonadotrophin responsive’. Primordial follicle initiation is determined by the balance between 
the inhibitory (blue line) and stimulatory factors (red line). 
 
It has been proposed that primordial follicles are preserved in a resting state by nearby 
inhibitory factors released by surrounding growing follicles. Both Anti-mullerian 
hormone (AMH) (Durlinger et al., 1999) and activin (Mizunuma et al., 1999) are 
produced by growing follicles and function to limit the activation rate. Given that the 
more growing follicles that are present nearby primordial follicles, the greater the 
signals that will be exhibited, thus reducing the rate of activation. However, in contrast, 




regulatory signals provided strong evidence for a local diffusing inhibitor (Da Silva-
Buttkus et al., 2009). Primordial follicle activation was unlikely to occur when the 
neighbouring primordial follicles were in close proximity. However, as the number of 
growing follicles nearby increases, it is more likely that the follicles will be activated. 
Thus it seems that growing follicles release a diffusing signal that employs a 
stimulatory effect on their neighbouring follicles (Da Silva-Buttkus et al., 2009). 
 
Importantly, recent studies have identified the role of the Hippo signalling pathway in 
primordial follicle initiation. The Hippo signalling pathway is a highly conserved cell 
signalling system. It functions to regulate cell proliferation, differentiation, apoptosis 
(Xiang et al., 2015) and is essential in preserving optimal organ size (Kawamura et 
al., 2013). Tissue shape and stromal density have been proposed to be attributed to the 
regulation of follicle growth initiation in vitro (Telfer and Zelinski, 2013). The 
follicular growth in vitro is hampered within the dense ovarian stroma and preparing 
ovarian cortical strips into cubes (1-2 mm3) leads to significant primordial follicle 
activation compared to tissue slice (Scott et al., 2004). Likewise, primordial follicle 
loss due to excessive activation is markedly increased in thin ovarian grafts compared 
to standard thickness graft (Gavish et al., 2014). Mice and human ovaries 
fragmentation triggers actin polymerization and Hippo pathway disruption and 
subsequently enhances primordial follicle growth (Kawamura et al., 2016, Li et al., 
2010b). Disrupting the Hippo pathway is intended to limit the activity of co-activators 
of the pathway, which are Yes-associated protein (YAP) and transcriptional co-
activator with PDZ-binding motif (TAZ). YAP and TAZ are phosphorylated by the 
Large tumour suppressor homolog 1 (LATS1), a core kinase of the Hippo pathway. 




al., 2015, Kawamura et al., 2013).  
1.3.1.2. Intra-oocyte Control and Regulation 
The insulin signalling pathway acts through insulin receptors located in granulosa and 
thecal cells of different species (Lighten et al., 1997, Samoto et al., 1993). The PI3K 
signalling pathway appears to be the primary non-gonadotropic insulin signalling 
pathway that regulates the growth and differentiation of follicles (Dupont and 
Scaramuzzi, 2016). PI3K is composed of a heterodimer of the p85 regulatory subunit 
and p110 catalytic subunit. In response to growth factors including KL, all regulatory 
subunits of PI3K interact with the insulin receptor substrate, and thereby activate the 
catalytic subunit. This interaction leads to the phosphorylation of membrane 
phospholipid phosphatidylinositol 4, 5-biphosphonate (PIP2). The PIP2 converts to 
phosphatidylinositol 3, 4, 5-trisphosphate (PIP3), which then serves as a second 
messenger to enable phosphoinositide-dependent kinase 1(PDK1) activation. PTEN, 
expressed by the oocyte, reverses this process by converting PIP3 to PIP2. 
 
PIP3 binds to Pleckstrin homology (PH) domain of PDK1 and Akt and recruits these 
two kinases to the subcortical area, which in turn activates PDK1 and Akt 
phosphorylation at Threonine (Thr308). Akt is further phosphorylated by mammalian 
target of rapamycin complex 2 (mTORC2) at serine 473 (Ser473) for its full activation, 
which then regulates a number of downstream targets. PDK1 also phosphorylates 
SGK, atypical isoforms of protein kinase C (PKC) and p70 ribosomal S6 kinase 1 
(S6K1). S6K1 is the kinase of ribosomal protein S6 (rpS6).  
 
PDK1 is indispensable in maintaining primordial follicle survival and preserving 




suppressed leading to a rapid depletion of primordial follicles and ultimately ovarian 
senescence (Reddy et al., 2009). Although PTEN loss is associated with increased Akt 
activation, coexisting loss with PDK1 prevents upregulation of rpS6 due to 
inactivation of Akt and S6K1. It seems likely that both PTEN and PDK1 loss leads to 
premature ovarian failure (POF) but through different mechanisms. PTEN loss is 
associated with excessive primordial follicle activation and subsequent follicular 
atresia, whereas PDK1 deficiency instigates accelerated clearance of primordial 
follicles straight from their quiescent state (Reddy et al., 2009). However, PTEN 
deletion in oocytes of primary and further developed follicles does not reveal any 
significant effects on follicular growth (Reddy et al., 2008). This may indicate follicle 
stage specific functions of the PTEN/PI3K pathway within the oocyte (Jagarlamudi et 
al., 2009). In addition, selective PTEN disruption in the granulosa cells of mice 
enhances granulosa cell proliferation and differentiation and thereby improves 
follicular growth (Fan et al., 2008).  
 
Another downstream substrate of Akt is mTOR, an atypical serine/threonine kinase. 
mTOR comprises of two distinct protein complexes, which are mTORC1 and 
mTORC2. Akt activates the mTOR1 pathway through the destabilization of the 
heterodimeric complex of tuberous sclerosis complex 1 (TSC1 or hamartin) and 
tuberous sclerosis complex 2 (TSC2 or tuberin). mTORC1 phosphorylates S6K1 at 
Thr389 and 4E-binding protein 1 (4EBP1) at Thr37, 46, 70 (Thr37, 46, 70) and Ser65 
and eventually promotes cell growth and proliferation. The lack of TSC 1 and TSC2 
in mouse oocytes has been proven to cause massive primordial follicle activation, 
leading to POF. Activated Akt, in turn, phosphorylates glycogen synthase kinase-3 




(FOXO3) and p27 (Adhikari et al., 2009, Adhikari and Liu, 2010). Once activated, 
FOXO3 is shuttled from the nucleus to the cytoplasm, which then suppresses their 
transcriptional function. 
 
The FOXO3 deleted mouse model displays global primordial follicle activation at the 
neonatal stage leading to primordial follicle loss and ovarian failure (Castrillon et al., 
2003, John et al., 2007). Conversely, overexpression of constitutively active FOXO3 
in the nucleus of mouse oocytes preserves the oocytes in a dormant state, enhance 
ovarian reserve and reproductive capacity (Pelosi et al., 2013). Within this framework, 
FOXO3 can be considered as a guardian of the primordial follicle pool, enhancing 
ovarian reserve and maintaining reproductive capacity (Castrillon et al., 2003, John et 
al., 2007, Pelosi et al., 2013). As a substrate of Akt, the function of FOXO3 is 
controlled by PI3K, and the expression is downregulated in oocytes of larger follicles 
(Liu et al., 2007). Upregulation of the downstream PI3K pathway also increases p27 
activity that can inhibit cyclin-dependent kinase 2 (Cdk2) activity in oocytes of 





Figure 1.4. PI3K pathway involved in Primordial follicle activation. Activation of follicles from the 
quiescent state is regulated by the PI3K pathway through the balance of activating and inhibitory 
factors. Activation of follicles from the quiescent state is regulated by the PI3K pathway through the 
balance of activating and inhibitory factors. A p85 regulatory subunit and a p110 catalytic subunit of 
PI3K are localised in cytoplasm and is initiated by growth factor receptor tyrosine kinases at the plasma 
membrane. Upon growth factor stimulation, all regulatory subunits of PI3K interact with the insulin 
receptor substrate, and thereby activate the catalytic subunit. This interaction leads to the recruitment 
of PI3K from the cytoplasm to the inner membrane induces phosphorylation of PIP2 to PIP3, which 
then enables PDK1 activation. PTEN reverses this process and increases PIP2 expression. Akt is 
phosphorylated by PDK1 at Thr308 and mTORC2 at Ser473. These events then trigger a cascade of 
PI3K downstream reactions involving proteins such as p27, Bad, FOXO3, TSC2, and GSK β3. 
Phosphorylation of TSC2 then increases mTORC1 activity which, in turn, phosphorylates S6K1 and 
leads to activation of rpS6. mTORC1 controls protein translation through S6K1 and 4EBP1 




Other factors that have been documented as oocyte-specific genes of the primordial 
follicle and are capable of either promoting or preventing primordial follicle activation 
are spermatogenesis and oogenesis specific basic helix-loop-helix 1 (Sohlh1), Sohlh2, 
factor in the germ-line alpha (FIGLA), newborn ovary homeobox gene (NOBOX) and 
LIM homeobox8 (LHX8) (reviewed by (Pangas and Rajkovic, 2006)). These genes 
are expressed in oogonia and oocytes within primordial and growing follicles. A study 
in a transgenic mouse model showed that NOBOX is a positive regulator of FOXO3 
in the oocyte of primordial follicles suggested that NOBOX functions to maintain the 
primordial follicle pool (reviewed by (Zhang et al., 2014)). LHX8 and NOBOX 
upregulate expression of several oocyte genes, including the TGFE family members 
GDF9 and bone morphogenetic protein-15 (BMP15). GDF9 is crucial for oocyte 
growth beyond the primary follicle stage (Dong et al., 1996), but GDF9 transcript in 
mice is also present in germ cell nests and primordial follicle. Mice deficient in 
NOBOX leads to increased oocyte nest and primordial follicle number and GDF9 
expression is downregulated in the ovaries (Choi and Rajkovic, 2006, Rajkovic et al., 
2004). While in human, NOBOX is essential during follicle formation in the human 
fetal ovary and GDF9 is increased at the same developmental period indicating the 
role of NOBOX in regulating GDF9 expression (Bayne et al., 2015). Unlike mice, 
GDF9 expression in sheep and cow oocytes emerge at the primordial follicle stage 
(Aaltonen et al., 1999). Such species specific GDF9 expression and activity may in 
part reflect that NOBOX activity throughout folliculogenesis is stage specific and may 






1.3.1.3. Granulosa Cells Secreted Factors  
Accumulating lines of evidence suggest a role of granulosa cells in follicular growth 
and development. Primordial follicle pre-granulosa cells initiate primordial follicle 
growth and are indispensable in regulating the dormancy or awakening of quiescent 
oocytes within primordial follicles (Zhang et al., 2014). A study utilising a mutant 
mouse model found that mTORC1 signalling in pre-granulosa cells has a major role 
in governing pre-granulosa cells differentiation into granulosa cells and eventually 
activates the growth of the oocyte through the mTORC1-mediated expression of KL. 
This process will then continue with a cascade of PI3K signalling pathway activation 
and subsequent oocyte awakening (Zhang et al., 2014). A transgenic mouse study 
targeting molecules constituting mTORC1 revealed that the absence of mTORC1 
activity in pre-granulosa cells prevents their differentiation into cuboidal cells and 
eventually inhibits the activation of primordial follicles. On the other hand, excess 
mTORC1 expression is associated with growth acceleration and differentiation and 
ultimately ovarian failure (reviewed by (Monniaux, 2016)). 
 
In addition, both estradiol and progesterone have been shown to inhibit primordial 
follicle growth initiation (Kezele and Skinner, 2003). In mice, high levels of maternal 
estradiol and progesterone have been suggested as inhibitory factors to germline nest 
breakdown during pregnancy and that the decline in these hormones after birth leads 
to primordial follicle formation (Jefferson et al., 2006). The addition of progesterone 
in vitro, and to a lesser extent, estradiol significantly increases the number of 
unassembled follicles in neonatal mice (Kezele and Skinner, 2003, Lei et al., 2010). 
 
Other factors contributing to the dormancy of the primordial follicle pool include 




2004). Pre-granulosa cells deficient gene encoding FOXL2 in mice fail to differentiate, 
resulting in oocyte death and massive follicular depletion (Schmidt et al., 2004). In 
addition, granulosa cell-derived factors KL and leukaemia inhibitory factor (LIF) are 
expressed at higher levels in granulosa cells of primordial and primary follicles and 
are imperative in granulosa cell proliferation. LIF triggers KL activity in granulosa 
cells and eventually promotes primordial follicle activation (Nilsson et al., 2002) 
(Figure 1.5).  
 
Figure 1.5. The localisation of follicular microenvironment key factors involved in primordial 
follicle activation. The figure shows the location of known factors contributing to primordial follicle 
activation, including factors produced by stromal cells. Primordial follicle activation is a result of the 
collective actions of these factors. AMH produced by surrounding early growing follicles inhibit 
primordial follicle development. Sohlh1 and Sohlh2 are positive regulator of NOBOX, LHX8 and 
FIGLA. FOXL is exclusively expressed in pre-granulosa cells. Its activation increases granulosa cells 
proliferation. PTEN and TSC1/2 in oocyte cytoplasm are the negative regulator of primordial follicle 
activation. While FOXO is located in the nucleus and NOBOX is a positive regulator of FOXO3. 
NOBOX activate GDF9 in stage and species-specific manner (more in growing follicle). GDF9 is 
oocyte secreting factor that may activate the activity of KL in granulosa cells and lead to granulosa cells 




follicle activation. BL (basal lamina), CTP (cytoplasm), NC (nucleus), pGC (primordial follicle 
granulosa cells), GC (granulosa cells), TC (theca cells), MC (mesenchymal cells), (+) activator, (-) 
inhibitor. Adapted from (Williams and Erickson, 2000). 
1.3.2. Primary and Preantral Follicle Development 
From primary stage onward, the granulosa cells become mitotically active and begin 
to express FSH receptor at the preantral stage (Oktay et al., 1997). Thereafter, the 
proliferation rate dramatically increases, and oocytes enlarge with multilayer 
granulosa cells surrounding the oocyte (reviewed by (Monniaux, 2016)). Oocytes 
become transcriptionally active to produce adequate proteins and mRNA transcript 
(Albertini, 2015, Pangas and Rajkovic, 2015) which are a prerequisite for oocyte 
development. At this stage, oocyte and granulosa cell growth do not predominantly 
depend on gonadotrophins until follicle growth reaches the late preantral or early antral 
stage (Oktay et al., 1997). 
 
Preantral follicles are distinguished from primary by the formation of the zona 
pellucida (ZP) and differentiation of theca cells (Albertini et al., 2001). Preantral 
follicle development is exemplified by several events, including the appearance of 
GDF9 and BMP15 and junctional connexin (Cx) proteins. GDF9 emerges during early 
stages and acts on granulosa cells throughout folliculogenesis. Sheep and cow oocytes 
begin to express GDF9 at the primordial follicle stage whereas it is very highly 
expressed in primary follicles in human (Aaltonen et al., 1999), mouse, and rat 
(Findlay et al. 2019). The expression of BMP15 occurs slightly later than GDF9 in 
human oocytes. In mouse oocytes, BMP15 is co-expressed with GDF9 during 
folliculogenesis (Laitinen et al., 1998). It is reported that short exposure to GDF9 and 




either BMP15 or GDF9 alone. Chronic use of BMP15 has been shown to decrease the 
growth rate and eventually induce atresia. Intriguingly, environmental low BMP15 
expression is favourable for oocyte development in mouse preantral follicles. SMAD 
2/3 expression is a downstream target of GDF9 activity and is predominantly observed 
in early-stage follicular development. In contrast, BMP15 acts on granulosa cells of 
preantral follicles, and increases the expression of SMAD 1/5/8, which act downstream 
of BMP15 and are more noticeable from the preantral stages (Fenwick et al., 2013). 
 
Another TGFβ superfamily member known to be involved in preantral follicle 
development is activin (Findlay, 1993, Findlay et al., 2002, Knight and Glister, 2001). 
Activin is produced by both oocyte and granulosa cells and is composed of a dimer of 
two beta subunits, A or B with activin A being the most prevalent isoform. During 
folliculogenesis, activin stimulates FSH production from the anterior pituitary 
(Katayama et al., 1990). Its intraovarian properties comprise increased aromatase 
activity, development of antral cavity and increased granulosa cell proliferation 
(Findlay, 1993, Mizunuma et al., 1999). Activin activity to promote preantral follicle 
growth in vitro has been shown in ovine, caprine and human (McLaughlin et al., 
2010a, Silva et al., 2006, Telfer et al., 2008, Thomas et al., 2003a). The regulation of 
KL, GDF9, and BMP15 is involved in a paracrine negative feedback mechanism. KL 
activation mediated by BMP15 and GDF9 leads to granulosa cell proliferation. Partly 
grown oocytes secrete BMP15 leading to KL activation in granulosa cells, while fully 
grown oocytes mainly produce GDF9 resulting in subsequent inhibition of KL 
expression in surrounding granulosa cells. In response to the accumulating effects of 




estrogen and androgen receptors that will be more pronounced with the growth of the 
follicles (Hutt et al., 2006, Joyce et al., 1999, Joyce et al., 2000). 
 
Secondary follicles increase in size and form multiple layers of granulosa cells to reach 
approximately 100-200 Pm in diameter. At this point onwards, oocytes enlarge, and 
theca cells differentiate into external and internal theca. The formation of theca cells 
is accompanied by angiogenesis leading to the neoformation of numerous small blood 
vessels. On completion of preantral phase, the follicle contains five distinct and 
interacting structures. These are a fully-grown oocyte encircled by a zona pellucida, 
multilayer (approximately 9) granulosa cells, a basal lamina, theca cells and a capillary 
net in the theca tissue. LH receptor (LHR) is expressed in internal theca cells (Williams 
and Erickson, 2000). 
 
 
1.3.3. Antral Follicle Growth and Ovulation 
The final stage of folliculogenesis i.e. ovulation occurs at puberty. Once follicles 
develop antral cavities and become dependent upon FSH, they are subject to follicle 
selection and maturation of dominant follicles, with only one follicle being ovulated 
in mono-ovular species such as human and cows. Once an antral cavity is formed, the 
granulosa cells differentiate into two distinct cell types that respond differently to 
hormonal cues: the cumulus and mural cells (McGee and Hsueh, 2000). Cumulus cells 
and oocytes form a complex known as the cumulus oocyte complex (COC). From this 
stage onward, FSHR and LHR are expressed abundantly and folliculogenesis depends 
on pituitary-secreted gonadotrophin (FSH and LH) support.  
 
The presence of FSH activity induces LHR mRNA expression. The interaction of LH 




which subsequently aromatises in the granulosa cells to produce estrogen (Fujita et al., 
1981, Sanchez and Smitz, 2012, Tajima et al., 2007). Both theca and granulosa cells 
in antral stage follicles proliferate with concurrent accumulation of follicular fluid in 
the antrum. The largest follicle contains a higher number of FSH receptors and 
therefore is more receptive to lower FSH levels, thus is selected as the dominant 
follicle. This process is concomitant with increased oocyte size. Other factors involved 
in antral follicle growth are activin and inhibin, both of which are secreted by 
granulosa cells. These are necessary to regulate the androgen producing activity of 
theca cells. Both activin and inhibin function to regulate granulosa cells proliferation, 
differentiation and oocyte maturation (reviewed by (Sanchez and Smitz 2012)).  
 
Oocyte-secreted factors, BMP15 and GDF9, are compulsory in regulating cumulus 
cell expansion. As evidenced in rat and human, these oocyte factors, either in 
combination or on their own enhance granulosa cell proliferation and differentiation 
(Hobeika et al., 2019, Shimasaki et al., 2004, Vitt et al., 2000). Lastly, on completion 
of the whole process, follicles containing fully-grown oocytes are ready to undergo 
ovulation, induced by the LH surge. At this point, oocytes undergo final nuclear and 
cytoplasmic maturation that results in dissolution of the nuclear envelope germinal 
vesicle breakdown (GVBD). Oocyte maturation progresses to metaphase 2 (M2) with 
emission of the first polar body and then arrests until fertilisation (McGee and Hsueh, 
2000). Suboptimal cytoplasmic and nuclear maturation may result in lower oocyte 
developmental capacity (Yerushalmi et al., 2014). Only oocytes that have 
accomplished both cytoplasmic and nuclear maturation are able to be fertilised (Eppig 
et al., 1994, Fan and Sun, 2019). A sequence of processes in oocytes occur in 




then released and subsequent tissue remodelling results in formation of the corpus 
luteum.  
1.4. Oocyte and Somatic Cell Bidirectional Communication  
Bidirectional intercellular connection between the oocyte and somatic cells is 
fundamental at every stage of folliculogenesis and is essential for the healthy 
maturation of the oocyte until the time of ovulation (Albertini et al., 2001, Eppig, 
1991). Gap junctions or intercellular channels regulate a distinctive form of 
communication between cells through a direct exchange of molecules. These 
intercellular channels are present in most cell types at some point during their 
development in mammals (Bruzzone et al., 1996). In every stage of folliculogenesis, 
gap junctions couple the granulosa cells with each other and with oocytes, thus, 
establishing a functional syncytium allowing the diffusion of ions, second messengers, 
and metabolite molecules, between adjacent cells (Ackert et al., 2001, Eppig, 1991, 
Kidder and Vanderhyden, 2010).  
 
Several types of connexins have been recognised and act in different tissue. Ovarian 
granulosa cells primarily express Cx43 while the oocyte predominantly expresses 
connexin37 (Cx37) (reviewed by (Granot and Dekel, 1998)). Cx37 and 43 have been 
known to be critical at each stage of folliculogenesis to maintain follicular 
development. Cx37 is localised in the oocyte interfaces both in developing (primary 
and preantral) and in Graafian follicle but not in primordial follicle while Cx43 is 
localised in gap junctions between granulosa cells but not on the surface of the oocyte 
and does not contribute significantly to oocyte-granulosa cell junctions. The 




in mice, abolishing the gap junctions between the oocyte and granulosa cells. The 
oocytes stop growing and ultimately degenerate, probably due to diminishing oocyte 
and granulosa cell connections that then causes premature luteinisation of granulosa 
cells (Simon et al., 1997). In contrast to Cx37, Cx43 is mainly expressed in the early 
stages of folliculogenesis in mouse ovaries (Juneja et al., 1999).  
 
In bovine ovaries, Cx37 is present in granulosa cells of primordial to the preantral 
stage and not restricted to the interface between the oocyte and granulosa cells. 
Oocytes exhibit diffuse cytoplasmic Cx37 labelling; hence, Cx37 contributes to the 
formation of channels between granulosa cells in bovine preantral follicles. Its 
expression is less detectable in antral stage follicle, whereas Cx43 is present in 
granulosa cells of follicular development at all stages. Cx43 begins to be expressed in 
the early stages of follicular development; its expression remains at a low level 
thereafter but then increases at the onset of antral follicle formation. Its expression 
increases gradually with an increase in follicular size to reach the highest level in antral 
follicles. Cx43 expression is not observed between the oocyte and granulosa cells or 
between atretic granulosa cells at any follicular stage (Nuttinck et al., 2000). It has 
been reported that connexin activity is determined by FSH level. It increases 
significantly with FSH but then declines subsequently at the peak LH level that triggers 
meiosis and ovulation. At the onset of meiosis, the high level of LH induces the closure 
of gap junctions through the activation of mitogen-activated protein kinase (MAPK)-
dependent gap junction that is a prerequisite for the oocyte to resume meiosis (Norris 
et al., 2008). LH surge consequently closed all Cx43 junctions, while the Cx37 






1.5. DNA Damage and DNA Damage Repair Pathway 
The DNA of a cell is continuously threatened by various types of damage that may 
cause a depreciation in cellular function, cell cycle progression and DNA repair 
(reviewed by (Branzei and Foiani, 2008)). Damage to DNA may cause errors in 
replication or transcription (Altieri et al., 2008). Exogenous sources of DNA damage 
include environmental agents such as ultraviolet, radiation, chemotherapeutic drugs, 
and thermal disruption. Endogenous sources of damage that are not preventable 
include spontaneous reactions such as ROS generated by respiration and lipid 
peroxidation, and DNA base lesions like hydrolysis and alkylation (Lindahl and 
Barnes, 2000). DSBs do not occur as frequently as the other lesions, but persistent 
unrepaired DNA DSBs are the most severe type of damage and may substantially lead 
to genomic instability (Jackson and Bartek, 2009, Khanna and Jackson, 2001, Menezo 
et al., 2010, Titus et al., 2013).  
 
Generally, DNA damage constitutes a major issue in non-dividing or slowly dividing 
cells due to DNA damage accumulating over time. Any damage that does not provoke 
cell cycle arrest will tend to induce replication errors leading to mutations. 
Nonetheless, all cells have the potential to repair the damage, which occurs 
predominantly at the G1/S and G2/M-phase transition (Oktay et al., 2015). Cells with 
DNA damage react in different ways to trigger a proper signalling pathway of DDR. 
A mild injury may not cause significant consequences as it can be restored directly 
without cell cycle arrest. Meanwhile, severe DNA damage may result in cell cycle 
arrest to allow sufficient time to repair the damage. During this time, a sequence of 
DNA damage repair proteins is activated. Once the repair mechanism is completed, 




The target of DNA damage repair responses can either stimulate the apoptotic 
pathways that eventually lead to cell demise, or endure the DNA lesions by 
commencing the repair process (Menezo et al., 2010). In this respect, the cell’s fate 
depends on the ability of the cells to repair the damage, as sufficient repair capacity 
permits cells to resist apoptosis (Kujjo et al., 2010).  
 
There are two major pathways to repair DNA DSBs: the non-homologous end joining 
(NHEJ) and homologous recombination (HR). HR is considered as error-free and 
limited to S and G2 phase of the cell cycle when sister chromatids are available as a 
template for the DNA repair process. On the other hand, NHEJ is error-prone since it 
arbitrates the direct re-ligation of the two ends of damaged DNA and is not based on 
a DNA sequence. NHEJ does not implicate a complementary DNA template. 
Mutations are more likely, including deletion or insertion of base pairs. NHEJ can 
occur during all stages of the cell cycle, but it primarily occurs in the G0/G1 phase 
(Heijink et al., 2013) and can be independent of the cell cycle (Bekker-Jensen and 
Mailand, 2010). NHEJ is the most common type of DNA damage repair in mitotic 
cells. HR is essential in DNA DSBs repair in all cell types (Hong et al., 2013), but it 
predominantly exists in meiotic cells (Sung and Klein, 2006).  
 
In NHEJ, the initial step is the detection and binding of the Ku heterodimer to the DNA 
DSBs. Ku is a heterodimer comprised of two subunits, Ku70 and Ku80 (Ku86). The 
capability of protein Ku to recognise and localise the DNA DSBs is likely due to its 
extraordinary binding affinity to DNA ends, its capacity to interact with DSBs in a 
sequence-independent manner, and its high concentration (~500,000 Ku 
molecules/cell). The Ku protein bound to the DSBs end, recruits DNA-dependent 




(XRCC4), DNA Ligase IV, XRCC4-like factor (XLF), and Aprataxin-and-PNK-like 
factor (APLF) to DNA DSBs sites. Protein and DNA-PKcs interaction results in 
translocation of the Ku heterodimer on the dsDNA strand and eventually initiates the 
activity of DNA-PKcs kinase. Ku protein and DNA-PKcs recruit the processing 
enzymes to the DSBs, and XRCC4/ Ligase IV complex is finally recruited to mediate 
ligation of the DSB. This interaction then allows the end processing that might require 
nucleus enzyme, Artemis. End processing results in overhang strands and DNA 
polymerase P and O then interact with protein Ku. Once the DNA polymerisation 
process is completed, DNA ligase enzymes are engaged and seal the nicks to complete 
the entire process (Chang et al., 2017) (Figure 1.6).  
 
Figure 1.6. DNA DSBs NHEJ repair pathway. Unlike HR, NHEJ does not require a template strand 




bind to the free ends of the DNA. This interaction then recruits DNA-PKcs, XRCC4, DNA Ligase IV, 
XLF, and APLF to interact with Ku protein and form a complex. At this stage nucleus enzyme Artemis 
binds to the DNA-PKcs and protein Ku complex. This interaction then leads to the end processing 
resulting in overhang strands following when DNA polymerase is recruited, and the whole process is 
completed and finalised by DNA ligase. 
 
Initiation of HR necessitates the detection of the DSBs by the meiotic recombination 
11 (MRE11)-Rad50, Nijmegen breakage syndrome 1 (NBS1) (MRN) complex (Rein 
and Stracker, 2014). The MRN complex is an early DSBs sensor bound to the two free 
ends of DNA DSBs, and it maintains DNA ends in adjacency to enable the repair 
which, in turn, induces the activation of DNA repair mechanism downstream pathway. 
The binding of MRN complex to DNA DSB free ends then permits the NBS1 protein 
to interact with ATM dimers leading to autophosphorylation of ATM at a serine 
residue. ATM, in turn, phosphorylates H2AX at the c-terminal serine 139 (JH2AX). 
JH2AX binds specifically to DNA damage site and initiates the downstream pathway 
resulting in DNA repair or cell cycle arrest (reviewed by (Oktay et al., 2015)). JH2AX 
is considerably phosphorylated from minutes to hours following DNA breaks and the 
intensity increases in line with the severity of the damage (Nazarov et al., 2003, 
Rogakou et al., 1998, Tomilin et al., 2001). Mediator DNA damage checkpoint protein 
(MDC1) is another protein involved in this pathway and is activated and bound to 
JH2AX mediated by breast cancer susceptibility gene 1 (BRCA1). MDC1 forms foci 
that co-localise with JH2AX and provides positive feedback to further recruits MRN 
complexes leading to propagation of JH2AX at the sites of DNA breaks (Jungmichel 
and Stucki, 2010).  
 




phosphatidylinositol 3-kinase-like kinases (PIKKs) family. In single strand breaks 
(SSBs) repair mechanism, activation of ATM and ATR is generated by replication 
protein A (RPA) coated SSB. ATM is recruited by MRN complex (Falck et al., 2005, 
Lee and Paull, 2005), whereas ATR is recruited by ATR-interacting protein (ATRIP) 
to RPA coated SSB (Cortez et al., 2001, Falck et al., 2005). Phosphorylation of ATM 
activates DNA repair proteins downstream pathway leading to either HR/NHEJ or 
phosphorylates checkpoint kinase 2 (Chk2) resulting in cell cycle arrest. On the other 
hand, checkpoint kinase 1 (Chk1) is a downstream target of ATR. Although it is 
commonly accepted that ATM and ATR activity are not interconnected, it has been 
shown that activation of ATM may depend on ATR in DDR, but it is restricted to S 
and G2 phase of the cell cycle (Jazayeri et al., 2006). 
 
In somatic cells, activation of Chk1 and Chk2 leads to p53 phosphorylation at Serine 
20, which is also a downstream target of either ATM or ATR. p53 is essential to 
maintain checkpoint at G1/S of the cell cycle (Basu and Haldar, 1998, Heijink et al., 
2013). Initiation of Chk1 and Chk2 simultaneously inhibit cell division cycle (Cdc) 25 
phosphatase that, in turn, activates cyclin-dependent kinase (Cdk) and restrain the cell 
cycle progression from G1 to S phase. p21 transcription is a downstream target of p53 
that inhibits Cdk2 and cyclin-dependent kinase 4 (Cdk4) transcription and ultimately 
leads to cell cycle arrest (reviewed by (Collins and Jones, 2016)) and allows DNA 
repair. Nevertheless, this repair mechanism does not function appropriately in severe 
DNA damage that may cause the accumulation of DNA DSBs. Pro-apoptotic gene 
Bcl- associated X protein (Bax) and p53 upregulated modulator of apoptosis (PUMA) 
are then activated and ultimately leading to apoptosis (Kerr et al., 2012b). 
 




(reviewed by (Oktay et al., 2015)). DNA repair process in meiosis requires an intact 
DNA strand as a template and the strand from homologous chromosome is preferred 
compared to DNA from sister chromatid to obtain the organised homologous 
chromosome segregation. Strand exchange at meiotic recombination is completed by 
the activation of Rad51 and DMC1. Rad51 is essential in mitotic and meiotic 
recombination, whilst DMC1 is specifically involved in meiotic recombination as it 
acts particularly in interhomolog rather than sister chromatid exchange (Hong et al., 
2013) (Figure 1.7). 
 
Figure 1.7. The intersection between DDR pathway and apoptosis. Detection and recognition of 
DNA breaks by MRN complex triggers a cascade of reactions involved in DNA damage repair 
downstream signalling pathways. The MRN complex activation, in turn, phosphorylates ATM in DNA 
DSBs response mechanism and ATR in SSB repair pathway. The ATR is recruited by ATRIP to RPA 
coated SSB. ATM, in turn, phosphorylates H2AX at serine 139 (JH2AX). Phosphorylation of ATM and 
ATR may either result in Chk2 and Chk1 phosphorylation or activation of p53 family member 
depending on the cell type. p53 induces cell-cycle arrest by activating the transcription of p21, which 




JH2AX via BRCA1 and forms foci that co-localise with JH2AX foci. In oocytes, the DNA strand 
resection is activated and leads to HR. The single-stranded DNA (ssDNA) is then coated by the ssDNA 
binding protein complex RPA. In germ cells, RPA is replaced by Rad51 and DMC1. Activation of Chk1 
and Chk2 inhibits Cdc25 and ultimately induces Cdk1 and Cdk2 activations leading to cell cycle arrest. 
p53 activates PUMA and NOXA as the consequences of severe DNA damage with a limited repair. 
Apoptosis is more likely as a result of the balance between pro-apoptosis (Bcl2) and anti-apoptosis 
(Bax) activity. 
 
1.5.1.  DNA Damage and DNA Repair Response of Oocytes and 
Granulosa Cells 
During reproductive life, oocytes and granulosa cells can be subjected to DNA damage 
as the consequence of external and internal insults of the cells to a considerable number 
of genotoxic agents (Titus et al., 2013). The ability of cells to respond to such damage 
is critical considering that severe damage during meiosis can end up with significant 
consequences when the cells cannot respond to such damage accordingly (Bzymek et 
al., 2010, Torgovnick and Schumacher, 2015). All types of follicles have different 
reactions to genotoxic agents, given the probability of changes in sensitivity 
concomitant with development and follicle growth (Hanoux et al., 2007, Winship et 
al., 2018).  
 
Oocytes within primordial follicles, non-dividing and remained arrested at the 
diplotene stage of meiosis prophase 1 for an extraordinary length of time, are more 
prone to DNA induced damage compared to other follicle types. Meanwhile, granulosa 
cells, as actively dividing cells, are more sensitive to DNA DSBs. Granulosa cells 
maintain genomic integrity by activating DNA damage DSBs repair signalling 




to germ cells, somatic cells are more proficient of actuating the DNA damage repair 
pathway dynamically. Apoptosis of the somatic cells ensues if a G1/S arrest is 
persistent, and the damage is irreparable (Roos and Kaina, 2006). The fate of oocytes 
with DNA DSBs depends on the severity of the damage. Oocytes with slight DNA 
DSBs can resume meiosis and progress to M2. As DNA DSBs are also a part of meiotic 
recombination process in oocytes during fetal life, it is important to ensure that this 
process runs properly as permanent DNA damage with limited repair may lead to DNA 
damage accumulation. A meiotic error is more likely leading to infertility. Given that 
oocytes are arrested at germinal vesicle (GV) stage for a long period of time, it is 
important to ensure that the DNA repair machinery in both oocytes and granulosa cells 
of immature follicles functions properly starting from sensing, recognising the 
damage, and regulating the DNA repair downstream pathway. 
 
1.5.2.  DNA Damage and Apoptosis Intersection in Non-growing and 
Early Growing Follicles, a Unique Regulation of p53 Family Members in 
the Oocyte Surveillance Mechanism 
Although the mechanism underpinning oocytes vulnerability toward DNA damage has 
not been fully understood, high susceptibility to apoptosis signals is thought to be one 
of the causes (Hanoux et al., 2007). The apoptosis process of oocytes within primordial 
follicle is mediated by a very distinct cell surveillance mechanism involving trans-
activating p63D (TAp63D) pathway (Amelio et al., 2012, Kerr et al., 2012b, Livera et 
al., 2008, Suh et al., 2006), a family member of p53 (Levine et al., 2011). TAp63D 
functions to respond to DNA damage primarily after prophase 1 of meiosis and is 
constitutively active only in female germ cells once DNA breaks occur (Livera et al., 




regulator in follicle loss during chemotherapy which may result in a reduced 
primordial follicular pool. Oocytes in the quiescent state show a high TAp63D 
expression that reduces gradually during follicular development. Mouse oocytes 
exposed to radiation resulted in primordial follicle loss that coincided with diminished 
TAp63D in the oocytes. Interestingly, the larger follicles survived the same radiation 
dose, revealing the indispensable role of TAp63D in the DNA damage response of the 
oocytes ((Suh et al., 2006).   
 
TAp63D is maintained in dimeric form by transcriptional inhibitory domain (TID) and 
further stabilised by the interaction of N-terminal transactivation (TAD) with TID and 
the oligomerisation domain. Inactivation of TID alters the dimeric to tetrameric state 
(Deutsch et al., 2011b, Deutsch et al., 2011a, Straub et al., 2010). In the dimeric state, 
the transactivation of TAp63α is suppressed by decreasing its DNA binding affinity 
and repressing the activity of the domain responsible for the transcriptional process 
(Deutsch et al., 2011a). Exposure to genotoxic agents such as radiation has been 
displayed to increase TAp63D in its tetrameric state (Deutsch et al., 2011b, Deutsch et 
al., 2011a, Straub et al., 2010) that, in turn, reduces TAp63D levels in oocytes and may 
finally cause apoptosis (Straub et al., 2010) and elimination of damaged oocytes. The 
presence of TAp63D in oocytes of immature follicles stresses the need for effective 
surveillance mechanism to ensure only oocytes with complete DNA damage repair are 
recruited to ovulation (Gebel et al., 2017, Livera et al., 2008, Suh et al., 2006) (Figure 
1.8). 
 
Phosphorylation of ATM is the first step in the initiation of G2 checkpoint activation 




in mouse oocytes exposed to irradiation failed to activate TAp63D that consequently 
blocked the apoptosis pathway and prevented oocyte death (Kim and Suh, 2014). 
Phosphorylation of Chk2 by ATM, in turn, leads to TAp63D phosphorylation on serine 
582 (Coutandin et al., 2016). Meanwhile, p53, a tumour suppressor gene, is known to 
be essential in somatic cell apoptosis. In the physiologic state, the p53 level is low. 
Activation of the apoptotic pathway due to unrepaired DNA damage increases p53 
expression, which consequently triggers cell cycle arrest or cell death (Deutsch et al., 
2011a) (Figure 1.8). Unlike in somatic cells, p53 is dispensable in oocytes against 
DNA damage (Coutandin et al., 2016). 
 
Figure 1.8. Oocytes within primordial follicles surveillance mechanism involving an interplay of 
dimeric to the tetrameric formation of TAp63D. The DNA DSBs recognition by MRN complex 
triggers ATM phosphorylation leading to Chk2 activation. TAp63D is a downstream target of 
phosphorylated ATM and Chk2. Phosphorylation of TAp63D ultimately transform inactive dimeric 




targets of TAp63D will be activated resulting in apoptosis by repressing the initiation of Bcl2 and 
inducing the activity of Bax. 
 
1.5.3. DDR in Fully Grown Oocytes of Growing Follicles  
The capacity of oocytes in fully grown follicles to activate G2 checkpoint during DDR 
is not as efficient as somatic cells and immature oocytes within non-growing follicles 
(Carroll and Marangos, 2013). The transcriptional silence of oocytes within ovulatory 
follicles is likely to underlie their inability to respond to DNA induced damage (Martin 
et al., 2018). GV oocytes with some DNA damage are able to progress to GVBD, enter 
Metaphase 1 (M1) and are capable of being fertilised (Carroll and Marangos, 2013). 
However, this may increase the risk of DNA damage in the embryo. The presence of 
severe DNA damage in GV oocytes will lead to an oocyte-specific checkpoint or 
spindle assembly checkpoint (SAC) activation which, in turn, prevents GV oocytes 
from exiting M-phase of the cell cycle leading to GV arrest at M-phase (Collins et al., 
2015, Marangos et al., 2015). In this respect, SAC may function to prevent the 
production of abnormal oocytes and embryos by inhibiting anaphase-promoting 
complex (APC) before chromosome separation (Marangos et al., 2007).  
 
However, severe DNA breaks due to exposure to high etoposide concentrations causes 
GVBD rate to decline. In addition, oocytes with high JH2AX expression following 
prolonged culture in a high concentration of etoposide are able to enter M phase 
suggesting that inadequate DNA damage checkpoints are more likely in severe DNA 
damage and the checkpoint adaptation does exist in the oocyte DNA damage response 





DNA damage in oocytes involves ATM and Chk1 activation dependent on the severity 
of the damage. However, the fact that oocytes can enter M phase in the presence of 
JH2AX hints to the lack of a checkpoint mechanism in the oocytes of fully grown 
follicles due to lower ATM sensitivity to DNA damage response (Carroll and 
Marangos, 2013). Though the exact cause of increasing the checkpoint activation 
threshold is not clear, the lack of ATM phosphorylation appears to be the cause of less 
responsive DNA damage checkpoints in fully grown oocytes (Mayer et al., 2016). 
Conversely, Rad51 functions efficiently in oocytes of fully-grown follicles. Mature 
oocytes exposed to doxorubicin in vitro exhibited a high Rad51 expression that is 
associated with a higher rate of oocyte survival (Kujjo et al., 2010).  
 
It is, however, worth noting that each species reacts differently to DNA damage. It has 
been reported that the DNA damage response in rodent oocytes was superior to the 
response in primates (Wang et al., 2017b). In addition, co-localisation of Rad51 and 
JH2AX was predominantly observed in mouse compared to monkey oocytes (Wang 
et al., 2017b) suggesting efficient DNA damage repair in mouse oocytes. However, 
bovine oocytes were less vulnerable to irradiation-induced DNA damage compared to 
mouse oocytes, demonstrated by more mouse oocytes undergoing necrosis, while no 
significant morphological changes were observed in bovine oocytes over the same 
time frame (Kujjo et al., 2012). However, it is pertinent to note that although bovine 
oocytes exposed to doxorubicin were able to be fertilised, further development of 
embryos was compromised suggesting that intact DNA damage repair is needed to 
ensure complete development of the oocytes to the embryo and to produce healthy 




1.6. DNA damage Associated with Ovarian Ageing, a Crosstalk 
between PI3K/Akt/PTEN Signalling Pathway, Ageing, and DNA Damage 
Response 
Ovarian ageing as a physiological process varies substantially among women 
depending on the number of primordial follicles and the degree of follicle loss (de 
Bruin et al., 2004, Faddy et al., 1992). It is also intensely associated with reduced 
oocyte quality (Li et al., 2012). However, the relationship between ovarian ageing and 
deviations in the follicular microenvironment are still far from being fully understood 
(Broekmans et al., 2009, Tatone et al., 2008). 
 
There is increasing evidence of a strong association between DNA damage and repair 
capacity of oocytes and increasing maternal age, with DNA repair becoming less 
efficient with ageing (Govindaraj et al., 2015, Govindaraj et al., 2017, Oktay et al., 
2015, Titus et al., 2013). A study in non-human primates confirmed a lack of DNA 
repair efficiency with advancing age. In the non-human primate, JH2AX expression is 
considerably elevated in granulosa cells and oocytes of early growing follicles with 
the advancing age. This may be related to less efficient DNA repair function, as is 
shown by lower BRCA1 expression in both oocytes and granulosa cells (Zhang et al., 
2015). In line with these findings, mouse oocytes of all follicle types exhibit high 
expression of γH2AX with increasing age. At the same time point, the oocyte appears 
to have an ineffective DNA repair mechanism as is shown by a profound drop in 
BRCA1, MRE11, ATM but not breast cancer susceptibility gene 2 (BRCA2). In a 
genetic BRCA1 mutation mouse model, the oocytes are overwhelmed by DNA 
damage that might be due to compromised DSBs repair regulatory or the damage 




BRCA2 perturb ovarian stimulation leading to yielded smaller litter size (Titus et al., 
2013). Similarly, women with BRCA2 mutations do not show a reduced response to 
ovarian stimulation (Oktay et al., 2010). However, it is worth considering that BRCA2 
deficient mice are able to produce competent and fertilised oocytes but more abnormal 
embryos are observed (Sharan et al., 2004) representing the decisive role of BRCA2 
in female mouse meiosis.  
 
The depreciation in reproductive performance is a major challenge in women with 
increasing age due to chromosomal abnormalities in oocytes. The decline in 
reproductive performance is also closely related to diminished ovarian reserve that 
seems to accelerate with age (Titus et al., 2013). Likewise, a diminished ovarian 
reserve mirrored by low AMH levels in women with BRCA1 mutation but not BRCA2 
(Phillips et al., 2016), validates the findings from transgenic mouse model. Increased 
JH2AX expression in oocytes after the age of 36 is not associated with increased DNA 
repair proteins MRE11, BRCA1, Rad51, and ATM but BRCA2 expressions (Titus et 
al., 2013). In addition, primordial follicles with BRCA1 mutations are more 
susceptible to DNA damage accumulation shown by high JH2AX expression in 
primordial follicles, which rises in BRCA mutation groups (Lin et al., 2017). 
 
As described above, mature oocytes have propensity to tolerate the damage. However, 
as an intact DNA repair process is obligatory to produce healthy offspring, the oocytes 
that survive despite the accumulation of DNA damage may be functionally impaired 
(Titus et al., 2013). Although some evidence leads to normal BRCA2 expression with 
age, complete loss of BRCA2 function results in ovarian dysgenesis leading to primary 




damage (Weinberg-Shukron et al., 2018). Genome-wide association study (GWAS) 
investigation also displays the association between DNA damage repair and age at 
menopause (Day et al., 2015), specifically emphasising links with BRCA1. 
 
In contrast, granulosa cells of growing follicles are unlikely to be affected by age, 
proposing the lack of an age-linked escalation of DSBs in the non–germ cell 
component of the ovarian follicles (Titus et al., 2013). It seems likely that granulosa 
cells capacity to respond to DNA damage is sufficient to prevent apoptosis (Titus et 
al., 2013). Follicles with both JH2AX and ATM expression in granulosa cells 
following exposure to doxorubicin do not show apoptosis (Soleimani et al., 2011). 
These findings are consistent with a previous study in rodents (Govindaraj et al., 
2015). However, a study using monkey ovaries showed that DNA damage in granulosa 
cells (and cumulus cells) increased significantly with advancing age in all follicle types 
including antral follicles (Zhang et al., 2015). These highly variable results can be 
caused by the nature of dynamic behaviour of granulosa cells as is generally observed 
in highly proliferative cells with high metabolic activity, particularly in developing 
follicles that seemingly generate an oxygen radical–rich milieu (Titus et al., 2013). 
These cells are more prone to DNA insults, but with the ability to exhibit dynamic 
DNA repair functions (Roos and Kaina, 2006). 
 
ROS accumulation in mitochondria can be an underlying factor of ageing, by 
increasing oxidative damage leading to a gradual decrease in ovarian quality (Shi et 
al., 2016). ROS overexpression in a cell may increase lipid peroxidation, oxidative 
stress and damage to macromolecules, including DNA leading to either SSBs or DSBs 




affected by ROS. Ageing has been linked to mitochondria dysfunction as mitochondria 
DNA deletions increase with age (Keefe et al., 1995, Kitagawa et al., 1993). PTEN 
upregulation, through modulation of the PI3K/Akt pathway, decreases ROS 
production in cells (reviewed by (Kitagishi and Matsuda, 2013, Nogueira and Hay, 
2013). Increased ROS production in mitochondria due to ageing can thus inhibit PTEN 
and increase Akt activation and further increase ROS production (Figure 1.9).  
 
Figure 1.9. Molecular relationship between PTEN/Akt activation, DNA damage and decreased 
ovarian reserve in ovarian ageing due to exogenous or endogenous DNA insults. The green dashed 
line represents ovarian ageing due to excessive activation of primordial follicles that can be an indirect 
effect of DNA induced damage agents. The red dashed line represents the direct effects of DNA induced 




DNA repair pathways. In addition, mitochondria are also one of the major sources of DNA damage. 
Excessive ROS production may harm macromolecules in the cells, including DNA, leading to SSBs or 
DSBs. High ROS expression in the mitochondria may lead to PTEN inhibition and increased Akt 
activation that may eventually further increase ROS production (Maidarti et al., 2020).  
1.7. The Development of an IVG System 
The growth of follicles in vitro is influenced by various factors such as the type of 
tissue, the method of culture, the composition of the medium, temperature, oxygen or 
CO2 concentration and supplements to the medium (Sadeu JC, 2008, Schubert B, 
2010). The complete development of oocytes from primordial germ cells in vitro has 
been demonstrated from mice and these have been able to promote normal follicle 
formation and subsequent yield of fertile offspring (Morohaku et al., 2016). 
Additionally, after a long process and trials, the entire process of oogenesis from 
mouse pluripotent stem cells has been successfully reconstituted in vitro yielding 
normal progeny (Hikabe et al., 2016). These cutting-edge studies have shed light on 
the development of IVG systems following the ground-breaking studies by the Eppig 
group (Eppig and Schroeder, 1989, Eppig and O'Brien, 1996, O'Brien et al., 2003). 
Since then, IVG systems starting from the early stages of follicle development have 
been persistently pushed further and have led to systems being developed to support 
oocyte development of large mammals and humans. 
 
Progress has been made to support the growth of ovarian follicles in vitro starting from 
the early stages of follicular development in a range of species (Brito et al., 2014, 
Hovatta et al., 1997, Hovatta et al., 1999, Picton and Gosden, 2000, Telfer and 
McLaughlin, 2012, Xiao et al., 2015). Work in our lab has shown that the multistep in 




growth and survival in human and domestic animal models (McCaffery et al., 2000, 
McLaughlin et al., 2018, Telfer et al., 2008, Thomas et al., 2007, Walters et al., 2006) 
(Figure 1.10).  
Figure 1.10. Proposed multistep IVG system to support complete oocyte development. Four steps 
IVG system consists of primordial follicle activation. Once a follicle is initiated and reaches 
multilaminar stages, isolated follicles are cultured individually in V-shaped microwell culture plates to 
support the development of follicles from preantral to antral stage. The fourth step of the IVG system 
is in vitro maturation (IVM) of the oocytes (Adapted from (Telfer et al., 2008, Telfer and McLaughlin, 
2012)).  
 
After initiation of follicle growth, the growing follicles consisting of multilaminar 
granulosa cells will not survive within the cortical environment thus preantral follicle 
isolation following primordial follicle activation is a prerequisite for the further growth 
of the growing follicles (McLaughlin and Telfer, 2010, Telfer et al., 2008). Two main 
techniques that are most frequently used to isolate preantral follicles are enzymatic and 
microdissection techniques. Microdissection allows the isolation of morphologically 
normal follicles with an intact basement membrane, thus allowing better interaction 
between oocytes and granulosa cells. However, this method is laborious and time-





Well preserved gap junctions are needed to maintain the interaction between cells and 
ensure the direct transport of important factors for follicular growth and oocyte 
maturation (Diaz et al., 2007, Eppig and Schroeder, 1989, Murray and Spears, 2000) 
during the culture period. Damage to gap junctions will interfere with the oocyte and 
somatic cells communication resulting in follicle atresia, as this communication is 
obligatory to overcome the lack of particular factors required for oocyte metabolism, 
including amino acids that are required for glycolysis and biosynthesis of cholesterol 
(Eppig et al., 2005, Su et al., 2009).  
 
The main issue currently is how to develop an appropriate IVG system that can 
preserve the three-dimensional (3D) structure of isolated ovarian follicles, maintain 
cell to cell communication, and enable their full growth and development. The 
importance of the spatial arrangement between cells has triggered several studies 
related to 3D hydrogel-based culture systems to support physiologic environment 
(Bissell et al., 2003, Weaver et al., 1996). A line of evidence suggests that a 3D system 
is capable of establishing oocyte and somatic cells communication, thus allowing 
direct transport of nutrients, hormones and oxygen (Bissell et al., 2003, Weaver et al., 
1996). 
 
It is worth considering that gene expression profiles of cells in 3D culture system are 
better at mimicking in vivo conditions (Hwa et al., 2007). Furthermore, the 3D 
structure has an essential role in determining the organisation of communication 
between cells and controlling cell differentiation (Griffith and Swartz, 2006). The use 
of V-shaped microwell culture plates in our lab has been shown to maintain the three-
dimensional structure of the follicles and promote interaction between oocyte and 




preantral follicles isolated mechanically and cultured for 6 to 8 days in V-shaped 
microwells are able to maintain inter-granulosa cells communication indicated by the 
presence of Cx43 between granulosa cells. In addition, activin is associated with a 
peripheral distribution pattern of Cx43 protein that may be indicative of a similar 
spatial pattern of growth with extensive intercellular communication. It is most likely 
that activin fosters some degree of granulosa cell adhesion to the zona pellucida 
(McLaughlin et al., 2010a). 
 
In addition to 3D culture systems, in vitro follicle co-culture with adipose-derived stem 
cells (ADSCs) for 14 days is a promising opportunity in developing the IVG system. 
This system is able to maintain cell to cell communication throughout the culture 
period and produces competent oocytes, improves steroidogenesis and increases the 
expression of transzonal projections (TZPs) (Green et al., 2019). Similarly, human 
preantral follicles enzymatically isolated and cultured in 3D matrices are able to 
preserve TZP networks surrounding oocytes and granulosa cells and produce GV stage 
oocytes (Xu et al., 2009). However, a complete IVG system starting from primordial 
follicle activation has been only achieved in human using a multistep IVG system. 
Preantral follicles isolated mechanically from cultured unilaminar ovarian cortical 
strips are capable of achieving M2 stage oocytes. Nevertheless, oocyte morphology is 
compromised with a larger polar body than in vivo grown oocytes and with less 
cumulus expansion (McLaughlin et al., 2018). These findings indicate the need to 
optimise the culture system at every stage of follicular development.  
 
1.8. Potential Consequences of Pharmacological Activation of 
Primordial Follicles  




accumulated effects of PI3K/Akt/PTEN modulation can determine the rate of 
primordial follicle activation. PTEN is an essential key factor in promoting normal cell 
proliferation both in somatic and germ cells (Jagarlamudi et al., 2009, Reddy et al., 
2008). As described above, investigation using knockout mice, where particular genes 
involved in this process have been eliminated or disrupted, shows a critical role of 
PTEN/PI3K/Akt to regulate primordial follicle initiation and growth (Adhikari et al., 
2009, Adhikari and Liu, 2009, Adhikari et al., 2010, Reddy et al., 2008, Reddy et al., 
2009). 
 
A lower dose of PTEN inhibitor has successfully triggered the growth of primordial 
follicles in mice and resulted in mature and fertilisable IVG oocytes (Adhikari et al., 
2012). Healthy mouse progeny has been achieved following ovarian tissue 
transplantation under kidney capsules and in vitro fertilization (IVF) procedure (Li et 
al., 2010a). These findings have been implemented translationally to human as a 
prospective approach in women with POI to optimise in vitro oocytes yield. 
Pregnancies have been attained after grafting ovarian cortical fragments exposed to 
PTEN inhibition into POI patients (Kawamura et al., 2013, Suzuki et al., 2015). This 
method has been acknowledged as a breakthrough to revolutionise reproductive 
capacity in women with POI. However, this pharmacological approach might impair 
follicle function (Grosbois and Demeestere, 2018, Lerer-Serfaty et al., 2013, 
McLaughlin et al., 2014). Despite a significant rise in primordial follicle activation 
perceived in ovarian cortical strips exposed to the PTEN inhibitor, bpv(HOpic), the 
growth of apparently healthy preantral follicles was compromised after 6 days of 
culture (McLaughlin et al., 2014). In addition, the use of alginate scaffold and 




presence of 100 PM bpv(pic) did not improve follicular development (Lerer-Serfaty 
et al., 2013).  
 
Similarly, constitutive PI3K activation in Cre+ transgenic mouse oocyte leads to 
nonparallel oocyte and granulosa cell growth, indicated by enlarged oocyte size 
surrounded by immature pre-granulosa cells. Although expression of the cell death 
markers Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling 
(TUNEL) and Bax was low, multioocytic follicles were noticeable with follicles 
exhibited a high inhibin A and B expression due to overgrowth of excess follicles with 
ovulation failure (Kim et al., 2015). These findings infer that this treatment may 
provoke an unsynchronised growth phase between oocyte and granulosa cells, which 
may underlie the poor follicle growth. 
 
PIKKs are envisaged as the central regulators of DNA damage repair capacity of cells. 
Akt activation implicates the Chk1 that has a principal role in DNA damage repair 
process as it will delay the cell cycle progression in S and G2 phase to repair an error 
of DNA damage prior to cell division (Hunt et al., 2012). PTEN is hypothesised to 
have a role in conserving genomic integrity. Nonetheless, the outcome of some studies 
with regards to the role of PTEN in DNA DSBs repair are debatable (Altiok et al., 
1999, Fraser et al., 2012, Plo et al., 2008). High level of Akt compromises HR 
mechanism of DNA DSBs capacity, which is considered as the more precise repair 
mechanism for DSBs in oocytes (Jia et al., 2013, Plo et al., 2008).  
 
Conversely, low Akt activity has been shown to impair the DNA damage repair 
mechanism by NHEJ (Kao et al., 2007). Cells with PTEN deficiency lead to 




DSBs (Puc et al., 2005). Furthermore, PTEN deletion is sufficient to markedly reduce 
the level of Rad51 that, in turn, leads to chromosomal instability (Brunet et al., 1999, 
Thacker, 2005). These findings indicate that the absence of PTEN may instigate the 
accumulation of spontaneous DNA damage, and DNA damage repair capacity might 
be weakened in the loss of PTEN (Shen et al., 2007). This mechanism is also 
imperative in cancer pathology as Akt impedes apoptosis and increases cell 
proliferation (Altiok et al., 1999, Plo et al., 2008). Whilst in normal cells, increased 
Akt level and DNA damage accumulation due to inefficient DNA repair are associated 
with Ras-induced senescence (Astle et al., 2012) (Figure 1.11). 
 
Figure 1.11. Crosstalk between AKT and DNA damage repair response. Intracellular high level of 
Akt increases DNA damage, represses nuclear and compromise HR in breast cancer cell line (Maidarti 
et al., 2020). 
 




oocytes has not been investigated further, this rapid grow leads to uncoordinated 
oocyte and granulosa cell growth (Kim et al., 2015) and is associated with granulosa 
cell tumour (GCT) due to excessive granulosa cells proliferation in mice (Kim et al., 
2016). While in human model, accelerated primordial follicle growth has been linked 
to decreased estradiol production, suggesting impaired granulosa cells function. 
Furthermore, lowering the activation rate seems to result in more physiological follicle 
development, with normal estradiol production in culture media following ovarian 
cortical fragments culture (Grosbois and Demeestere, 2018). These findings imply that 
the rapid growth is associated with a disordered intrafollicular oocyte and somatic cell 
relationship (Smitz and Cortvrindt, 2002). However, the cellular basis was not 
clarified, but this outcome could be due to a theca cell defect, as the site of androgen 
production that is then converted to estrogen. Intriguingly, the presence of theca cells 
in mouse preantral follicle culture reveals insufficient oocyte growth (Morohaku et al., 
2016). In contrast, removal of theca cells from the follicle leads to an increase in 
estradiol and progesterone production (Morohaku et al., 2016). In this context, the 
function of theca cells in vitro might not be essential as it can be replaced by 
appropriate medium culture. 
 
The PI3K/Akt/mTORC signalling pathway has been related to follicle loss during 
chemotherapy. It was shown that cyclophosphamide (CP) reduced primordial follicles 
density in mouse ovaries through the activation of PI3K/Akt/mTOR. Taking advantage 
of this relationship, mTOR inhibition has been investigated as a means to safeguard 
the ovaries during chemotherapy in mice (Goldman et al., 2017, Zhou et al., 2017). 
This positive effect is due to mTOR downregulation that subsequently reduced 




primordial follicle, thus maintaining ovarian reserve and fertility (Goldman et al., 
2017).  
 
Similar to Akt activation, mTOR inhibition effects on DDR study has been limited to 
cancer cells with diverse outcomes. Constitutive mTOR activation enhances apoptosis 
triggered by chemotherapy through persistent DNA damage as is shown by the 
upregulation of JH2AX protein in mouse embryonic fibroblast cell lines. In parallel, 
the absence of both PTEN and TSC2 upregulates JH2AX expression. Intriguingly, 
mTOR inhibition prior to treatment is able to protect the cells from etoposide-induced 
apoptotic cell death, as evidenced by improved cell viability and decreased apoptosis 
rate with reduced JH2AX expression (Wang et al., 2013). However, further 
investigations towards its effects on the DNA DSBs and the repair capacity of the 
oocytes and granulosa cells are needed. Additional insights into the interaction of these 
aspects may provide a better understanding of DDR during primordial follicle 
activation. Importantly, as defects in DDR are the starting events of apoptosis, this 
insight may provide opportunities to find an effective strategy to improve the IVG 
system.  
 
Despite the unfavourable consequences of DNA damage to oocytes and granulosa 
cells, the investigation with regards to primordial follicle activation is mostly focused 
on the later stages of apoptotic events. If an approach leading to a decrease in 
endogenous DNA damage can be developed, the survival of follicular growth in vitro 
might be substantially increased. A summary of recent studies investigating the impact 
of PI3K/Akt/mTOR pathway is detailed in Table 1.1. The studies were retrieved 




2020). Specific articles focused on primordial follicle activation was selected using 
specific terms such as ‘primordial follicle activation’, ‘PI3K/ Akt’. Articles selection 
is as presented in Figure 1.12. 
 
Figure 1.12. Methods for study selection. Flow chart following preferred reporting items for 
systematic reviews and meta-analyses (PRISMA) guidelines to determine the study included into 




Table 1.1. Recent studies investigating the impact of PI3K/Akt/mTOR pathway either as a part of genetic 
modification/pharmacological activation, chemotherapy treatment or ovotoxicity exposure on primordial follicle activation, 






Species/ methods Effects on follicular 
growth/survival 




1 and 10 PM bpv(HOpic) 
for 24 hours/ PTEN 
inhibitors. 
Increase PI3K/Akt  Bovine/ ovarian 
cortical fragments 
cultured. 
Decreases in higher 
dose. 
Compromises DDR. 
(Wang et al., 
2019a) 
20, 40, 60, 80, 120, and 140 
PM DZN 
Inhibit PI3K/Akt Porcine isolated 
granulosa cells. 
Granulosa cells death Increase DNA damage, 
mRNA level of ATM, 





30μM bpv(HOpic) + 150 
μg/ml 740Y-P for 24 and 48 
hours, or 100 nM 
everelimus. 
Increase PI3K/Akt 







Lowering the rate of 
activation improves 





(Zhou et al., 
2017) 
 CP 75 mg, 100 mg, 150 mg 
per kg body weight and 
5mg/kg body weight per day 
PI3K/Akt 
activation 
Mice, in vivo CP induces non-









1 week before and after CP 
administration. 
CP induced primordial 
follicle activation. 
(Kim et al., 
2016) 





Cre+ and Cre- 
Normal secondary 
follicles, GCT in 
primordial and 
primary follicles. 
Bilateral GCT due to 








exposed to BPA. 
BPA induces DNA 
damage both in 
oocytes and granulosa 
cells. PI3K signalling 
pathway involved in 
BPA-induced DNA 
damage. 
Primordial follicle is 
activated to replace the 
larger follicle depletion. 
(Kim et al., 
2015) 









and granulosa cells 
growth. 
(Novella-
Maestre et al., 
2015) 
100 μM bpv(pic) for a total 
















(Sun et al., 
2015) 
200 μM phosphatidic acid 
(PA) and 50 μM propranolol 
(PRO) for 24 hours in mice.; 
bpv (100 μM) /740Y-P (250 
μM /ml) for 24 hours, 
740Y-P (250 μM /ml) only 
for another 24 hours; PA 
(100 mM)/740Y-P (200 
μM)/PRO (50 μM) for 24 
hours in human. 
Increase PI3K/Akt 
/mTOR activation. 







No damage to the 
follicular growth. 
Not available (NA) 
(Suzuki et al., 
2015) 
30 μM of bpv(HOpic), and 
150 μM /ml of 740YP for 
24 hours followed by 
incubation with 740YP 











procedure to infertility 
related POI patients. 
NA 
(McLaughlin 
et al., 2014) 
1 PM bpv(HOpic) and 10 











follicular growth. The 
lower dose is 
associated with 
deleterious effects on 
subsequent growth of 
preantral follicles. 
NA 
(Chang et al., 
2015) 
Once daily at doses of 0.5, 
1.0, 1.5, and 2.0 mg/ kg for 






proportion of growing 




cisplatin in mice follicles. 
(Lerer-Serfaty 
et al., 2013) 
100 μM bpv(pic) and 500 
μM /ml 740Y-P for 24 and 













30 μM bpv(HOpic) and  150 








following IVA.  
Promotes primordial 
follicle activation both 












follicles activation in 



















to female mice. 
Does not compromise 
follicular health. 
More mature and 
fertilised oocytes in 




(Li et al., 
2010b) 
100 μM bpv(pic) and/or 500 
μg/ml 740Y-P for 48 hours 
or bpv(pic) plus 740Y-P 
together with the Akt 
inhibitor SH-550 μM or the 






Mice and human 
cortical fragments 




Increases in the 
number of secondary 
and antral stage 
follicles following 
xenografting and does 
not affect follicular 
health. 
No malignancy 





Mice lacking TSC1, PTEN; 
TSC1 and PTEN; PDK1 and 


















Homozygous mutant female 








Depletion of follicles 
reserve.  
(Reddy et al., 
2009) 
Female mice lacking PTEN, 
PDK1 and rpS6 




in PDK1 deletion and 
enlarge oocytes in 
PTEN deletion.   
The absence of PTEN 
causes POI that can be 
reversed by PDK1 
deletion. 
(Reddy et al., 
2008) 
PTEN deletion mice. Increases PI3K/Akt PTEN mutant 
mice 
Tend to be normal 
follicle morphology 
with enlarge oocytes 
and flattened 
granulosa cells. 




1.9. Hypothesis and Aims 
Hypothesis 
The studies in this Thesis address the Hypothesis that the use of a PTEN inhibitor to 
initiate and promote primordial follicle growth may compromise DNA repair capacity 
in oocytes and granulosa cells. 
Secondly, reducing the rate of activation may improve the DDR of oocytes and 
granulosa cells in vitro and subsequent preantral follicle growth and development. 
 
Aims 
To test the hypothesis, the following specific aims were defined: 
1. To investigate the effect of PTEN inhibitor on primordial follicle activation, DNA 
DSBs and DNA damage repair capacity of oocytes and granulosa cells in vitro 
2. To investigate the effects of mTOR inhibition on primordial follicle activation, 
DNA DSBs and DNA damage repair capacity of oocytes and granulosa cells in 
vitro.  
3. To investigate whether isolated preantral follicles originated from tissue exposed 
to PTEN and mTOR inhibitors can grow optimally to antral follicle stages, recover 
DNA repair capacity of the oocytes and granulosa cells and maintain oocyte and 


















General Materials and Methods 
  
 64 
2.1. Ovarian Cortical Fragment Preparation and Dissection 
2.1.1. Collection of Bovine Ovaries  
Bovine ovaries were obtained from the local abattoir and transported in pre-warmed 
holding medium (section 2.1.2). At the laboratory, ovaries were rinsed in 70% alcohol 
and thin slices of ovarian cortex were removed by peeling from the ovary using a 
scalpel blade no. 24 in a laminar flow hood. Then the tissue was transferred into fresh 
dissection medium comprising preheated supplemented Leibovitz medium (Gibco 
BRL, Life Technologies Ltd. Paisley, Renfrewshire, UK) (section 2.1.3).  
 
2.1.2. Holding Medium for Ovarian Transport 
Holding medium for transport comprised of M199 (HEPES buffered) (Gibco BRL, 
Life Technologies Ltd., Paisley, Renfrewshire, UK) supplemented with sodium 
pyruvate (2 mM), penicillin G (75 μg/ml), streptomycin (50 μg/ml) and amphotericin 
B (2.5 μg/ ml) (all chemicals from Sigma-Aldrich Chemicals, Poole, Dorset, UK). pH 
was adjusted to 7.2 - 7.4. 
 
2.1.3. Dissection Medium  
Dissection medium was utilised as handling or holding medium for pieces of ovarian 
cortical strips and ovarian follicle isolation prior to treatment allocation and culture. 
Dissection medium was prepared from Leibovitz medium (GIBCO BRL, Life 
Technologies Ltd., Paisley, Renfrewshire, UK) supplemented with sodium pyruvate 
(2 mM), glutamine (2 mM), BSA (Fraction V. 3 mg/ml), penicillin G (75 Pg/ml) and 
streptomycin (50 Pg/ml). This dissection medium was preheated to 37oC before use. 
 
2.1.4. Ovarian Cortical Tissue Dissection 
Ovarian cortical fragments were placed in a petri dish in dissection medium and 
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examined carefully under light microscopy to characterise ovarian cortex and 
underlying stroma. One to two pieces of ovarian cortical tissue sized approximately 1 
x 0.5 x 0.1 cm were removed from each ovary. Damaged and/or haemorrhagic tissue 
was excised thus allowing the strips to flatten. Excess stromal tissue was trimmed 
away from the ovaries using forceps and scalpel blade. The tissue was gently stretched 
using the blunt edge of a scalpel blade with the cortex uppermost. Using an angled 
incision, the tissue was cut into small strips (sized 4 x 2 x 1 mm) equal to the number 
of treatment groups, then randomly distributed to each group to ensure that each group 
consisted of strips from different ovaries (Figure 2.1). Each fragment was examined 
under a dissecting microscope (Olympus, UK) for the presence of follicles. Any 
follicles measuring more than 40 μm were excised from the tissue fragments using the 
25-gauge needles attached to 1 ml syringe barrels and a blade no 15 and fine forceps 
to ensure a presumptive population of unilaminar follicles. Some tissue fragments, 
depending on the aim of the experiments, were selected from each biopsy as 0-hour 
control and fixed in 10% neutral buffered formalin (NBF) for histological 
examination. The remaining bovine cortical strips were cultured in flat-bottomed 24-
well culture plates (Corning Costar Europe, Badhoevedorp, The Netherlands). 
 
2.2. Tissue Culture 
2.2.1. Culture Medium 
Basic culture medium comprised of McCoys 5A medium with bicarbonate and HEPES 
(20 mM) (GIBCO BRL, Life Technologies Ltd. Paisley, Renfrewshire, UK) 
supplemented with BSA (1 mg/ml), glutamine (3 mM), penicillin G (0.1 mg/ml), 
streptomycin (0.1 mg/ml), transferrin (2.5 μg/ml), selenium (4 ng/ml), insulin (10 
ng/ml), FSH (1 ng/ml), and ascorbic acid (50 μg/ml) (all obtained from Sigma-Aldrich 
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Chemicals, Dorset, UK, unless otherwise stated). Following preparation and prior to 
use, the medium was filter sterilised (Corning Costar Europe, Badhoevedorp, The 
Netherlands) and equilibrated in a humidified incubator at 37oC and an air atmosphere 
with 5% CO2. Basic culture medium was used for all experiments including tissue and 
individual isolated follicles culture. 
 
2.2.2. Ovarian Cortical Fragments Culture 
Pieces of bovine cortical strips were cultured in flat-bottomed 24-well culture plates. 
One cortical slice was randomly placed in individual well containing 300 μl of culture 
medium or treated medium, depending on the aim of the experiment, at 37oC in a 
humidified air atmosphere with 5% CO2 for 24 hours. Medium was removed from the 
tissue fragments and replaced with fresh culture medium without treatment after 24 
hours. Some of the fragments were subjected to western blotting and the remaining 
fragments were incubated for a further 5 days. During this time, half of the volume of 
medium per well was removed and replaced with fresh medium every two days. Each 
experiment was performed under constant conditions (Figure 2.1). 
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Figure 2.1. Ovarian cortical tissue dissection and culture. Scale bar = 1 cm. 
2.3. Preantral Follicle Isolation and Culture 
2.3.1. Preantral Follicle Dissection 
Preantral follicle isolation was performed after 6 days of culture. On completion of the 
culture period, tissue fragments were placed in dissection medium and examined under 
a dissecting microscope. Preantral follicles were dissected using 25-gauge needles, 
scalpel blade no 15 and fine forceps (Terumo Europe, Belgium) under a dissecting 
microscope (Olympus, UK) with a calibrated eyepiece graticule (Graticules Ltd, 
Tonbridge, Kent, UK). To investigate whether the treatments could improve the 
growth of the follicles, all preantral follicles sized more than 66 Pm (Telfer et al., 
2008) in diameter were included in the culture system. The reasoning behind the 
diameter of follicles dissected and selected for culture was that the diameter of 
preantral follicles size ranging from 66 – 139 Pm cultured in the presence of activin A 
was able to increase to 58% after 4 days of culture (Telfer et al., 2008).  
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2.3.2. Individual Preantral Follicle Culture 
Preantral bovine follicles were cultured individually in 96-well V-bottomed culture 
plates (Corning Costar Europe, Badhoevedorp, The Netherlands) with 150 Pl of pre-
warmed culture medium (section 2.2.1) for 6 to 8 days within an incubator in a 
humidified air atmosphere with 5% CO2 at 37oC. Half the volume of medium per well 
was changed with fresh culture medium on alternate day during the culture period. On 
the day of isolation and on every 2 days thereafter, simultaneous with refreshing the 
culture media, the diameter of the follicles was measured. The average of two 
perpendicular measurements was used to determine a mean follicle diameter at these 
specific time points. After 6 to 8 days of culture, the follicles were fixed using 10% 
NBF overnight at 4oC. 
 
2.4. Histological Techniques  
2.4.1. Tissue Fixation, Embedding, and Sectioning 
 
Samples subjected to histology examination were fixed by being placed in 10% NBF 
solution for 24 hours at room temperature. Fixative was then removed, and the tissue 
was dehydrated through a series of graded ethanol baths (70, 90 and 100%) for one 
hour each to displace the water. Ethanol with eosin (coloured ethanol) was used to 
dehydrate the tissue when fixing individual follicles, thus allowing follicles 
visualisation during subsequent tissue processing. Absolute alcohol was cleared and 
replaced with cedarwood oil (BDH Laboratory Supplies, Poole, UK) for a minimum 
of 24 hours. Following dehydration, the tissue was then subsequently placed in toluene 
in a fume hood (Fisher Scientific UK Ltd, Loughborough, UK) for 30 minutes to 
achieve complete oil clearances. The tissue was embedded manually into paraffin wax 
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blocks at 60oC for 4 hours with hourly changes of wax to ensure complete removal of 
toluene.  
 
2.4.2. Sectioning and Mounting 
Wax mounted ovarian cortical fragments and isolated follicles were serially sectioned 
at 5 μm using a microtome (Leica, model Jung RM2035, Nussloch, Germany), then 
floated on a water bath at 42oC and then mounted on SuperFrost Plus slides (VWR 
International Ltd., Leicestershire, UK) and left to dry overnight at 37oC in a slide oven.  
 
2.4.3. Dewaxing and Tissue Rehydration  
Sections were dewaxed by placing the slides in xylene (VWR International) for 30 
minutes (2 x 15-minute immersions) and rehydrated by subsequent immersions in 
decreasing concentrations of alcohol (two washes in 100, then 90, 80 and 70% for 1 
minute each). Slides were then washed in tap water prior to staining or antigen 
retrieval. 
 
2.4.4. H & E Staining  
Following dewaxing and rehydration and rinsing in tap water, the sections were placed 
in Harris' Haematoxylin (BDH Laboratory Supplies, Poole, UK) for 4 minutes then 
washed in tap water, immersed in Scott’s tap water substitute (STWS; CellPath) for 2 
minutes and placed back in tap water for at least 2 minutes. Slides were then dipped in 
1% eosin (Sigma Chemicals, Poole, Dorset UK) solution for 2 minutes, washed in tap 
water and inspected under a light microscope to assess the quality of staining. Finally, 
they were placed in potassium aluminium solution for 2 minutes prior to a tap water 
rinse and dehydration through increasing concentrations of ethanol (70%, 90%, 95% 
and two washes of 100%) for 3 minutes each. Slides were then immersed in xylene for 
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15 minutes and subsequently mounted using Dibutylphthalate Polystyrene Xylene 
(DPX) mounting medium (BDH Laboratory Supplies, Poole, UK) and glass coverslips 
(BDH Laboratory Supplies, Poole, UK) and left to dry in a fume hood at room 
temperature. 
 
2.5. Immunohistochemistry  
2.5.1. Immunohistochemistry Protocol 
Ovarian strips and follicles were processed and embedded as described in Section 2.4. 
Immunohistochemistry was performed to determine the localisation of antigens used 
in this study. Details of the primary and secondary antibodies used, incubation time, 
and the concentration of primary and secondary antibodies, antigen retrieval method, 
endogenous peroxidase quenching and visualisation techniques for specific antibody 
are detailed in the Methods and Materials sections of each chapter. All primary 
antibodies used to detect DNA damage and DNA repair proteins had never been tested 
in bovine, hence antibody optimisation was performed to determine the most 
appropriate antibody and concentration with maximum level of detection and 
minimum non-specific staining. Uncultured human ovarian cortical strips from 
caesarean section patients were utilised as a positive control, as all antibodies had 
previously been tested in human tissue.  
In general, following dewaxing and rehydration in decreasing concentration of 
ethanol, slides were immersed in water for 5 minutes and then washed twice in Tris-
buffered saline (TBS) 0.05 M with Tween 20 (TBST). Slides were then equilibrated 
for 5 minutes in 10 mM sodium citrate (pH 6.0) and antigen retrieval was performed 
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by heating the slides in sodium citrate using a microwave. The slides were allowed to 
cool in the buffer for approximately 20 minutes.  
 
Following antigen retrieval, slides were washed in TBST (2 x 5 minutes) and then 
placed in 3% hydrogen peroxide (H2O2, Sigma-Aldrich) in methanol (VWR 
International) for 10 minutes to block endogenous peroxidase activity and then washed 
again in 2 x 5 minutes TBST. Sections were then incubated with appropriate blocking 
(Vectastain® ABC Kit, Vector Laboratories, Peterborough, UK) diluted in TBST (3 
drops of serum (150 Pl in 10 ml TBST) for 1 hour. The slides were then incubated 
overnight with the diluted primary antibodies (diluted in serum blocking solution) at 
4oC. Primary antibody was replaced with blocking solution for negative control. 
Following incubation with the primary antibody, slides were washed in TBST (2 x 5 
minutes) and sections were incubated for 30 minutes with biotinylated secondary 
antibody at room temperature (Vectastain Elite ABC kit, Vector Laboratories, 
Peterborough, UK) and then washed in TBST (2 x 5 minutes). The secondary 
antibodies were selected based on the primary antibody of choice. Slides were then 
incubated with Streptavidin Horseradish Peroxidase (Streptavidin HRP) (made up as 
per the manufacturer’s instructions; Vectastain® ABC Kit) for 30 minutes at room 
temperature. Following the TBST wash, DAB (3, 3′-diaminobenzidine) peroxidase 
substrate kit (Vector Laboratories, made up as per the manufacturer’s instructions) 
solution was added to the sections for between 2 and 5 minutes. The slides were placed 
in tap water to stop the DAB reaction and then counterstained with haematoxylin and 
STSW and finally dehydrated in graded alcohol and mounted with DPX.  
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Analysis of follicles was made under the light microscope with a crossed micrometre 
under x40 magnification. The examiner was blinded to the treatment groups. The 
category of positive and negative staining was determined before the analysis and 
applied to all experiments (Figure 2.2). 
Figure 2.2. DAB category for immunohistochemistry analysis. A). Negative staining in oocyte 
(Negative staining in nucleus and positive in cytoplasm) and granulosa cells (Negative staining in 
nucleus and minimal in cytoplasm). B). Positive staining in oocyte (Positive staining in nucleus and 
minimal staining in cytoplasm. Negative staining in granulosa cells (Negative staining in nucleus and 
minimal staining in cytoplasm). C). Negative staining in oocyte (Negative staining in nucleus and 
negative in cytoplasm) and granulosa cells (Negative staining in nucleus and negative in cytoplasm). 
D). Positive staining in oocyte (Positive staining in nucleus and less staining in cytoplasm. Positive 
staining in granulosa cells (positive staining in nucleus and less staining in cytoplasm). E). Positive 
staining in oocyte (Equal staining in nucleus and cytoplasm. Positive staining in granulosa cells (equal 
staining in nucleus and cytoplasm or less staining in cytoplasm). Scale bar = 20 Pm. 
 
2.5.2. Immunofluorescence Protocol 
As previously described mounted tissue sections were deparaffinised and rehydrated 
and then washed in in phosphate-buffered saline (PBS) with 0.1% triton X-100 (PBST) 
(pH 7.2 - 7.4) for 2 x 5 minutes. Slides were then equilibrated for 5 minutes in 10 mM 
sodium citrate prior to antigen retrieval, then left to cool for approximately 20 minutes 
and incubated for 1 hour at room temperature with blocking solution (5% goat serum 
in PBST). Tissue sections were then probed with primary antibody overnight at 4oC. 
Blocking solution without primary antibody served as a negative control. After 
A B C D E
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washing with PBST (4 x 10 minutes), sections were incubated with appropriate 
secondary antibodies for 1 hour and then washed for 2 x 10 minutes. The slides were 
then mounted in vectashield hardset with 4′,6-diamidino-2-phenylindole (DAPI) (H-
1500, Vector Laboratories). 
 
2.5.3. Image Acquisition and Processing 
Images were captured using confocal microscope (detailed in each chapter) with x20 
magnification in the IMPACT imaging facility (Centre for Discovery Brain Sciences, 
The University of Edinburgh) with identical laser, gain, contrast, offset, pinhole, 
resolution and frame (focus) setting to all samples. Images were analysed using 
ImageJ, and JH2AX expression in oocytes and granulosa cells was determined. The 
number of oocytes with positive expression per total number of follicles was 
calculated. The protein expression in granulosa cells was quantitatively analysed by 
calculating the proportion of positive granulosa cells per total number of granulosa 
cells per follicle. Immunofluorescence analysis of isolated follicle culture detailed in 
chapter 5. 
 
2.5.4. Collection and Analysis of Histological Results  
Analysis of follicles within cortical pieces was made under the light microscope with 
a crossed micrometre under x40 magnification. For all morphological and numerical 
analyses, the examiner was blinded to the treatment groups. Analysis of follicles 
within tissue fragments was elaborated in each chapter. Pyknotic granulosa cells were 
identified as misshapen and had much darker staining than others. Follicle 
development was examined and classified based on the modification of Pederson 
classification (Pedersen and Peters, 1968): 
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(1) Primordial follicles: oocyte surrounded by a complete or incomplete single layer 
of a flattened granulosa cell.  
(2) Transitory follicles: oocyte surrounded by a mixed layer of flattened and cuboidal 
granulosa cell. 
(3) Primary follicles: oocyte surrounded by a single layer of cuboidal granulosa cells. 
(4) Secondary stage: oocyte surrounded by two or more complete layers of cuboidal 
granulosa cells. 
(5) Antral follicles: oocyte surrounded by two or more complete layers of cuboidal 
granulosa cells and the presence of the antral cavity. 
 
Primordial and transitory follicle were grouped and classified as non-growing follicle 
due to the evidence suggesting that in the bovine ovary, these follicles remain in a 
quiescent state (van Wezel and Rodgers, 1996). The number of follicles at each stage 
of growth was recorded, for day 0 (D0) and day 6 (D6) of each treatment. The 
classification of healthy follicles was based on the same criteria as Telfer et al. (2008) 
with modifications (McLaughlin and Telfer, 2010, Telfer et al., 2008). For follicles to 
be categorised as morphologically normal the oocyte must be grossly circular, 
surrounded by a zona pellucida, have a visible germinal vesicle and defined nucleolus 
and have less than 10% of pyknotic granulosa cells present.  
 
The proportion of follicles at different developmental stages was defined as a 
percentage of follicle type over the total follicle count (Brunet et al., 1999). 
Immunohistochemistry analysis in every chapter was divided into oocytes and 
granulosa cells. The protein expression in granulosa cells was quantitatively analysed 
by calculating the proportion of positive granulosa cells per total number of granulosa 
cells per follicle. 
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2.6. Western Blotting  
2.6.1 Protein Extraction and Measurement  
The number of replicates, tissue analysed, primary and secondary antibodies used were 
detailed in each chapter. Protein expression was only analysed in cultured tissue. 
Ovarian cortical strips were placed in gentle MACS M tubes (Miltenyi Biotec Ltd, 
Surrey, UK) and suspended in Radioimmunoprecipitation assay (RIPA) extraction 
buffer (Fisher Scientific, Loughborough, UK) supplemented with 1% Halt Protease 
and Phosphatase Inhibitor Cocktail (PI) (Thermo Scientific, Loughborough, UK). The 
tissue was dissected with clean scissors on ice as quickly as possible to prevent 
degradation by proteases and then homogenised using a GentleMacs dissociator 
program protein 0101. Then the sample was centrifuged at 3400 x g for 5 minutes at 
4oC.  
 
2.6.1.1. Protein Concentration using Coomassie Blue 
The protein concentration of each sample was quantified using Coomassie-Plus 
Reagent (Thermo Scientific Pierce, Northumberland, UK). Coomassie Blue, 1 ml, was 
pipetted into a cuvette to equilibrate at room temperature for 15 - 20 minutes. Samples 
were compared with BSA concentration standards using Spectrophotometry. Sample, 
1 μl, was added to 1ml Coomassie Blue. Next, it was pipetted up and down to distribute 
and leave to incubate at room temperature for 10 minutes. The UV/Visible 
Spectrophotometer (Ultrospec 3100 pro, Amersham Biosciences) was set to read at 
595 nm, and the reference was set using Coomassie Blue with no added protein. BSA 
was used in increasing concentrations to obtain absorbance readings, which were then 
plotted against their known concentrations to create a standard curve. The absorbance 
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was then read from unknown samples and plotted them against the standard curve to 
determine protein concentration. 
 
2.6.2. Protein Purification Method 
Preliminary experiments showed that different protein concentrations between 20 and 
30 μg either failed to detect the phosphorylated antibodies. Protein purification was 
performed to allow a sufficient sample to be loaded onto the gels. Following 
centrifugation and protein measurements, lysates were transferred to Vivaspin tubes 
(Sartorius Mechatronics Ltd, Epsom, UK) with filter capacity adjusted to the 
molecular weight of protein of interest. The sample was loaded into Vivaspin tube 
from the round end, the top was secured, then centrifuged at 300 x g for 5 minutes. 
Filtrate with molecular weight less than the protein of interest in the pointed end was 
then removed. The tube was then inverted with the round end pointing downwards. 
The pointed end was then attached to the round end, then centrifuged again at 300 x g 
for 5 minutes. Lysates with molecular weight more than protein of interest molecular 
weight were than collected in the rounded end of the tube and protein concentration 
was measured again using Coomassie-Plus reagent (Thermo Scientific Pierce). 
 
2.6.3. Protein Separation and Transfer 
Protein samples were added to an equal volume sample buffer (detailed in each 
chapter) and denatured at 95 - 100oC for 5 - 10 minutes. Depending on the experiments, 
equal amounts of lysates (between 20 - 30 μg) was loaded onto the wells of the sodium 
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE), along with 
molecular weight marker (PageRulerTM Plus; Thermo Scientific). Gels were run at 125 
V for 1 hour or until the loading dye had reached the bottom of the gel. Gels were 
rinsed in distilled water (dH2O) prior to use. Nitrocellulose membranes (Amersham 
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Pharmacia) and 4 pieces of filter papers were cut to size and soaked in transfer buffer 
for at least 2 minutes. The transfer sandwich was then assembled, and the roller was 
utilised to ensure there were no air bubbles trapped underneath the gels. The gels were 
run in chilled transfer buffer with the time and voltage adjusted to the protein 
molecular weight. 
 
2.6.4. Antibody Incubations, Chemiluminescence Detection 
After transfer, the nitrocellulose membranes were blocked in BSA (5%) in TBST for 
1 hour at room temperature with gentle agitation. The membranes were then probed 
with appropriate dilutions of primary antibody in blocking buffer overnight at 4oC with 
gentle agitation. The following day, blots were washed in 0.1% TBST 5 times for 5 
minutes each and then incubated with appropriate secondary antibodies in 5% BSA 
for 1 hour at room temperature. After 5 x 5 minutes washes in TBST, the signal was 
developed. To enhance chemiluminescence detection, nitrocellulose membranes were 
placed in Amersham (ECL) prime western blotting detection reagent (GE health care) 
for 1 minute, and exposed to autoradiographic film for different lengths of time in the 
darkroom and then paced in the developer until bands appeared, briefly rinsed with 
water and then placed in fixer. Western blots were digitally scanned and analysed 
using ImageJ. All analysis was normalised to alpha tubulin. 
 
2.7. Commonly Used Solutions  
2.7.1. Sodium Citrate 
The stock solution of 0.1 M sodium citrate was made by dissolving 29.4 g dihydrate 
tri-sodium citrate in 1000 ml of dH2O. The pH was altered to 6.0 with sodium 
hydroxide (all Sigma-Aldrich). When used, 900 ml of dH2O was added to 100 ml stock 
solution to reach a final concentration of 10 mM. 
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2.7.2. PBS and PBST  
PBS used was prepared by dissolving 5 PBS tablets (Sigma-Aldrich) into 1000 ml of 
distilled water. PBST was made by adding 1 ml of triton X-100 to 1000 ml of PBS. 
 
2.7.3. TBS and TBST 
A stock of 10x TBS was made by adding 2 tablets of TBS (Sigma-Aldrich) to 1000 ml 
of dH2O. TBS x 1 was used in experiments by diluting 100 ml of stock solution in 
1000 ml dH2O. TBST was prepared by dissolving 0.5 ml -1 ml of tween 20 (Sigma 
Aldrich) to 1000 ml TBS. 
 
2.7.4. Transfer Buffer 
Transfer buffer for western blotting was prepared by adding 6 g tris buffer, 28.6 g 
glycine, 400 ml methanol to 1.6 l dH2O (All Fisher scientific, UK Ltd).  
 
2.8. Statistical Analysis  
Statistical Package for the Social Sciences (SPSS) version 22 (SPSS, Inc., Chicago, 
USA) and Graph Pad version 7 (chapter 3) and version 8 (chapter 4) (GraphPad Inc., 
San Diego, California, USA) Statistical Software were used to analyse the data. The 
analysis of qualitative data was run by Chi-square or Fisher exact test as appropriate. 
Quantitative data were analysed either by one-way ANOVA for normally distributed 
data or by the Kruskal Wallis test with Dunn’s Bonferroni test (post hoc test for 
Kruskal Wallis provided by SPSS) for data that was not normally distributed. 
Quantitative data were presented as mean ± SEM and as percentage for qualitative. 
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3.1. Introduction  
The data in this chapter have been published in the journal Human Reproduction 2019 
Feb 1;34(2):297-307. doi: 10.1093/humrep/dey354. 
 
Since it was demonstrated that rodent immature oocytes could be developed to 
maturity in vitro (Eppig and Schroeder, 1989, Eppig and O'Brien, 1996), efforts have 
been made to apply this to larger mammalian species such as human (Telfer et al., 
2008) and bovine (McLaughlin et al., 2010a, McLaughlin et al., 2018). A great deal 
of research has concentrated on trying to increase oocyte yield and improve oocyte 
quality by enhancing primordial follicle activation and the subsequent development of 
growing follicles. However, the safety and efficacy of this accelerated follicle 
activation and growth is still questionable. This process may lead to a deterioration in 
the quality of oocytes as they undergo further development and has been associated 
with ovarian pathology in mice (Kim et al., 2015, Kim et al., 2016). Further 
investigations into how manipulating activation of primordial follicles affects oocyte 
development are essential to improve oocyte quality in vitro (Van den Hurk et al., 
2000). 
 
As explained in chapter 1, a limited control of primordial follicle growth and activation 
is the main difference between in vitro and in vivo follicle growth system (Smitz and 
Cortvrindt, 2002). Within in vitro culture systems, rapid and precocious growth of 
several primordial follicles is more likely to occur (Bertoldo et al., 2018). Attempts to 
increase primordial follicle activation in vitro may lead to a disintegration of oocyte 
and granulosa cells coordination (Bertoldo et al., 2018) that might be linked to poor 
oocyte yield and quality. 
 
 81 
It has been demonstrated that the PI3K signalling pathway has an important role in 
regulating the activation of primordial follicles (Adhikari and Liu, 2009, Liu et al., 
2006) as well as being a primary pathway in cancer cell pathology (Lee and Chang, 
2019). Activation of this pathway has been shown to induce malignancy, is associated 
with poor disease prognosis, and increases drug resistance (Lee and Chang, 2019). Akt 
activation during cell cycles in normal cell proliferation upregulates numerous 
substrates at the G1/S and G2/M transition, some of which are involved in DNA 
damage repair pathway. Several publications involving Akt activation in cancer cell 
pathology (Plo et al., 2008, Puc and Parsons, 2005, Thacker, 2005) support the idea 
that oocytes lacking PTEN may accumulate DNA damage, with reduced DNA damage 
repair capacity. Unrepaired DNA DSBs may potentially impact upon the quality of 
oocytes (Carroll and Marangos, 2013, Oktay et al., 2015, Winship et al., 2018).  
 
It is, however, worth noting that analysis of follicle survival in studies involving the 
IVG system has been limited to morphologically healthy follicles and apoptosis 
markers (Bezerra et al., 2018a, Bezerra et al., 2018b, Dubey et al., 2011, Santos et al., 
2014). Additional insights into DDR defects may provide a better understanding of 
how to support oocyte development in vitro, given that they are the starting events of 
apoptosis and can be detected even in the absence of morphological changes. The 
overall aim of the experiments described in this chapter was to determine whether 
PTEN inhibition affected DNA damage and repair mechanisms in bovine ovarian 








3.2. Materials and Methods  
3.2.1. Ovarian Cortical Tissue Collection and Preparation 
Bovine ovaries were collected and transported to the lab as described in chapter 2 
section 2.1.1. Then the tissue was cut and prepared as described in section 2.1.3. 
 
3.2.2. Ovarian Tissue Fragments Culture 
Basic culture medium was prepared as described in section 2.1. Following tissue 
preparation and cutting, 10 to 12 fragments per culture were randomly selected as 0-
hour control for histological examination. The remaining tissue fragments were 
cultured in flat-bottomed 24-well culture plates containing 300 μl basic culture 
medium or culture medium supplemented with the PTEN inhibitor, (bpv(HOpic) 
(Merck Millipore chemicals Ltd, UK), at 1 or 10 PM. After 24 hours, all media was 
removed and replaced with fresh basic culture medium. At this point 6 - 9 tissue 
fragments from each group were snap-frozen and stored at -80oC for western blot 
analysis of Akt phosphorylation. Remaining tissue fragments were incubated for a 
further 5 days, with half the media removed and replaced with fresh every 2 days. On 
completion of the culture period, all remaining tissue fragments were fixed in 10% 
NBF for histological examination to determine the effect of PTEN inhibitor on follicle 
development (Figure 3.1). 
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Figure 3.1. Experimental design. Small ovarian cortical fragments were cultured individually in 24 
cultured plate in culture medium and medium containing either 1 or 10 μM bpv(HOpic), in vitro for 24 
hours. A sub-group of tissue fragments were collected for western blot analysis after bpv(HOpic) 
exposure. The remainder were incubated in control medium for a further 5 days and then analysed 
histologically and by immunohistochemistry to detect DNA damage and repair pathways. 
 
3.2.3. Histological Methods and Tissue Analysis  
Details of histological analysis was as in chapter 2 section 2.4. In brief, after fixation 
in NBF for 24 hours, tissue fragments were further processed and embedded 
individually into paraffin wax blocks and serially sectioned at 5 Pm thickness. At least 
four adjacent sections from each tissue sample from the start and end of the tissue were 
used for H & E staining, and six sections in the middle were used for 
immunohistochemistry and immunofluorescence. For all morphological and 
numerical analyses, the examiner was blinded to the treatment groups. The follicles 
were analysed on every section under the light microscope with a crossed micrometre 
under x40 magnification. Follicle developmental stage was categorised using a 
modification of an established system (Pedersen and Peters, 1968). Primordial and 
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transitory follicles were classified as non-growing follicles. The number of follicles 
within each stage of development was recorded, for D0 and D6 of each treatment. The 
proportion of follicles at different developmental stages was defined as a percentage 
of morphologically healthy follicles over the total follicle count.  
 
3.2.3.1. Immunohistochemistry  
Quantitative analysis of DNA damage was performed using immunofluorescence. 
DNA damage repair proteins were localised in tissue sections using antibodies against 
JH2AX, MRE11, ATM, BRCA1, BRCA2, and Rad51 (Table 3.1). 
Immunohistochemistry protocol was run as described in chapter 2 section 2.5.1. 
Antigen retrieval was performed by microwaving the slides in 10 mM sodium citrate 
(pH 6.0) at simmer setting for 20 minutes. The endogenous peroxidase activity was 
then quenched. Sections were then incubated with appropriate blocking solution 
(Table 3.1) for 1 hour at room temperature. Excess serum was shaken off the slides 
and primary antibody applied. Primary antibodies were omitted in the slides for 
negative control and replaced with blocking solution. On the following day, primary 
antibody was washed off, and sections were incubated for 30 minutes with biotinylated 
secondary antibody (Table 3.2). Slides were then incubated with Streptavidin 
Horseradish Peroxidase (Streptavidin horse-radish peroxidase (HRP)) for 30 minutes 
at room temperature. Following a TBST wash DAB peroxidase substrate kit solution 
was applied and counterstained with haematoxylin. 
 
Immunohistochemical analysis was made in both oocytes and granulosa cells, as these 
two types of cells have a different response to DDR and every stage of follicular 
development has a distinct surveillance mechanism. The proportion of oocytes positive 
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for DNA repair protein was the number of follicles with oocytes positive for DNA 
repair protein expression in the nucleus over a total number of follicles at the same 
stage. While granulosa cells positive for DNA repair protein defined as the average 
proportion of the number of granulosa cells positive for DNA repair protein expression 
in the nucleus per the total number of granulosa cells per follicle. Non-nuclear 
detection for FOXO3 as a marker of activation defined as the number of follicles with 
negative staining for FOXO3 in the nucleus of the oocytes per total number of follicles. 
 
3.2.3.2. Immunofluorescence 
Localisation of γH2AX (a marker of DNA damage) was detected and quantify by 
immunofluorescence. Immunofluorescence pAkt Ser473 was performed only to show 
the pAkt Ser473 localisation within the follicles (Figure 3.3 B 1-5), whilst the 
quantification was made by western blot analysis. 
 
As previously described, mounted tissue sections were deparaffinised and rehydrated 
and then washed in 0.1% PBST. Slides were then subjected to high-temperature 
antigen retrieval for 20 minutes using a microwave. After 20 minutes, the slides were 
let to cool for at least 20 minutes in room temperature. After several washes in PBS, 
slides were incubated for 1 hour at room temperature with blocking solution (5% goat 
serum in PBST). Tissue sections were then probed with primary antibody (Table 3.1) 
overnight at 4oC. Blocking solution without primary antibody served as a negative 
control. Sections were then incubated with appropriate secondary antibodies (Table 
3.2) for 1 hour on the following day, and then washed and mounted in vectashield 
hardset with DAPI. 
 
Images were captured using a Zeiss LSM 800 confocal microscope with x20 
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magnification in the IMPACT imaging facility (Centre for Discovery Brain Sciences, 
The University of Edinburgh). A tiling that focused on the area with the presence of 
follicles was set to obtain a full image of every section. Images were analysed using 
ImageJ and JH2AX expression in oocytes and granulosa cells was determined. The 
number of oocytes with JH2AX foci per total number of follicles was calculated. The 
JH2AX expression in granulosa cells was quantitatively analysed by manually 
calculating (using ImageJ) the number of JH2AX positive granulosa cells per total 
number of granulosa cells per follicle and expressed as percentage. 
 
Table 3.1. Primary antibodies used for immunohistochemistry analysis 











Goat serum (Sigma 
Aldrich) 
JH2AX NB100-384 Rabbit 
polyclonal 
1 Pg/ml (1 
mg/ml) 
Novusbio 














150 Pl horse serum+ 
10 ml TBST 










BRCA1 Ab16781 Rabbit 
polyclonal 
0.5 Pg/ml (0.1 
mg/ml) 
Abcam 
BRCA2 Ab27976 Rabbit 
polyclonal 








150 Pl horse serum+ 
10 ml TBST 










150 Pl horse serum+ 
10 ml TBST 
FOXO3 NBP2-24579 Rabbit 
polyclonal 






Table 3.2. Secondary antibodies used for immunohistochemistry analysis 





VECTASTAIN Elite ABC 
HRP Kit (peroxidase, 
mouse IgG)  
PK 6101 50 Pl biotinylated 
secondary antibody+ 
150 Pl goat serum+ 
10 ml TBST 
Vector Laboratories 
VECTASTAIN ABC-Elite 
ABC HRP Kit (peroxidase, 
mouse IgG) 
PK  6102 50 Pl biotinylated 
secondary antibody+ 
150 Pl horse serum+ 
10 ml TBST 
Vector Laboratories 
Cy3 AffiniPure Donkey 
Anti-Rabbit IgG (H+L) 
711-165-152 
 




3.2.4. Western Blotting  
Six to nine ovarian cortical strips per group per experiment (4 replicates) were used 
for western blotting. Protein extraction and purification have been outlined in chapter 
2 section 2.6.1 and 2.6.2. Vivaspin tubes with 50 kDa filters was utilised to obtain only 
protein with molecular weight more than 50 kDa included in the analysis. Protein 
samples were added to the same amount of a 2x sample buffer (Table 3.3). Lysates 
then denatured at 100oC for 10 minutes. After brief centrifugation, 20 μg protein was 
loaded onto 4 - 20% gradient gels (Table 3.3) and run at 125 V for 1 hour. Proteins 
were transferred to nitrocellulose membranes (Amersham Pharmacia). BSA (5%) in 
TBST was used to block the nitrocellulose membranes. Blots were incubated, with 
primary antibodies (Table 3.4) and with a mouse monoclonal antibody against alpha-
tubulin as a loading control, overnight at 4oC with gentle agitation. On the following 
day, blots were washed and then incubated with appropriate secondary antibodies 
(Table 3.5) in 5% BSA for 1 hour at room temperature. Chemiluminescence detection 
was performed as described in chapter 2 section 2.6.4. Western blots were digitally 
scanned and analysed using ImageJ. All analysis was normalised to alpha tubulin. 
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Table 3.3. Gel and running buffer used for each antibody 
Antibody Molecular 
weight 




Akt 60 kDa NuPAGE Novex 
4-12% Bis-












pAkt Ser473 56 kDa 
pAkt Thr308 55 kDa 
Alpha tubulin 50 kDa 
 





Species raised Final concentration 
(stock solution) 
Source 
Akt 9272 Rabbit 
polyclonal 
0.01 Pg/ml (34 Pg/ml) Cell Signalling 
pAkt Ser473 ab81283 Rabbit 
monoclonal 
0.52 Pg/ml (0.259 
mg/ml) 
Abcam 
pAkt Thr308 ab 105731 Mouse 
monoclonal 
5 Pg/ml (1 mg/ml) Abcam 
Alpha tubulin ab7291 Mouse 
monoclonal 
0.20 Pg/ml (1 mg/ml) Abcam 
 
Table 3.5. Secondary antibodies used for western blotting 




Goat polyclonal antibody raised 
against mouse IgG (heavy and 
light chain)  
115-035-146 0.16 Pg/ml (0.8 
mg/ml) 
Jackson laboratory 
Goat polyclonal antibody raised 
against rabbit IgG (H+L) 




3.2.5. Statistical Analyses  
All data were analysed using SPSS statistical software version 22 (SPSS, Inc., 
Chicago, USA) and the graph was generated by GraphPad Software version 7 Inc., 
San Diego, California, USA. Quantitative data were presented as mean ± SEM. Chi-
square test was used to analyse the proportion of healthy and unhealthy follicles, the 
distribution of follicle stages and the proportion of oocytes expressing proteins related 
to DNA damage and DNA DSB repair. Granulosa cell expression of JH2AX, MRE11, 
ATM, Rad51, BRCA1, and BRCA2 and nuclear exclusion of FOXO3 were 
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determined using one-way ANOVA test followed by Bonferroni post hoc test. Western 
blotting was analysed using Kruskal Wallis. Statistical significance was assigned at p 























3.4. Results  
3.4.1. Analysis of Follicle Distribution  
Histological sections of freshly fixed cortical fragments were analysed to determine 
the distribution of follicle proportion and developmental stage on D0. A total of 8833 
follicles from 32 fragments (10 to 12 fragments per culture) were analysed. The most 
common type of follicle counted on D0 was non-growing follicles, which constituted 
79.6 % of total follicle number, whereas the remainders were at the primary stage 
(19.0%) and secondary stage (1.4%) (Table 3.6). Additionally, more than 80.0% of the 
follicles at all stages on day 0 within the ovarian cortical strips were healthy (Figure 
3.2). No antral follicles were observed at D0 in any tissue fragments.  
 
3.4.2. Assessment of Follicle Distribution, Activation and Survival 
Follicular activation was determined in all groups after 6 days of culture. Microscopic 
examination of 20,717 follicles from a total of 147 ovarian cortical tissue fragments (n 
= 15 - 18 fragments per group per culture) after 6 days of culture showed that the 
proportion of non-growing follicles reduced significantly in all groups compared to 
uncultured control (Table 3.6). 
  
This reduction was balanced by a significant increase in the proportion of growing 
follicles either in cultured control or in bpv(HOpic) exposed tissue (primary and 
secondary follicles in D0: 20.4%, control: 70.5%, 1 PM bpv(HOpic): 78.6% and 10 
PM bpv(HOpic): 88.7%) (p ≤ 0.001). A higher proportion of growing follicles was 
observed in 10 PM bpv(HOpic) compared to control and 1 PM bpv(HOpic) (p ≤ 
0.001). Secondary follicles were the most mature growing follicle stage found in 
control and either of the treatments. The proportion of follicles progressing to the 
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secondary stage in the presence of bpv(HOpic) was significantly higher in 1 PM (9.7%, 
p d 0.001) and 10 PM (10.6%, p d 0.001) compared to control (6.2%). Nonetheless, it 
was similar in 1 and 10 PM bpv(HOpic) (p = 0.530) (Table 3.6). 
 
Table 3.6. Total number of follicles in each treatment group, at day 0 and after 










Day-0 7,029 (79.6) a 1,681 (19.0) a 123 (1.4) a 8,833 
Control 1,896 (29.5) b 4,129 (64.3) b 401 (6.2) b 6,426 
1 PM bpv(HOpic)  1,400 (21.4) c 4,513 (68.9) c 633 (9.7) c 6,546 
10 PM bpv(HOpic)  880 (11.4) d 6,047 (78.1) d 818 (10.6) c 7,745 
  Total  29,550 
 
 (a), (b), (c) and (d) denote a significant difference between treatment groups. A significantly greater 
proportion of primary and secondary follicles were observed in treatment groups compared to control 
(p < 0.05), Chi test square test. p-value < 0.05 was considered significant.   
 
Despite more growing follicles observed in bpv(HOpic) 10 PM group, a significant 
reduction in the proportion of morphologically healthy follicles was found in higher 
concentration bpv(HOpic) (non-growing: 67.8%, primary: 47.9%, secondary: 41.0%) 
compared to lower concentration (non-growing: 80.2 %, primary: 77.6 %, secondary: 
74.9 %) and control group (non-growing: 81.6 %, primary: 76.4 %, secondary: 77.1%) 
(p < 0.05). The lower concentration of bpv(HOpic) had no significant effect vs control 
group for all follicle types (non-growing, p = 0.960, primary, p = 0.181, secondary, p 
= 0.133) (Figure 3.2). 




Figure 3.2. Proportion of morphologically healthy follicles at each stage of development. D0 
(yellow), control medium (green), 1 PM bpv(HOpic) (red), and 10 PM bpv(HOpic) (blue). Chi square 
test, p-value < 0.05 was considered significant, asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 0.05. The total 
number of follicles analysed for each stage and treatment is shown in Table 1. Data here represent the 
proportion that were classified as healthy.  
 
3.4.3. The Effects of bpv(HOpic) on PI3K Downstream Pathway Activation 
3.4.3.1. Initiation of Akt 
We used immunofluorescence microscopy to visualise phosphorylation of pAkt 
Ser473 within the follicles. Once phosphorylated, Akt transport from cytoplasm to the 
inner membrane of oocytes and granulosa cells. However, as is shown in Figure 3.3, 
pAkt Ser473 expression was not detected in oocytes, but expression can be clearly 
seen in granulosa cells, particularly in activated follicles following 24 hours exposure 
to bpv(HOpic) (Figure 3.3 B 4-5). 
 93 
 
Figure 3.3. Akt activation as an effect of PI3K downstream pathway. A. A schematic Figure of 
PI3K/PTEN activation in the absence of PTEN. Full Akt activation is achieved after both sites are 
phosphorylated (Ser473 and Thr308). B. Immunofluorescence microscopy showing pAkt Ser473 
localisation in follicles of (1) negative control, (2-3) non activated follicle in control group, (4-5) pAkt 
Ser473 location in activated follicles of (4) 1 PM bpv(HOpic) and (5) 10 PM bpv(HOpic). pAkt Ser473 
expression is not seen in oocytes, but expression can be clearly observed in granulosa cells, particularly 
in activated follicles following 24 hours exposure to bpv(HOpic) Scale bar = 20 μm. 
 
Western blot analysis of two Akt phosphorylation sites was conducted to quantify the 
effects of treatments in either higher or lower dose bpv(HOpic) on the activity of Akt 
as a downstream target of PTEN inhibition/PI3K activation. The western blot analysis 
was compared to control group (n = 4 replicates). Western blot analysis showed an 
increase in the ratio of pAkt Ser473 to Akt in bpv(HOpic) exposed tissue compared to 
control (2.25 r 0.3 and 6.23 r 1.1-fold higher in 1 and 10 μM bpv(HOpic) respectively 
(p < 0.05) (Figure 3.4 A, B 1). Full Akt activation is achieved after both 
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phosphorylation sites are activated. The relative expression of phosphorylated Akt at 
Thr308 increased 2.9 r 0.16 and 5.8 r 0.14-fold in tissue exposed to bpv(HOpic) 1 
μM and 10 μM respectively compared to control (p < 0.05) (Figure 3.4 A, B 2). 
 
Figure 3.4. The ratio of pAkt Ser473 and Thr308 and Akt in control and bpv(HOpic) treated 
tissue. (A) Western blot showing phosphorylated Akt (pAkt) at both sites and total Akt expressions in 
all groups. (B) A significant increase in expression of (1) pAkt Ser473 and (2) Thr308 and Akt ratio in 
bpv(HOpic) groups compared to control. Kruskal Wallis, p-value was assigned at < 0.05. Green: 
control, red: 1 μM bpv(HOpic), blue: 10 μM bpv(HOpic).  
 
3.4.3.2. Nuclear Exclusion of FOXO3 
To examine the nuclear exclusion of FOXO3 as a downstream effect of PTEN 
inhibitor, FOXO3 localisation was determined by immunohistochemistry (Figure 3.5). 
A total of 1704 follicles were analysed over 3 separate cultures and the mean 
percentage r SEM of oocytes showing non-nuclear detection of FOXO3 per total 
number of follicles was counted. Data were expressed as a proportion of follicles with 
non-nuclear detection of FOXO3 per total number of follicles of each ovarian 
fragment. A significant increase of follicles with nuclear exclusion of FOXO3 was 
perceived in tissue exposed to bpv(HOpic) 1 μM (69.1% ± 11.7) and 10 μM (81.2% ± 
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12.4) compared to controls (38.3% ± 9.2) (p < 0.05). Furthermore, the proportion of 
follicles with nuclear exclusion of FOXO3 was significantly higher in 10 μM 
bpv(HOpic) compared to 1 μM (p = 0.02) (Figure 3.5 D). 
 
Figure 3.5. Analysis of FOXO3 localisation by immunohistochemistry. (A) Negative control, (B) 
FOXO3 was specifically expressed by oocytes of non-activated follicles indicated by brown staining in 
the nucleus (red arrow), (C) Once the follicle is activated, FOXO3 is shuttled from nucleus to cytoplasm 
(black arrow) as was seen in primary follicles in bpv(HOpic) group. Scale bar = 20 μm. (D) Comparison 
of oocyte nuclear export of FOXO3 in control and bpv(HOpic) groups. ANOVA and Bonferroni post 
hoc analysis, data show mean percentage ± SEM from 3 cultures per treatment. Asterisk (***) ≤ 0.001, 





3.4.4. The Effects of PTEN Inhibitor on DNA Damage  
Immunohistochemistry and immunofluorescence were performed to characterise the 
effect of PTEN inhibitor on DNA damage and DSBs repair capacity of the oocytes of 
all ovarian section in all groups with antibodies against JH2AX, MRE11, ATM, 
BRCA1, BRCA2, and Rad51. All antibodies had never been tested in bovine, thus 
human ovarian biopsies of obstetric patients aged 23 and 24 years old and post cisplatin 
exposure adult mouse testis were used as positive controls for DSBs repair and JH2AX 
antigen. MRE11 was used as a representative marker for MRN complex activation 
(Figure 3.6). Mouse testis exposed to cisplatin was used as a positive control for 
JH2AX expression as cisplatin treatment induces DNA damage in testis (unpublished 
data). It cannot be predicted whether healthy ovarian tissue from obstetric patients can 
be used as a positive control for DNA repairs (MRE11, ATM, Rad51, BRCA1 and 
BRCA2) as they will be activated once cells are exposed to DNA damage. However, 
it has been shown that patients of a young age exhibit a functional DDR, thus oocytes 
will contain the relevant repair proteins (Lin et al., 2017, Titus et al., 2013). Primordial 
follicles that are expected to be high in young obstetric patients, are known to be 
sensitive to DNA induced damage. Primordial follicles also display a well preserve 
DNA repair mechanism (Winship et al., 2018). It has been reported that DNA repair 
proteins significantly increase in ovarian tissue of young patients. In addition, during 
reproductive life, DNA repair proteins help cells to survive damage that may arise as 
a normal by product of cell activity (Jackson and Bartek, 2009). This is the basis for 
choosing ovarian tissue from young obstetric patients as a positive control.  
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Figure 3.6. Positive control of antibodies used to examine DNA damage and DNA repair proteins. 
(A) Mouse testis following cisplatin exposure was utilised as a positive control of JH2AX antibody. 
Human ovaries from obstetric patients were used as a positive control for (B) MRE11, (C) ATM, (D) 
BRCA1, (E) BRCA2 and (F) Rad51.  
 
γH2AX co-localisation in each group was analysed in oocytes (Figure 3.7 A-E) and 
granulosa cells (Figure 3.7 F-H). Analysis of 567 follicles from 3 independent 
experiments after six days of culture showed that the proportion of oocytes positive 
for γH2AX was markedly reduced from 79.0% (D0) to 30.0% and 59.0% in non-
growing and primary follicles respectively (p < 0.001) (Figure 3.7 I). Culture did not 
affect γH2AX expression in oocytes of secondary follicles. However, bpv(HOpic) 
increased γH2AX expression in oocytes of all follicle types at both concentrations of 
bpv(HO)pic (1 μM: non-growing, 83.0%; primary, 76.0%; secondary, 77%; 10 μM: 
non-growing, 77.0%; primary, 84.0%; secondary, 89.0%) (p < 0.05), with no alteration 
between doses (Figure 3.7 I). While in the most mature follicles, DNA damage was 
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lower on D0 (25.0%) compared to control (50.0%) (p < 0.001). Nonetheless, an 
increase was seen in both treatment groups (77 vs 89%) compared to control 
(bpv(HOpic 1 μM, p < 0.05; bpv(HOpic) 10 μM, p < 0.001).  
 
In granulosa cells, γH2AX expression in non-growing follicles did not significantly 
differ between groups (Figure 3.6 J). Similarly, no significant differences were 
observed between D0, control and the lower concentration of bpv(HOpic) in primary 
follicles (Figure 3.7 J). A significant increase was observed in primary follicles in the 
higher (36.9 r 4.2%) compared to the lower concentration (11.8 r 3.39%) and control 
(16.9 r 2.9%) (p d 0.001) (Figure 3.7 J). γH2AX expression in granulosa cells of 
secondary follicles were similar between D0 and control. A significant increases were 
found in both bpv(HOpic) groups (1 μM: 76.9 r 12.2%, p = 0.024; 10 μM bpv(HOpic): 
77.8 r 14.0%, p = 0.011) compared to control (16.7 r 16.7%). There was no significant 




Figure 3.7. Representative images showing localisation by immunofluorescence of γH2AX bovine 
ovarian tissue in each treatment group. γH2AX (red) and DAPI (blue) staining in oocyte and 
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granulosa cells (A-H). γH2AX staining appeared as bright points (foci) within nuclei (white arrows) in 
oocytes (A-E). The green arrows indicate areas where there is no γH2AX expression. (A) Negative 
control, (B) γH2AX positive and negative in the oocytes of D0, (C) Positive and negative staining in 
cultured control, (D) Positive staining in 1 μM bpv(HOpic) and (E) 10 μM bpv(HOpic). Localisation of 
γH2AX expression (white arrows) in granulosa cells (F-H). (F) Control, (G) 1 μM and (H) 10 μM 
bpv(HOpic). Scale bar = 20 μm. Comparison of proportion of follicles showing γH2AX positive 
staining in the oocytes (I) and granulosa cells (J) in all groups. γH2AX expression was analysed using 
chi square test (oocytes) and ANOVA-Bonferroni post hoc test (granulosa cells). Data shows mean 
percentage ± SEM from 3 replicates. Asterisk (***) p ≤ 0.001, (**) p ≤ 0.01, (*) p < 0.05. Yellow, D0; 
green, cultured control; red, 1 PM bpv(HOpic) and blue, 10 PM bpv(HOpic).  
 
3.4.5. The Effects of PTEN Inhibitor on DNA DSBs Repair Capacity in 
Follicles 
To further investigate the effects of PTEN inhibitor on DNA DSBs repair capacity of 
both oocytes and granulosa cells, protein expression of each stage of key DNA repair 
pathway was analysed in all stages of follicle development after 6 days of culture. In 
contrast to γH2AX, MRE11 expression in oocytes within primary follicles in 1 μM 
(42.0%) and 10 PM (47.0%) declined significantly compared to control (68.0%) (p d 
0.001) (Figure 3.8 A 1-5 and 3.9 A). The expression decreased significantly in oocytes 
of non-growing follicles in 10 PM bpv(HOPic) (44.1%) compared to control group 
(56.7%) (p = 0.029), and no significant changes observed between 1 PM bpv(HOPic) 
(57.6%) and control group (p = 0.834). Similarly, a significant reduction of MRE11 
was observed in granulosa cells exposed to bpv(HOpic) in non-growing (1 PM: 41.2 
r 2.9%; 10 PM: 52.3 r 3.9%) and primary follicles (1 PM: 56.2 r 1.9%; 10 PM: 58.3 
r 2.5%), compared to control (non-growing: 75.9 r 1.4% and primary follicles: 79.0 
r 1.8%) (p < 0.05 for all groups). It appeared that bpv(HOpic) did not affect MRE11 
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expression in granulosa cells of secondary follicles (Figure 3.9 B). 
 
On the other hand, ATM expression was low in all treatment groups regardless of 
follicle types. bpv(HOpic) 1 and 10 PM reduced ATM expression in oocytes of non-
growing from 41.6% in control group to 23.8% and 19.4% in 1 μM and 10 μM 
respectively (p d 0.001). Furthermore, the expression in primary and secondary 
follicles was reduced from 46.9% and 58.7 in control group to 26.0 and 10.0% in 1 
μM bpv(HOpic) and 18.0 and 15.3 % in 10 μM bpv(HOpic) (p d 0.001) (Figure 3.8 B 
1-5; Figure 3.9 C). In granulosa cells, ATM expression in bpv(HOpic) groups of non-
growing and primary follicles was significantly lower compared to control (p < 0.05) 
(Figure 3.8 B and 3.9 D).  
 
 
Figure 3.8. Immunohistochemical detection of MRE11 and ATM in oocytes and granulosa cells 
of follicles in all groups. Photomicrographs of (A) MRE11 localisation in oocytes and granulosa cells. 
(B) ATM expression in oocytes and granulosa cells. Negative control (1); positive staining (brown) in 
the oocytes and granulosa cells of D0 (2), control (3); 1 μM (4) and 10 μM bpv(HOpic) (5). Scale bar 
= 20 μm.  
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Figure 3.9. Immunohistochemistry analysis of MRE11 and ATM expression in oocytes and 
granulosa cells. (A) The proportion of MRE11 in oocytes and (B) granulosa cells, (C) ATM positive 
oocytes per total number of follicles in each stage of follicle development and (D) ATM positive in 
granulosa cells. MRE11 and ATM expression were analysed using chi square test (oocytes) and 
ANOVA-Bonferroni post hoc test (granulosa cells). Error bars show mean percentage ± SEM. Yellow 
bars, D0; green bars, cultured control; red bars, bpv(HOpic) 1 PM and blue bars, bpv(HOpic) 10 PM. 
The total number of follicles analysed: 4,659 (MRE) and 5,309 (ATM). Asterisk (***) ≤ 0.001, (**) ≤ 
0.01, (*) < 0.05. p-value was assigned at < 0.05.  
 
The impact of treatment on BRCA1, BRCA2, and RAD51 was also tested both in 
oocytes and granulosa cells (Figure 3.10 A-C). BRCA1 expression was upregulated in 
oocytes of non-growing and primary follicles in control group (19.0 vs 13.0% and 22.0 






























































































































bpv(HOpic) did not significantly affect BRCA1 activity in oocytes all follicle types (p 
> 0.05). However, increasing the dose of bpv(HOpic) was sufficient to decrease the 
expression in 10 μM compared to 1 μM bpv(HOpic) and control group (p < 0.001) 
(Figure 3.10 A 1-5, 3.11 A). Similarly, BRCA1 expression was rarely expressed in 
granulosa cells of secondary follicles exposed to 10 μM bpv(HOpic) (Figure 3.11 B). 
However, primary follicles showed a different response to BRCA2 as culture condition 
did not significantly improve its expression in the oocytes (20.0%) compared to day 0 
(p < 0.001). Surprisingly, it rose significantly in bpv(HOpic) 1 μM (36.0%, p = 0.01) 
but declined in bpv(HOpic) 10 μM (p < 0.001) (Figure 3.11 C). There was no 
significant difference in the expression within granulosa cells among all groups in 
growing follicles (Figure 3.10 B 1-5, 3.11 D). 
 
It is intriguing that Rad51 activity was lower in oocytes of non-growing follicles 
following exposure to low dose (22.3%, p = 0.002)) but not to high dose (37.2%, p > 
0.05) bpv(HOpic) compared to control (37.5%). In contrast, Rad51 expression in 
oocytes of primary follicles was significantly reduced in both bpv(HOpic) groups 
(control vs 1 and 10 μM bpv(HOpic): 48.0% vs 34.0% vs 24.0%) (p < 0.05), without 
significant changes in secondary follicles (Figure 3.10 C1-5, 3.11 E). Rad51 
expression was observed infrequently (< 10%) in granulosa cells, mainly in secondary 
follicles with no significant changes observed among the groups (p > 0.05) (Figure 
3.10 C1-5, 3.11 F). 
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Figure 3.10. Immunohistochemical detection of BRCA1, BRCA2, and Rad51. Photomicrographs 
of BRCA1 (A1-5), BRCA2 (B1-5) and Rad51 (C1-5) expression in oocytes and granulosa cells. 
Negative control (A1, B1, C1); positive staining (brown) in the oocytes and granulosa cells of D0 (A2, 
B2, C2), control (A3, B3, C3); 1 μM (A4, B4, C4) and 10 μM bpv(HOpic) (A5, B5, C5). Scale bar = 
20 μm.  
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Figure 3.11. Immunohistochemistry analysis of BRCA1, BRCA2, and Rad51 in oocytes and 
granulosa cells. The proportion of oocytes (A, C and E) and granulosa cells (B, D and F) expressing 
BRCA1, BRCA2 and Rad51 in each treatment group. DNA repair protein eexpression was analysed 
using chi square test (oocytes) and ANOVA-Bonferroni post hoc test (granulosa cells). (Yellow bars, 
D0; green bars, control; red bars, bpv(HOpic) 1 PM and blue bars, bpv(HOpic) 10 PM). Analysis of 
1,315 (BRCA1) 1,134 BRCA2) and 4,148 (Rad51) follicles. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 
0.05).  

































































































































































































Bovine ovarian tissue fragments exposed to 1 and 10 μM bpv(HOpic) for 24 hours 
showed increased primordial follicle activation, consistent with our previous findings 
in human tissue (McLaughlin et al., 2014). PI3K initiation as a downstream pathway 
of PTEN inhibition was confirmed by increased phosphorylated Akt at both 
phosphorylation sites in western blot analysis and non-nuclear detection of FOXO3 in 
the oocytes. However, the immunofluorescence staining to localise the pAkt Ser473 
did not indicate the location in oocytes with most of the expression being observed in 
the membrane of granulosa cells, specifically within activated follicles. Negative 
expression in oocytes might indicate a weak pAkt expression or it could be due to the 
natural behaviour of the phosphorylated antibody particularly in 
immunohistochemistry (reviewed by (Mandell, 2008)). In addition, protein 
phosphorylation is recognised to alter the protein affinity toward its interacting partner 
and enzymatic activity (Goto and Inagaki, 2007). The weakness of western blot 
analysis is that it fails to localise the site of antigen expression in the tissue. In this 
context, the expression can be either in oocytes or granulosa cells. The quantification 
of pAkt using western blot analysis revealed an increase in bpv(HOpic) group and it 
has been previously demonstrated in mice that PI3K activation increases Akt 
phosphorylation in both granulosa cells and oocytes (Fan et al., 2008, Reddy et al., 
2008). 
An adverse effect on follicle morphological health was observed with the higher dose 
bpv(HOpic), in parallel with data from human ovary (Lerer-Serfaty et al., 2013, 
McLaughlin et al., 2014). The present data extended the observations from previous 
studies by demonstrating that enhanced activation coincided with increased DNA 
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damage and diminished DNA repair in ovarian follicles and oocytes in particular. The 
outcomes of the experiments in this chapter support the view that the PTEN/Akt/PI3K 
pathway implicates other intracellular pathways (Blanco-Aparicio et al., 2007) that 
may have damaging effects on follicle growth. The initiation of PTEN/PI3K/Akt 
activity impacts on DNA damage and repair (Hunt et al., 2012, Ming and He, 2012) 
and has a fundamental role in controlling the apoptosis cascade activity (Lu et al., 
2016, Weng et al., 2001). As DNA damage precedes the apoptotic process and can 
exist without any significant morphological changes, we determined the effect of 
PTEN inhibition on DNA damage and DNA repair capacity of oocytes and granulosa 
cells. The cell’s fate depends on the capability of cells to repair damage, as sufficient 
DNA damage repair function permits cells to resist apoptosis initiated by DNA 
damage (Kujjo et al., 2010). It was shown that low concentrations bpv(HOpic) was 
sufficient to induce DNA damage and compromised DNA repair capacity of the 
follicles.  
 
The DNA damage repair pathway encompasses γH2AX that binds exclusively to the 
site of damage and controls recruitment of DNA repair proteins to the locations of 
damage. We discovered that γH2AX expression was considerably higher in uncultured 
D0 tissue compared to control. Nevertheless, it was concomitant with increased 
expression of MRE11, ATM, Rad51 at all stages of follicle development. These data 
could indicate latent damage owing to mild injury during tissue preparation and 
transport that seems to be briskly resolved and may not trigger severe consequences. 
This type of damage can be restored without cell cycle arrest (Menezo et al., 2010), as 
was denoted by the attenuation in γH2AX expression following tissue culture and there 
being fewer morphologically unhealthy follicles in the cultured control tissue. All 
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types of follicles in control cultures generated ample DNA repair capacity compared 
to treatment groups which may suggest a culture medium with a nutrient-rich milieu 
is valuable to cell metabolism (Paynter et al., 1999).  
 
DNA damage in the oocytes of both bpv(HOpic) treatment groups was not 
accompanied by increased DNA repair protein expression. In the DNA damage repair 
pathway, BRCA2 is essential in controlling the action of Rad51. Increased BRCA2 
expression in oocytes was in parallel with the expression of Rad51 except in the higher 
dose of bpv(HOpic) of non-growing follicles wherein low level of BRCA2 was not 
associated with a change in Rad51 expression. In contrast, BRCA2 expression was 
elevated in 1 PM bpv(HOpic) exposed primary follicles, but was not related with 
enhanced Rad51 expression. This may imply compromised HR and designate Akt 
activation perturbs DNA damage repair protein interactions. This similar finding has 
previously been linked to ovarian ageing in human and mouse studies (Titus et al., 
2013). Nevertheless, BRCA1, BRCA2 and Rad51 expression reduced significantly in 
parallel with increased concentration of bpv(HOpic). It is worth noting that a reduction 
in DNA repair proteins can be an indication of reduced DNA damage, but in this study, 
DNA damage in the higher dose group was significantly increased. This data may 
suggest that DNA damage in follicles exposed to higher concentration bpv(HOpic) is 
severe resulting in limited repair capacity.  
 
High γH2AX expression was detected in granulosa cells of growing follicles in the 
bpv(HOpic) treated groups. Nonetheless, DNA DSBs repair capacity of secondary 
follicles was not affected, except in BRCA1, which declined with higher dose 
bpv(HOpic). This finding may be related to the nature of granulosa cells in growing 
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follicles which are mitotically and metabolically very active that might substantially 
increase with Akt activity. In this regard, granulosa cells of secondary follicles are 
more susceptible to DNA induced damage. A reduction in granulosa cell DNA repair 
function seemed to arise more slowly than DNA damage, in parallel to the process 
occurred with ageing (Zhang et al., 2015). However, a reduction in DNA repair 
capacity in the oocytes and granulosa cells may also indicate that the minimal impacts 
of the treatment on DNA damage. 
 
It is intriguing that the proportion of morphologically normal follicles was similar 
between 1 PM bpv(HOpic) and control group regardless of the presence of DNA 
damage and lack of DNA repair capacity. However, as it has been reported that the 
growth of apparently healthy preantral follicles isolated from bpv(HOpic) group was 
eventually compromised following a further six days of culture (McLaughlin et al., 
2014). This finding may suggest that the dose of bpv(HOpic) also affects the time 
frame between the occurrence of DNA damage and apoptotic events.  
It is worth considering the wider implication of these findings since PTEN inhibition 
has been utilised to stimulate primordial follicles in POI patients by incubating the 
tissue in medium containing Akt activators prior to grafting (Suzuki et al., 2015). The 
present data imply that further investigation is required to determine whether the in 
vivo environment may overcome the DNA damage following ovarian tissue 
replacement after 48 hours incubation in PTEN inhibition. The impact of DNA damage 
on oocytes may range from meiotic dysfunction to cell death (Oktay et al., 2015), 
possibly leading to reduced fertility (Adriaens et al., 2009, Kirk and Lyon, 1982, 
Meirow et al., 2001, Menezo et al., 2007). It is reported that despite more than 50% of 
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oocytes with severe DNA DSBs ultimately resume meiosis, but none of these oocytes 
progress to M2 (Lin et al., 2014). This implies that intact oocytes DNA DSBs repair 
capacity is vital to achieve mature and competent oocytes. 
 
This study has depended upon the use of immunohistochemistry and of course there 
are limitations with this technique. It is important to consider the controls that are used, 
and it is worth noting that omitting the primary antibody to represent the negative 
control in the present study may be less appropriate for specificity of the primary 
antibody. It is important to substitute the primary antibody for a pre-immunised serum, 
ideally from the same animal or normal serum from the same species (Ivell et al., 
2014). Another method that would be appropriate is the use of immunoglobulin G 
(IgG) (Burry, 2011). 
 
In summary (Figure 3.12), the experiments in this chapter demonstrate that increasing 
activity of the PI3/AKT pathway via a short exposure to bovine ovarian tissue 
fragments to bpv(HOpic) results in increased primordial follicle activation. However, 
this was accompanied by increased DNA damage and compromised DNA DSBs repair 
capacity, in both oocytes and granulosa cells. These findings highlight the 
complexities and interactions between the regulation of initiation of follicle growth 
and the maintenance of follicle health and indicate the need for caution in developing 





Figure 3.12. Summary of findings of the experiments in chapter 3. The presence of bpv(HOpic) in 
culture medium to inhibit PTEN is sufficient to induce primordial follicle activation, but it increases 
DNA damage and decreases DNA repair protein expression of MRE11, ATM and compromise HR 
indicated by low Rad51 expression. But it did not affect BRCA1 and BRCA2 expression. The increasing 
of BRCA2 expression in bpv(HOpic) of primary follicles that is not followed by increased Rad 51 
expression may indicate compromised HR. These observations may suggest the association between 
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As demonstrated in chapter 3, PTEN inhibition to trigger primordial follicle activation 
adversely affected the DDR of oocytes and granulosa cells in bovine ovarian cortical 
fragments. A reduction in DNA repair proteins and a resultant increase in DNA 
damage was observed. Whilst the influence of the Hippo signalling pathway in 
fragmenting the ovarian cortex was not fully explored, it is now well recognised that 
cutting the tissue into strips is associated with Hippo signalling pathway disruption 
and further augments follicle growth activation (Kawamura et al., 2013). Activation 
of primordial follicles observed in tissue exposed to PTEN inhibition may reflect 
synergistic effects of Akt activation and Hippo signalling pathway disruption. Most 
importantly, massive disruption of Hippo signalling has been linked to cancer 
pathology (Fan et al., 2017b) suggesting that DNA damage with limited repair may be 
due to mutual effects of both PI3K/Akt activation and Hippo pathway disruption.  
 
Targeting the benefits of the fine balance between follicle growth acceleration and 
deceleration (Zhou et al., 2017) through the PI3K/PTEN/Akt/mTORC pathway, 
substrates to inhibit mTORC have been investigated to protect ovaries against the 
damaging effects of chemotherapy, and to maintain ovarian function and fertility in 
mice (Goldman et al., 2017). Inhibition of mTOR has been proven to reduce excessive 
primordial follicle activation and to maintain the primordial follicle pool (Adhikari et 
al., 2013, Zhang et al., 2013, Zhou et al., 2017). Short exposure to a specific inhibitor 
of mTORC1 partially hindered follicular activation while improving follicle survival 
and steroidogenesis (Grosbois and Demeestere, 2018). However, it is still unclear 
whether the modulation of PI3K/Akt/mTOR substrate including either inhibition or 
activation of a part of this pathway affects DDR in oocytes and/or granulosa cells. The 
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aim of this chapter was to investigate whether the combination of modulation of PTEN 
inhibitor to activate primordial follicles and mTOR inhibitor to attenuate activation 
affected the DNA damage and DNA repair capacity of bovine ovarian follicles 
activated in vitro.  
 
4.2. Material and Methods 
4.2.1. Ovarian Cortical Fragments Collection and Preparation 
Bovine ovaries were obtained from the abattoir and collected in culture medium as 
previously detailed in the material and methods section of Chapter 2 and 3.  
 
4.2.2. The Screening Process to Determine Drug Concentrations 
The bpv(HOpic) concentration selected in these experiments was based on the results 
presented in chapter 3. Only the lower concentration of bpv(HOpic), 1 PM, was used 
in the experiments of this chapter since the higher dose of bpv(HOpic) compromised 
follicle health. The rapamycin concentration was selected based on unpublished 
findings from the Telfer lab examining the effects of rapamycin on bovine primordial 
follicle activation. Several doses were included to find the lowest rapamycin 
concentration that might result in increased activation while minimising effects on 
DNA damage in oocytes in vitro. The doses of 0.01 pM and 0.1 nM rapamycin were 
included in the screening process to find the appropriate concentration. Screening was 
performed with analysis of morphologically activated primordial follicles and JH2AX 
expression from 2 independent experiments. The final concentration of Dimethyl 
sulfoxide (DMSO) used was 0.02%. The dose selection method, in detail, is presented 
in Figure 4.1. 
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Figure 4.1. The screening process to determine the concentration used as the treatments.  
 
4.2.3. Treatment and Culture 
Four to six fragments per culture were selected as 0-hour controls for histological 
examination. The remaining tissue fragments were cultured in flat-bottomed 24-well 
culture plates containing 300 μl of DMSO as vehicle control, bpv(HOpic) and 
rapamycin either on their own or in combination, at 37oC in a humidified air 
atmosphere with 5% CO2. After 24 hours, all media was removed from tissue 
fragments and replaced with fresh culture medium. Some tissue fragments from each 
group were subjected to western blot analysis. The remaining tissue fragments were 
cultured for an additional five days, with half the medium being removed and replaced 
every two days. After six days of culture, all fragments were fixed for histology and 
immunohistochemistry (Figure 4.2). 
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Figure 4.2. Experimental design to investigate the effects of the final treatment on DDR of follicles 
in vitro.   
 
4.2.4. Histological Methods and Tissue Analysis 
Follicle developmental stage was categorised using the same system as described in 
chapter 3. Oocytes and granulosa cells morphology were assessed by the same criteria 
as previously published with modifications (McLaughlin and Telfer, 2010, Telfer et 
al., 2008). Immunohistochemistry and immunofluorescence microscopy protocols, 
including primary and secondary antibodies used, are as described in the material and 
methods section in chapter 2 and 3. Immunofluorescence images were captured using 
a Nikon A1R confocal microscope with x20 magnification. A tiling that focused on 
the area with the presence of follicles was set to obtain a full image of every section. 
Images were analysed using ImageJ as described in chapter 3 Section 3.2.3.2. 
 
4.2.5. Western Blotting  
Ovarian cortical strips (16 - 20 per group per experiment) were suspended in RIPA 
extraction buffer supplemented with 1% PI with the final concentration was 3x (30 
ml/ml). The tissue was cut with scissors and homogenised using a GentleMacs 
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dissociator. The sample was centrifuged at 3400 x g for 5 minutes, and protein was 
purified using Vivaspin tubes with 10 kDa filters. Protein samples were denatured at 
95oC for 5 minutes, and 25 to 30 μg of protein sample was loaded onto gels (Table 
4.1) and run at 125 V for 1 hour. Proteins were transferred to nitrocellulose membranes 
(Amersham Pharmacia). BSA (5%) in TBST was used to block the nitrocellulose 
membranes for 1 hour at room temperature. Blots were then incubated in antibodies 
against Akt, pAkt Ser473, pAkt Thr308, rpS6, phosphorylated (prpS6), 4EBP1 and 
phosphorylated 4EBP1 (p4EBP1) (Table 3.3 and 4.2) overnight at 4oC. Antibody 
against alpha-tubulin was used as a loading control. The blots were then washed in 
TBST and incubated with secondary antibodies (Table 4.2) diluted in 5% BSA for 30 
minutes at room temperature. Nitrocellulose membranes were then placed in 
Amersham (ECL) prime western blotting detection reagent for 1 minute and exposed 
to autoradiographic film. The relative intensity was calculated using ImageJ. All 












Table 4.1. Gel and running buffer used for each antibody 
Antibody Molecular 
weight 
Gel used Sample buffer Running 
buffer 
Akt 60 kDa NuPAGE Novex 4-




















pAkt Thr308 55 kDa NuPAGE Novex 4-












32 kDa NuPAGE Novex 4-










rpS6  32 kDa NuPAGE Novex 4-








































Table 4.2. Additional antibodies used for western blotting 































4.2.6. Statistical Analysis 
SPSS version 22 (SPSS, Inc., Chicago, USA) was used to analyse the data. Graph Pad 
version 8 (Inc., San Diego, California, USA) was utilised to generate the graphs. 
Qualitative data, including the proportion of follicles morphological health, follicle 
stages distribution and the proportion of oocytes with DNA damage and DNA DSB 
repair protein expression, were presented as a percentage. The analysis was run by 
Chi-square or Fisher exact test as appropriate. Quantitative data of nuclear exclusion 
of FOXO3, western blotting, granulosa cells expression of JH2AX, MRE11, ATM, 
Rad51, BRCA1, BRCA2 were analysed either by the Kruskal Wallis test followed by 
Dunn’s Bonferroni test for data that were not normally distributed or by using one-
way ANOVA followed by Bonferroni post hoc test for normally distributed data. 


















4.3.1. Determination of Rapamycin Concentration to Use 
Preliminary experiments were conducted to determine the concentration of rapamycin 
used in this chapter. A total of 2870 follicles were analysed after 6 days of culture to 
determine the proportion of activated follicles. A significant increase in the proportion 
of activated follicles was observed in 1 PM bpv(HOpic) (62.3%, p d 0.001), 1 PM 
bpv(HOpic) + 0.01 pM rapamycin (54.7%, p d 0.001), 1 PM bpv(HOpic) + 0.1 nM 
rapamycin (46.6%, p = 0.009) compared to control (36.2%). Whilst 0.01 pM (39.7%), 
and 0.1 nM rapamycin (30.0%) (p = 0.065) did not reveal a significant reduction.  
 
The activated rate in tissue fragments exposed to 1 PM bpv(HOpic) + 0.01 pM 
rapamycin (54.7%) was similar to 1 PM bpv(HOpic) group (62.3%) (p = 0.055). On 
the other hand, the proportion of activated follicles was much lower in 1PM 
bpv(HOpic) + 0.1 nM rapamycin (p d 0.001) compared to 1 PM bpv(HOpic) group. 
In this context the addition of 0.1 nM rapamycin to medium containing 1 PM 
bpv(HOpic) was sufficient to increase the activation compared to control but with a 
much lower rate than that in bpv(HOpic) group (Figure 4.3 A). 
 
The number of follicles included for JH2AX analysis was 520 follicles from 2 
independent experiments. Primary and secondary stage follicles were categorised as 
growing follicles. A marked increase in JH2AX expression was observed in oocytes 
of non-growing and growing follicles in 1 PM bpv(HOpic) (64.4% and 59.6%) 
compared to control (17.9%, p d 0.001 and 22.9%, p = 0.001), 0.1 nM rapamycin 
(35.8% and 23.5%, p = 0.005), and 1 PM bpv(HOpic) + 0.1 nM rapamycin (16.9%, p 
d 0.001 and 18.8%, p d 0.001). However, the addition of a low dose rapamycin either 
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on its own (0.01 pM rapamycin: 45.8%, p = 0.271) or in combination with bpv(HOpic) 
did not significantly change the expression in oocytes of activated follicles (1PM 
bpv(HOpic) + 0.01 pM rapamycin: 52.4%, p > 0.05) with only non-growing follicles 
were affected (26.9%, p=0.002 and 41.1%, p = 0.017). Based on these findings, we 
included 0.1 nM rapamycin alone and with 1PM bpv(HOpic) as the final concentration 
used in this chapter (Figure 4.3 B).  
 
 
Figure 4.3. Analysis of follicle distribution in all treatment groups included in the screening. (A) 
Follicle distribution after six days of culture. (B). γH2AX expression in oocytes. A significant increase 
of growing follicles can be seen in 1 PM bpv(HOpic) and 1 PM bpv(HOpic) + 0.1 nM rapamycin (A). 
However, the bar graph shows an increased in γH2AX expression in the oocytes of 1 PM bpv(HOpic) 
group. Chi square test, p-value < 0.05 was considered significant. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, 
(*) < 0.05.  
4.3.2. The Effect of PTEN and mTOR Inhibition on Follicle Growth  
A total of 116 ovarian cortical strips and 13,033 follicles from four independent 
experiments were analysed, and 2,845 follicles from 20 ovarian cortical strips were 
examined on D0. Non-growing follicles were the most prevalent, constituting 89.9.0% 
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of total follicle count on D0 (freshly fixed tissue). The remaining were primary (8.6%) 
and secondary (1.5%) with no antral follicles present on D0 (Table 4.3 and Figure 4.4). 
In addition, all follicle types in control and treatment groups had similar proportion of 
healthy follicles throughout the culture period. 
 
Ovarian cortical sections exposed to 1 PM bpv(HOpic) (27.4%) and combined 1 PM 
bpv(HOpic) and 0.1 nM rapamycin (38.7%) displayed a significant reduction in the 
proportion of non-growing follicles compared to control (48.9%), reflecting an 
increased in the growing follicle proportion (control: 51.2%; 1 PM bpv(HOpic): 
73.7%; 1 PM bpv(HOpic) +1 nM rapamycin: 60.5%) (p < 0.05). Secondary follicles 
were the most mature stage observed in all groups. There was no significant influence 
of any the treatments on the proportion of secondary follicles, with the highest 
proportion observed in the combined group (6.0%) (p > 0.05) (Table 4.3). 
 
Table 4.3. The total number of follicles in each treatment group, at day 0 and 
after 6 days of culture                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Group Non-growing 
       n (%) 
Primary 
   n (%) 
Secondary 
    n (%) 
Total 
D0 (freshly fixed) 2,558 (89.9) a 244 (8.6) a 43 (1.5) a 2,845 
Control 1,952 (48.9) b 1,916 (48.0) b 127(3.2) a 3,995 
1 PM bpv(HOpic) 455 (27.4) c 1,126 (67.9) c 98 (5.8) a 1,659 
1 PM bpv(HOpic) + 1 
nM rapamycin 
942 (38.7) d 1,327 (54.5) e 145 (6.0) a 2,434 
 
1 nM rapamycin 1083 (51.6) e 956 (45.5) b, f 61 (2.9) a 2,100 
Total 13,033 
 (a), (b), (c), (d), (e), and (f) denote a significant difference between treatment groups. A significantly 
higher proportion of primary and secondary follicles were observed in treatment groups compared to 
control (p < 0.05). Chi square test, p-value < 0.05 was considered significant.   
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Figure 4.4. Photomicrographs H & E staining of ovarian cortical strips after 6 days of culture. 
The appearance of follicles in ovarian cortical fragments in freshly fixed and after 6 days of culture. (1) 
Freshly fixed ovarian tissue fragment, (2) Control, (3) bpv(HOpic), and (4) combined bpv(HOpic) and 
rapamycin, and (5) rapamycin group. Scale bar = 20 Pm.  
 
4.3.3. Effects of PTEN and mTOR Inhibition on PI3K/Akt Downstream 
Pathway 
Western blot analysis was utilised to evaluate the effects of treatments with PTEN or 
mTOR suppression to disrupt the PI3K/Akt/mTOR downstream pathway. All 
experiments were conducted on fresh tissue precisely 24 hours after exposure and 
repeated 2 - 3 times. For each experiment, material from 16 to 20 ovarian fragments 
per group was used per lane. In each lane, 25 - 30 Pg of protein sample was loaded. 
Western blot analysis revealed an increase in ratio of pAkt Ser473 and Thr308 to Akt 
and in bpv(HOpic) (3.24 r 0.58 and 2.65 r 0.75-fold higher) and combined 
bpv(HOpic) and rapamycin group (2.52 r 0.50 and 2.06 r 0.35-fold changes) 
compared to control (p < 0.05) (Figure 4.5 B and C 1, 2).  
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The ratio did not change with rapamycin alone (0.65 r 0.10 and 0.96 r 0.19-fold, p > 
0.05). Activation of Akt consequently increased the expression of the downstream 
effector prpS6 to rpS6 ratio in bpv(HOpic) ((3.4 r 0.72-fold higher) and the combined 
bpv(HOpic) and rapamycin group (2.4 r 0.58-fold higher) compared to control (p < 
0.05) (Figure 4.2 B and C 3), whereas a reduction in the rapamycin group did not reach 
significance (0.49 r 0.14-fold lower-fold lower) compared to control (p > 0.05). No 
significant changes in p4EBP1 to 4EBP1 ratio were detected, regardless of the 




Figure 4.5. PTEN and mTOR inhibition impacts on primordial follicle activation through the 
modulation of PI3K/Akt/mTOR downstream pathway. (A) A reflection of PTEN and mTOR 
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inhibition effects on PI3K/Akt/mTOR downstream substrate. (B, C) Short term exposure to PTEN and 
mTOR inhibition effects on PI3K/Akt/mTOR downstream substrates of (1) pAkt S473 to total Akt ratio, 
(2) pAkt Thr308 to total Akt, (3) prpS6 to rpS6 ratio and (4) p4EBP1 to 4EPB1 ratio in all groups. 
Kruskal Wallis, p-value < 0.05 was considered significant. Different letters indicate p < 0.05.  
 
Nuclear export of FOXO3 as an effect of PTEN inhibition on PI3K downstream 
pathway was determined by immunohistochemistry. A total of 656 follicles were 
analysed. Nuclear exclusion of FOXO3 was detected in a higher proportion of oocytes 
in the bpv(HOpic) alone (78.7 r 2.3%) and bpv(HOpic) and rapamycin groups (59.1 
r 4.8%) compared to control (38.5 r 5.2%, p d 0.001 and p = 0.016) and the rapamycin 
only groups (34.0 r 3.6, p d 0.001 and p = 0.001 respectively) (Figure 4.6). 
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Figure 4.6. Nuclear export of FOXO3 in control and treatment groups. The graph shows an average 
proportion of oocytes showing non-nuclear detection of FOXO3 in every section. (1-3) Representative 
photomicrographs showing localisation of FOXO3 in bovine follicles. (1) Negative control, (2) Non-
nuclear exclusion of FOXO3 in non-growing follicles with brown staining in the nucleus, and (3) 
Nuclear export of FOXO3 from the nucleus of the activated follicles indicated by brown staining in the 
ooplasm and negative staining within the nucleus. (4) The graph shows a significant increase in nuclear 
export of FOXO3 in bpv(HOpic) and combined bpv(HOpic) and rapamycin group. Data shows mean 
percentage ± SEM from 4 replicates. ANOVA and Bonferroni post hoc test, p-value was assigned at < 
0.05. Different letters indicate p < 0.05. Scale bar = 20 Pm.  
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4.3.4. PTEN/Akt/mTOR Modulation Pathway Impacts on DNA Damage 
within Oocytes and Granulosa Cells of Each Follicle stage 
Non-growing and primary follicles of freshly fixed tissue exhibited a high γH2AX 
level (68.2% and 80.0%) compared to controls (20.5% and 16.7%) (p < 0.05). Its 
expression rose significantly in bpv(HOpic) (80.0% and 64.5%) compared to control 
groups (p < 0.05). Furthermore, the presence of rapamycin either on its own (18.3% 
and 33.7%) or in combination with bpv(HOpic) reduced γH2AX expression compared 
to bpv(Hopic) group. Importantly, the combined effects of bpv(HOpic) and rapamycin 
was still sufficient to induce growth activation (Although it was not as high as in 
bpv(HOpic) group) but with decreased γH2AX expression (p < 0.05). Nevertheless, in 
oocytes of secondary follicles, a marked difference was only observed between 
bpv(HOpic) (66.7%) and control group (22.7%) (p < 0.05) (Figure 4.7 A, B). 
Meanwhile, γH2AX expression in granulosa cells was higher in bpv(HOpic) (16.0 r 
1.2%) of growing follicles compared to control (0.48 r 0.19%) and significantly 
reduced with the addition of rapamycin (1.4 r 1.3%) (p < 0.05). Notwithstanding, the 
highest expression in the secondary stage was seen in bpv(HOpic) group, but it did not 










Figure 4.7. γH2AX localisation by immunofluorescence in control and treatment groups. (A) 
Photomicrograph of immunofluorescence microscopy represent γH2AX positive staining displayed as 
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bright red points (foci) (white arrows) and negative staining DAPI (blue) indicated by green arrows 
within the nucleus of oocytes and granulosa cells. (1) Negative control, (2) Freshly fixed tissue, (3) 
Control with negative and weak γH2AX expression within oocytes of primary follicles, (4) γH2AX 
positive within the nucleus of oocytes and granulosa cells in 1PM bpv(HOpic) group, (5) Combined 
bpv(HOpic) and rapamycin, (6) Negative expression of γH2AX in rapamycin group. Scale bar = 20Pm. 
(B) Bar graphs show an increase in the proportion of γH2AX-positive oocytes and (C) Expression of 
γH2AX in granulosa cells showing the proportion of granulosa cells positive staining in nucleus over a 
total number of granulosa cells. Analysis of 130-220 follicles per group from 4 independent 
experiments. Chi square test (oocytes) and ANOVA (granulosa cells), p-value was assigned at < 0.05. 
Data are presented in mean ± SEM. Asterisk (***): p ≤ 0.001, (**): p ≤ 0.01, (*): p < 0.05.  
 
4.3.5. Impact of PTEN and mTOR Inhibition on DNA DSB Repair Capacity 
of Oocytes and Granulosa cells 
We performed immunohistochemistry for key DNA repair proteins MRE11, ATM, 
BRCA1, Rad51 and BRCA2, to determine the DNA repair capacity of both oocytes 
and granulosa cells at all stages of follicle development. MRE11 expression declined 
in oocytes of more growing follicles in bpv(HOpic) group (primary: 69.5%; 
secondary: 72.7%) compared to control (primary: 88.2%; secondary: 94.7%) (p < 
0.05). The presence of rapamycin either in combination with bpv(HOpic) (93.2% and 
85.7%) or on its own (86.4% and 76.5%) upregulated MRE11expression in non-
growing and primary but not secondary follicles compared to bpv(HOpic) group (p < 
0.05). A decrease in MRE11 expression was also observed in granulosa cells of non-
growing (75.3 r 2.24%) and primary follicle (76.2 r 2.97%) in bpv(HOpic) compared 
to control group (88.9 r 1.77%) (p = 0.012) and (86.4 r 2.60%) (p = 0.039). The 
addition of rapamycin did not significantly alter the expression in all follicle types (p 
> 0.05) (Figure 4.8 A 1-6 and 4.9 A, B).  
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Similarly, ATM expression in non-growing (16.7%) and primary follicles (30.1%) 
showed a significant decline in oocytes in bpv(HOpic) treated tissue compared to 
control (63.0%, and 65.5%) (p < 0.05) (Figure 4.8 B 1-7 and 4.9 C). A marked increase 
was observed with combined bpv(HOpic) and rapamycin treatment (57.8%, p = 0.001 
and 65.0%, p d 0.001). However, a significant increase in rapamycin group observed 
in primary follicles (66.7%, p d 0.001) (Figure 4.9 C). In granulosa cells, ATM was 
expressed at lower level in non-growing (45.8 r 10.4%), and primary follicles (72.1 r 
4.4%) of bpv(HOpic) group compared to controls (90.6 r 4.5% and 91.8 r 2.6%, p < 
0.05) (Figure 4.9 D). Unlike MRE11, the presence of rapamycin alone (88.5 r 3.9% 
and 87.5 r 3.1%, p < 0.05) or together with bpv(HOpic) (91.1r 4.3% and 90.4 r 2.4%, 
p < 0.05) seemed to diminish the negative effects of bpv(HOpic) on lower ATM 
expression. Nonetheless, no changes were observed in secondary stage follicles with 
either treatment (Figure 4.9 D). 
 
Rad51 is required to complete the DNA repair process and has an essential role in HR. 
It is evident from the results presented in Figure 4.9 E that Rad51 was reduced in non-
growing (21.1%) and primary follicles (31.3%) of bpv(HOpic) group compared to 
control (83.8%, p d 0.001 and 72.2%, p d 0.001), rapamycin (49.2% and 59.6%, p < 
0.05) and combined bpv(HOpic) and rapamycin group (61.4%, p = 0.002; 49.3, p = 
0.007). Furthermore, we previously demonstrated that Rad51 was rarely expressed in 
granulosa cells. In the present study, treatments did not alter Rad51 expression in 
granulosa cells with the highest level observed in the control group (Figure 4.8 C1-7 
and 4.9 F). 
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Figure 4.8. Localisation of DNA repair protein MRE11, ATM, and Rad51 in oocytes and 
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granulosa cells of follicles in all groups. Representative images of MRE11 localisation (A1-6), ATM 
(B1-6) and (C1-6) expression in oocytes and granulosa cells. (1) Negative control; positive staining 
(brown) in the oocytes and granulosa cells of (2) D0, (3) Control, (4) 1 PM bpv(HOpic) (5) 1 PM 
bpv(HOpic) and 0.1 nM rapamycin and (6) 0.1 nM rapamycin. Scale bar = 20 Pm.  
 
 
Figure 4.9. Analysis of markers for DSBs: MRE11, ATM, and Rad51 in oocytes and granulosa 
cells of follicles in all groups. The proportion of (A) MRE11, (C) ATM and (E) Rad51 in oocytes 
(shown as percentage) and granulosa cells (B, D, and F) (shown as mean percentage ± SEM). Oocytes: 
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Chi square; granulosa cells: ANOVA, except for Rad51: Kruskal Wallis test, asterisk (***) ≤ 0.001, 
(**) ≤ 0.01, (*) < 0.05. p-value was assigned at < 0.05.  
 
In contrast to MRE11, ATM and Rad51, the DNA DSBs key proteins BRCA1 and 
BRCA2 rose significantly in oocytes of activated follicles (13.5 and 63.5%) in 
bpv(HOpic) group compared to control (4.8 and 43.7%) (p < 0.05). However, BRCA1 
or BRCA2 levels in both non-growing and secondary follicles were not affected. 
Interestingly, rapamycin (16.7%) and combined bpv(HOpic) and rapamycin (13.6%) 
enhanced BRCA1 expression in oocytes of non-activated follicles (p < 0.05) (Figure 
4.10 A B and 4.11 A and C). We also analysed these two DNA repair proteins in 
granulosa cells. We found that bpv(HOpic) seemed to increase BRCA1 expression in 
granulosa cells in non-growing (12.8 r 1.2%) and primary follicles (4.1 r 1.1) of 
bpv(HOpic) group compared to the control (8.4 r 0.9%) and (0.8 r 0.4%) (p < 0.05) 
(Figure 4.10 A1-7 and 4.11 B). BRCA2 activity was downregulated in non-growing 
follicles of bpv(HOpic) (10.7 r 3.3%) compared to control group (26.8 r 4.1%) (p < 
0.05) without any significant changes observed in primary follicles. Expression was 
increased in the presence of rapamycin in culture media (62.7 r 6.3%) (p < 0.05) 
(Figure 4.10 B 1-7). No significant differences were detected between any treatments 
in the expression of BRCA1 and BRCA2 in granulosa cells of growing secondary 




Figure 4.10. Photomicrograph of immunohistochemical detection of BRCA1 and BRCA2 in 
oocytes and granulosa cells of follicles in all groups. Representative image of BRCA1 localisation 
(A1-6) and BRCA2 (B1-6) expression in oocytes and granulosa cells. (1) Negative control; positive 
staining (brown) in the oocytes and granulosa cells of (2) D0, (3) Control, (4) 1 PM bpv(HOpic) (5) 1 









Figure 4.11. Immunohistochemical detection of BRCA1 and BRCA2 in oocytes and granulosa 
cells of follicles in all groups. The proportion of BRCA1 and BRCA2 in oocytes (A7, B7, and C7) and 
granulosa cells (A8, B8, and C8) shown as mean percentage ± SEM. Chi square and ANOVA. Asterisk 












The findings in chapter 3 indicated that accelerated growth in the presence of PTEN 
inhibition in culture media was associated with increased DNA damage with limited 
repair. These results have led to the question of how lowering the activation rate would 
impact on DDR. In these experiments rapamycin was used to inhibit mTOR and 
therefore decrease activation, and bpv(HOpic) was used to inhibit PTEN to increase 
the activation. By utilising both of these treatments, it can be determined whether 
modulation of one or both of these pathways to alter the activation rate improves the 
DDR of oocytes and/or granulosa cells.  
 
The results in this chapter confirm the previous findings, that demonstrated an increase 
in primordial follicle activation after exposure to bpv(HOpic), which was concordant 
with an increased DDR, exclusively in oocytes. Enhanced activation was observed in 
all treatment groups after 6 days of culture without affecting follicle health. Increased 
primordial follicle activation with bpv(HOpic) alone or in combination with 
rapamycin was in accordance with increased pAkt to Akt ratio, at both phosphorylation 
sites. The addition of rapamycin alone did not change the pAkt to total Akt ratio. It is 
commonly accepted that in the PI3K/Akt/mTORC signalling pathway, primordial 
follicle activation is the result of FOXO3 nucleocytoplasmic shuttling following Akt 
phosphorylation and mTOR-induced protein translation. The primary action of mTOR 
is governing the translation of protein synthesis, cell cycle progression, apoptosis and 
metabolic regulation through upregulation of Akt (Adhikari et al., 2010). In our case, 
it seems likely that FOXO3 phosphorylation as a downstream substrate of Akt was 
functionally more dominant than reduced protein translation in the presence of 
bpv(HOpic) and rapamycin. Mutual effects of modulation of these pathways resulted 
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in increased activation compared to control. It is, however, important to note that five 
rpS6 phosphorylation sites have been recorded, including serine 235, serine 236, serine 
240, serine 244 and serine 247 (reviewed by (Ruvinsky and Meyuhas, 2006)). 
 
A decrease in DNA damage alongside the reduced activation rate might suggest the 
importance of preventing an accelerated and precocious growth. Recent publications 
provide evidence that mTORC1 inhibitor could retain the follicle in a functionally 
integrated state, preserve follicle ultrastructure and promote the continuance of oocyte 
and granulosa cells communication throughout culture period that is in parallel with 
delayed follicular growth (Grosbois et al., 2019). Those outcomes supports the notion 
that precocious growth in vitro contributes to uncoordinated growth of oocytes and 
granulosa cells (Smitz and Cortvrindt, 2002), and that reducing the rate of activation 
may sustain oocyte and granulosa cell coordination.  
 
However, in contrast to our findings, porcine granulosa cells isolated from antral 
follicles exposed to high dose organophosphorus insecticide diazinon (DZN), 
recognised to inhibit PI3K/Akt activation and induce DNA damage in a dose-
dependent manner. It appeared that damaged granulosa cells reacted by generating 
DNA repair proteins ATM, Rad51, and BRCA1 but not MRE11. Although the DDR 
response is pertinent, a significant increase in p53 expression was detected, and most 
cells eventually underwent apoptosis (Wang et al., 2019a). Nevertheless, this study 
was focused on granulosa cells of growing follicles and performed in a different 
species. It is generally accepted that oocytes and granulosa cells exhibit different 
reactions to DNA induced damage (Hanoux et al., 2007, Roos and Kaina, 2006, 
Winship et al., 2018). It has been reported that despite increased expression of JH2AX 
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in oocytes and granulosa cells with age in the rhesus monkey, BRCA1 is not affected, 
which may help to repair DSBs accumulated with age (Zhang et al., 2015).  
 
Moreover, each species reacts differently to DNA damage and exhibit a unique DNA 
repair mechanism (Kujjo et al., 2010, Kujjo et al., 2012, Perez et al., 2007, Wang et 
al., 2017b). Likewise, human ovarian cortical strips cultured in a higher dose than that 
used in the present experiment resulted in empty follicles, which may be a result of 
granulosa cell phagocytosis of oocytes (McLaughlin et al., 2011). This finding 
together with the data in porcine granulosa cells may suggest that profound mTORC 
inhibition can interfere with the delicate balance of PI3K/Akt/mTOR pathway leading 
to cell death mediated by either apoptosis or autophagy. 
 
In addition, follicles exposed to Akt activators showed decreased estradiol production, 
perhaps due to uncoordinated growth of oocyte and granulosa cells (Grosbois and 
Demeestere, 2018). In contrast, short exposure to another mTORC1 inhibitor, 
everolimus, was able to mitigate the negative effect of Akt activators on estradiol 
production (Grosbois and Demeestere, 2018). In the present study, we used a much 
lower dose of rapamycin, and this low dose and short exposure significantly reduced 
DNA damage and increased DNA repair protein expression. By using either 
rapamycin alone or in combination with bpv(HOpic), we could demonstrate a gradual 
decrease in the activation rate together with reduced DNA damage. These findings 
highlight the importance of maintaining the physiological balance of the 
PI3K/Akt/mTOR pathway in oocytes.  
 
The results with combined bpv(HOpic) and rapamycin treatment may reflect the 
mechanism by which rapamycin or other type of mTOR inhibitors protects the ovary 
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against chemotherapy. In a mouse model, the mTOR inhibitor was able to counteract 
the primordial follicle activation and follicle loss induced by CP (Goldman et al., 2017, 
Zhou et al., 2017) and cisplatin (Tanaka et al., 2018). However, Akt phosphorylation 
following CP exposure did not reflect CP-induced PI3K/Akt activation with only 
prpS6 affected implying that excessive primordial follicle activation is mediated by 
upregulation of mTORC1 signalling pathway (Goldman et al., 2017, Zhou et al., 
2017).  
In a study investigating the mechanism by which cisplatin provoked ovarian failure, 
reduced PTEN expression in oocytes gave rise to primordial follicle activation. Once 
follicles were activated to grow, they became more vulnerable to apoptosis and showed 
loss of LHR expression. This condition may contribute to reduced oocyte meiotic 
competence and ovulation failure (Chang et al., 2015). Granulosa cells of secondary 
follicles were also the most adversely affected, as indicated by high levels of 
cleaved (Adenosine Diphosphate)-Ribose Polymerase (PARP) (Chang et al., 2015). 
Furthermore, the PI3K/Akt inhibitor was sufficient to reduce follicle loss in an 
endometriosis mice model (Takeuchi et al., 2019). It is known that the presence of 
endometriosis (Choi et al., 2018, Kitajima et al., 2014) or chemotherapy treatments 
(Chang et al., 2015, Kerr et al., 2012a, Kerr et al., 2012b, Nguyen et al., 2018) 
treatments are associated with increased DNA damage, suggesting that rapamycin 
might be beneficial to ameliorate the negative impact of PI3K/Akt activation in those 
situations, which is concomitant with our findings.  
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In conclusion, the addition of a low dose of rapamycin to ovarian tissue treated with 
bpv(HOpic) reduced DNA damage and improved DNA repair capacity of the oocytes, 
whilst maintaining increased follicle activation (Figure 4.12). 
 
Figure 4.12. Summary of findings of the experiments in chapter 4. The presence of rapamycin and 
bpv(HOpic) in the culture medium is sufficient to induce primordial follicle activation, attenuate 
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The experiments described in chapter 3 and 4 have confirmed that the use of PTEN 
inhibition to activate primordial follicles may have a detrimental effect on the DDR of 
oocytes and granulosa cells in vitro. Bovine ovarian cortical strips cultured in the 
presence of bpv(HOpic) resulted in more than 70% of follicles being activated within 
six days of culture. These findings confirmed that the culture system supported the 
spontaneous recruitment of dormant follicles into the growing pool and that this was 
enhanced by PTEN inhibition, in agreement with earlier studies in the human and 
bovine model (McLaughlin and Telfer, 2010, McLaughlin et al., 2018, Telfer et al., 
2008). However, follicular growth in this IVG system is in contrast to physiological in 
vivo conditions where activation occurs gradually and it may take several months to 
reach the antral stage in larger animals and humans (Gougeon, 1998, Smitz and 
Cortvrindt, 2002). The evidence presented in chapter 3 brings into question the benefit 
and safety of this massive activation for supporting further follicular growth and 
follicle quality. These observations highlight the importance of amending the direction 
of managing in vitro follicular growth, as demonstrated in chapter 4. 
 
The results presented in chapter 4, showed that the addition of rapamycin to inhibit 
mTORC1 on its own or in combination with bpv(HOpic) improved DDR of oocytes 
and granulosa cells whilst still supporting increased activation of primordial follicles. 
The experiments in the previous two chapters were limited to primordial follicle 
activation and any implications for later stages of follicle development were not 
assessed. It should be pointed out that previously published findings from our lab 
showed that despite more growing follicles being observed after exposure to 
bpv(HOpic), the subsequent growth of these follicles was compromised following a 
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further 6 days of culture (McLaughlin et al., 2014). These data emphasised the need 
to extend the experiments to the subsequent stage of the follicle development in this 
study. 
 
The prime issue in all stages of the IVG system is how to maintain oocyte and 
granulosa cell connections, as the exceptional growth of the follicle is vulnerable to 
compromised cell interaction throughout the culture period (Smitz and Cortvrindt, 
2002). Upon activation, follicles grow and develop to large multi-laminar structures. 
These follicles will not survive within the cortical environment and they need to be 
removed from the cortical stromal and be cultured individually in order to avoid the 
influence of follicle interactions (Telfer et al., 2008, Telfer and McLaughlin, 2012). 
Preantral follicles are primarily characterised by oocyte growth and development that 
is in line with increased production of GDF9 and pronounced junctional connexin 
expression within the follicles (Elvin et al., 2000). The rapid growth of follicles 
observed in vitro may be related to a deficit in intercellular communication that may 
decrease oocyte quality (Smitz and Cortvrindt, 2002). Preantral follicle growth is also 
typified by increased basal lamina expansion (Rodgers et al., 2003). The major 
problem is how to substitute the in vivo environment to support preantral follicle 
growth in vitro. The results illustrated in chapter 4 challenged us to investigate further 
whether modifying follicular recruitment might provide an environment that is closer 
to physiological conditions.  
 
The endpoints of the experiments in this chapter were to investigate the effect of PTEN 
and mTOR inhibition on subsequent isolated preantral follicular growth, survival and 
development in vitro and whether the size of isolated follicles at the starting point 
would determine their growth potential. The same approach employed in previous 
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chapters was used i.e. a two-step culture system designed to enhance the activation of 
primordial follicles within ovarian cortical strips (step one) and then growth and 
development of isolated secondary follicles (step two).  
 
5.2. Material and Methods 
5.2.1. Ovarian Cortical Fragments Culture 
Ovarian cortical fragments collection, preparation, the treatment and cultured were as 
described in chapter 4. In brief, the tissue fragments were cultured in 24-well culture 
plates containing basic culture medium comprising DMSO as vehicle control, 
bpv(HOpic) and rapamycin either on its own or in combination with bpv(HOpic) at 
37oC in a humidified air atmosphere with 5% CO2.  
 
5.2.2. Follicle Isolation and Culture 
After six days of culture, ovarian cortical fragments were subjected to follicle isolation 
as detailed in chapter 2 section 2.3.1 and 2.3.2. In brief, the tissue fragments were 
placed in dissection medium and assessed under light microscopy. Follicles measuring 
t 66 Pm in diameter (Telfer et al., 2008) were isolated mechanically using 25 gauge 
needles, scalpel blade and fine forceps (section 2.3.1). Isolated follicles were then 
placed individually in 96-well V-bottomed culture plates in 150 Pl of culture medium 
(Section 2.2.1) supplemented with 100 ng/ml recombinant activin A (rhAct A) (R & 
D Systems, Abingdon, UK). Isolated follicles were cultured for a further 6 to 8 days 
at 37oC in humidified air with 5% CO2. Half of the culture medium was removed and 
replaced and at the same time follicle diameter was measured in two perpendicular 
dimensions using a dissecting microscope with a crossed micrometer and 
the mean value recorded on the day of isolation (D6) and every alternate day (Figure 
 146 
5.1). Measurements were taken from basement membrane from one side to the other. 
Theca was excluded from the measurements. 
 
 
Figure 5.1. Experimental design to investigate the effects of the treatments on the subsequent 
follicular growth and survival. 
 
5.2.3. Histological Analysis 
H & E staining was performed to analyse morphology of follicles. Analysis of isolated 
follicle was performed under the light microscope with a crossed micrometre under 
x40 magnification. The analysis was made on the section with the presence of a 
nucleolus, except when defining the presence of an antrum where all sections of the 
follicle were observed. Mean follicle and oocyte diameter were recorded for each 
isolated follicle. In this chapter, we categorised the isolated preantral follicles into 2 
groups based on the follicle size (Araujo et al., 2014, Braw-Tal and Yossefi, 1997, 
Wandji et al., 1996b), which were < 100 and t 100 Pm. 
 
5.2.4. Detection of JH2AX, ATM, Cx43, GDF9 and Laminin Antigen by 
Immunofluorescence Microscopy. 
Double staining with immunofluorescence for JH2AX and ATM was performed to 
provide information on whether DNA damage and repair occurred at the same time 
point. Immunofluorescence method was as described in chapter 2, 3 and 4. Details of 
 147 
antibodies used are shown in Table 5.1. In brief: slides were subjected to high-
temperature antigen retrieval for 20 minutes using a microwave. Following incubation 
in blocking solution for 1 hour, slides were then probed with primary antibody against 
JH2AX and ATM (Table 5.1) overnight at 4oC. Blocking solution without primary 
antibody served as a negative control. Sections were then incubated with appropriate 
secondary antibodies (Table 5.2) for 1 hour on the following day, and then washed and 
mounted in vectashield hardset with DAPI. Images were captured using a Zeiss LSM 
800 confocal microscope with x20 magnification with identical setting for all samples. 
Images were analysed using ImageJ and protein expression was determined both in 
oocytes and granulosa cells, except for Cx43 and laminin which were analysed in 
granulosa cells only. Tissue permeabilisation with 0.1% triton was applied to all 
samples, including laminin, to investigate laminin expression in basal lamina and 
membrana granulosa of the follicle.  
 
Table 5.1. Primary antibodies used for immunohistochemistry analysis 











Goat serum (Sigma 
Aldrich) 
JH2AX NB100-384 Rabbit 
polyclonal 
1 Pg/ml (1 
mg/ml) 
Novusbio 
Goat serum (Sigma 
Aldrich) 
























Goat serum (Sigma 
Aldrich) 










Table 5.2. Additional secondary antibodies used for immunohistochemistry 
analysis 
Secondary antibody Product 
number 
Final concentration (stock 
solution) 
Source 
VECTASTAIN Elite ABC 
HRP Kit (peroxidase, 
mouse IgG)  
PK 6101 50 Pl biotinylated secondary 
antibody + 150 Pl goat serum+ 




ABC HRP Kit 
(peroxidase, mouse IgG) 
PK  6102 50 Pl biotinylated secondary 
antibody+ 150 Pl horse serum+ 
10 ml TBST. 
Vector 
Laboratories 
Cy3 AffiniPure Donkey 
Anti-Rabbit IgG (H+L) 
711-165-152 
 
5.98 Pg/ml (1.5 mg/ml) Jackson 
Laboratories 
Cy2 AffiniPure Goat Anti-
Mouse IgG (H+L) 
115-225-146 
 
5.98 Pg/ml (1.5 mg/ml) Jackson 
Laboratories 
 
5.2.5. Quantitative Analysis of JH2AX, ATM, Cx43, GDF9 and Laminin 
ImageJ was used to quantify the immunofluorescence intensity or the area with 
positive staining for JH2AX, ATM, Cx43 and GDF9. The level of fluorescence in the 
nucleus of oocytes was calculated using mean gray value. The area of cells with 
positive antibody staining was calculated by setting a threshold value on the 
fluorescence intensity. This is achieved by manually adjusting the intensity value to 
cover the positively stained area. We then normalised the measured area by dividing 
it with the total area of the granulosa cells compartment and expressed as percentage 
(Figure 5.2). Data are presented as mean r SEM. 
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Figure 5.2. Diagram showing the method to analysis the JH2AX and ATM expression in (1) oocyte 
(nucleus) and (2-5) granulosa cells. 
 
The expression of Cx43 and intrafollicular laminin was determined by measuring the 
area of positive expression as described above. This measurement was then averaged 
over the values obtained in the section with the largest oocyte diameter (middle 
section), two sections in between the first and middle section and between the last and 
middle section (Figure 5.3). 
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Figure 5.3. Representative images of a serial section to determine laminin and connexin43 
expression within granulosa cells. Permeabilisation of the membrane was performed to determine the 
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laminin expression surrounding the granulosa cells and basal lamina of the follicles. Depending on the 
size of the follicle, approximately 3 to 7 sections were analysed in each follicle per group. The section 
containing the oocyte nucleus and therefore the point of the largest diameter was considered the middle 
section, The analysis started from this middle section, then moved to sections in both directions. Two 
sections between the middle section and the last section either on the left or the right side were included 
into the analysis. Scale bar = 50 Pm. 
 
5.2.6. Immunohistochemistry  
DNA damage repair protein Rad51 was localised in tissue sections using antibodies 
against Rad51 (Table 3.1). Immunohistochemistry protocol was run as described in 
chapter 2 section 2.5.1. The expression of Rad51 was determined in oocytes and 
granulosa cells. The proportion of oocytes positive for Rad51 was defined as the 
number of follicles with positive expression in oocytes per total number of follicles in 
each group. The mean proportion of granulosa cells was determined as the number of 
granulosa cells positive for Rad51 over a total number of granulosa cells in each 
follicle. The expression was presented as mean r SEM.  
 
5.2.7. Statistical Analysis 
SPSS version 22 was used to analyse the data. GraphPad version 8 was utilised to 
generate the graphs. Qualitative data were presented as a percentage. The analysis was 
run by either Chi-square or Fisher exact test. Quantitative data were analysed either by 
the Kruskal Wallis followed by the Dunn’s Bonferroni test for the data that was not 
normally distributed or one-way ANOVA followed by Fisher least significant 
differences (LSD) post hoc test for normally distributed data. The follicle and oocyte 
diameter were compared among treatment groups at D6 and every second day of the 
culture period using ANOVA and LSD post hoc test. The difference of growth rate 
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from D6, D8, D10 and D12 was assessed using general linear model repeated measure. 
The pairwise comparison t-test was simultaneously generated within the analysis. p-
























5.3.1. Isolated Follicle Growth and Survival  
The amount of stromal tissue surrounding isolated follicles varied due to the 
dissimilarity in stromal density in tissue fragments. During isolation, care was taken 
to ensure basal lamina was intact and adequate theca cells was presented as they are 
fundamental to preserve follicle growth and development. In this experiment, we 
included 9 replicates of ovarian strip cultures. After 6 days, growing follicles were 
mechanically isolated from all strips. A total of 578 follicles were isolated from all 
groups after six days of ovarian strip culture. The follicles isolated ranged in size from 
66.1 to 144.6 Pm, of which a total of 237 (41%) follicles were greater than 100 Pm.  
 
A significant increase in the mean proportion of isolated follicles (regardless of 
diameter at isolation) from every culture was observed in bpv(HOpic) group (35.7 r 
18.5%) compared to control (21.1 r 2.6%) and rapamycin (11.9 r 3.2%) on its own (p 
< 0.05). The combined bpv(HOpic) and rapamycin group (30.6 r 3.0%) did not exhibit 




Figure 5.4. The average proportion of isolated follicle number per each group. 1) The average 
percentage of follicles isolated from ovarian cortical strips in each group after 6 days of culture. A total 
of 578 follicles were isolated from 9 separate cultures. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 0.05. 
Kruskal Wallis test, p-value was assigned at < 0.05. Data shows mean percentage r SEM from 9 
replicates. Photomicrograph of isolated follicles from each group. 2) Control, 3) 1 PM bpv(HOpic), 4) 
Combined 1 PM bpv(HOpic) and 0.1 nM rapamycin and 5) 0.1 nM rapamycin. Scale bar = 100 Pm.  
 
The proportion of isolated follicles in each group based on the diameter at isolation 
(more or < 100 Pm) was calculated. Follicles sized t 100 Pm in diameter (at isolation) 
was significantly higher in bpv(HOpic) (56.8%) compared to control (35.9, p d 0.001), 
rapamycin (19.4%, p d 0.001) and combined bpv(HOpic) and rapamycin group 
(36.1%, p = 0.001) (Table 5.3). The number of follicles isolated from combined 




























































Table 5.3. The distribution of isolated follicles sized more and < 100 Pm in each 
group of ovarian fragments after 6 days of culture. 
Group Follicle size Total 
 < 100 Pm (n, %) t 100 Pm (n, %)  
Control 82 (64.1) a 46 (35.9) a 128 
1PM bpv(HOpic) 83(43.2) b 109 (56.8) b 192 
1 PM bpv(HOpic) + 0.1 nM 
rapamycin 
122 (63.9) a 69 (36.1) a 191 
0.1 nM rapamycin 54 (80.6) d 13 (19.4) d 67 
Total 341 (59.0) 237 (41.0) 578 
(a), (b), (c) and (d) denote a significant difference between treatment groups. Different letters indicate 
p < 0.05. Chi square test, p-value < 0.05 was considered significant.   
 
The mean follicle diameter measured < 100 Pm at isolation was 84.9 r 0.5 Pm, and 
116.4 r 0.7 Pm for the follicles t 100 Pm in diameter. However, overall, the follicle 
isolated from rapamycin group were tended to be smaller compared to other groups 
(110.7 r 3.6 Pm). Analysis within the group showed that the diameter of the follicles 
isolated from the control group (sized t 100 Pm at isolation) rose from 118.4 r 1.8 on 
D6 to 220.5 r 11.0 Pm on D12 with a significant increase in the measurement during 
the subsequent 6 days of culture period (p d 0.001). Likewise, in combined 
bpv(HOpic) and rapamycin and rapamycin alone group, follicle size increased 
significantly from D6 (118.3 r 1.3 and 110 r 3.6 Pm) to D12 (196.9 r 9.9 and 178.6 
r 15.2 Pm) (p d 0.001) (Figure 5. 5 A, C, D, E, F). On the other hand, follicles isolated 
from the tissue exposed to bpv(HOpic) exhibited an increase in diameter, with limited, 
nonsignificant growth from D10 (134.9 r 4.2 Pm) to D12 (136.5 r 6.9 Pm (p > 0.752). 
Eventually, the follicle diameter in bpv(HOpic) was significantly reduced compared 
to control group on the completion of culture period (136.5 r 6.9 vs 220.5 r 11.0 Pm, 
 156 
p d 0.001). No changes were observed in combined bpv(HOpic) and rapamycin and 
rapamycin alone (p > 0.05) (Figure 5.5 A). 
 
Meanwhile, the treatment did not affect the growth of follicles < 100 Pm (Figure 5.5 
B), and it appeared to be very slow, though a significant increase was still observed 
from D6 to D12 in all groups. The proportion of isolated follicles (sized < 100 Pm) 
that was able to grow and reach the diameter > 50% of the original size at the start of 
culture (D6) after 6 days of culture was similar across the groups ranging from 23.6 to 
28.1%. Nevertheless, it only occurred when the diameter of the follicles on D6 was 
88.9 r 0.9 Pm (p d 0.001) regardless of the initial treatment in ovarian cortical 
fragments.  
 
Figure 5.5. The follicular growth charts. (A) The growth of follicles sized t 100 Pm (B) < 100 Pm at 
isolation. Follicle growth sized t 100 Pm at isolation increased significantly after 6 days of culture in 
control group. While follicles in bpv(HOpic) group displayed a limited and non-significant growth. The 
follicle growth was tended to be similar in the follicles sized <100 Pm at isolation. Statistical analyses 
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were performed in comparison with the control group. ANOVA, the p-value was assigned at < 0.05. 
The difference of growth rate from D6, 8, 10 and 12 was assessed using general linear model repeated 
measure. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 0.05. Data shows mean percentage r SEM from 9 
replicates. (1- 4) Photomicrographs of isolated follicles after a total of 12 days in culture. (1) Control, 
(2) bpv(HOpic), (3) combined bpv(HOpic) and rapamycin, and (4) rapamycin group. Scale bar = 100 
Pm. 
 
The variability in the stromal density surrounding the isolated follicles led to 
difficulties in precisely assessing the growth of the oocyte during the culture system. 
In this respect, the oocyte diameter was determined on the D12 of culture by evaluating 
the growth of the oocytes within histological sections. In parallel with follicle growth, 
oocyte diameter within the follicles sized t 100 Pm at isolation was significantly 
smaller in bpv(HOpic) (39.2 r 1.6 Pm) compared to control group (60.1 r 2.8 Pm, p 
d 0.001) (Figure 5.6 A). Likewise, rapamycin either on its own or in combination with 
bpv(HOpic) did not significantly affect the oocyte diameter. Furthermore, in parallel 
to follicle growth there was no significant difference in the mean oocyte diameter 
(within follicles sized < 100 Pm) at isolation across all groups on completion of the 
culture period (p > 0.05) (Figure 5.6 B). 
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Figure 5.6. Oocytes growth after six days of culture. (A) Oocyte diameter in the follicles with a 
diameter t 100 Pm and (B) < 100 Pm at isolation show an increase in oocyte diameter in control 
compared to bpv(HOpic) group when the size of the follicles at the start was t 100 Pm. Oocyte diameter 
tended to be similar across the groups in follicles < 100 Pm. Analysis of 341 and 237 follicles 
respectively. ANOVA, the p-value was assigned at ≤ 0.05. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 
0.05. Data shows mean percentage r SEM from 9 cultures replicates.  
 
Most of the follicles were morphologically unhealthy after 6 days of culture. Further 
analysis showed that all follicles regardless of the diameter at isolation demonstrated 
a decline in morphological health in bpv(HOpic) (1.6% healthy) compared to control 
group (7.0%, p < 0.05) (Figure 5.7 A). The presence of rapamycin either alone or in 
combination with bpv(HOpic) did not alter the proportion of morphologically healthy 
follicles (p > 0.05) (Figure 5.7 A). The analysis was then separated based on follicle 
diameter at isolation and a similar observation was found in follicles t 100 Pm in 
diameter (at isolation) in bpv(HOpic) group (1.8%) compared to control (11.6%, p < 
0.05) (Figure 5.7 B). Rapamycin alone (12.5%, p > 0.05) or in combination with 
bpv(HOpic) (5.8%, p > 0.05) did not change the proportion compared to bpv(HOpic) 
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group. However, all treatments showed no difference in follicles < 100 Pm (at 
isolation) (p > 0.05, Figure 5.7 C).  
 
Meanwhile, antral follicles were only observed in control (1.7%) and rapamycin group 
(1.3%) and no significant difference observed among the groups (p > 0.05, Figure 5.7 
D). Nevertheless, no antral follicles were healthy irrespective of the treatments and, 
none of the follicles < 100 Pm (at isolation) reached the antral stage (Figure 5.7 4). 
 
Figure 5.7. Morphologically healthy follicles analysis in all groups. (A) Proportion of 
morphologically healthy follicles regardless of follicles diameter when the culture was initiated, (B) 
Follicles diameter was t 100 Pm and (C) < 100 Pm at isolation. Data are presented as a proportion (%) 
from 9 replicates (analysis of 578 follicles). Fisher exact test, p-value was assigned at < 0.05. Asterisk 
(***) ≤ 0.001, (**) ≤ 0.01, (*) < 0.05. Adjacent photomicrographs of isolated follicles in (1) control, 
(2) bpv(HOpic) with limited follicle growth, (3) bpv(HOpic) and rapamycin showing follicle increased 





5.3.2. Effects of the Treatment in Tissue Fragments on DDR in Isolated 
Follicles. 
Only follicles with initial diameter t 100 Pm at isolation were included for analysis of 
DDR markers using immunofluorescence microscopy. The follicles subjected to 
analysis were randomly chosen from each culture group. After 6 days of culture, 
γH2AX expression within oocytes and granulosa cells was similar across the groups 
regardless of treatment (p > 0.05) (Figure 5.8 A and B, 5.9 A-E). However, ATM 
expression in both oocytes (40.5 r 10.5) and granulosa cells (11.8 r 0.9%) of 
bpv(HOpic) group was significantly lower compared to control (90.5 r 14.3 and 18.4 
r 2.9%, p < 0.05) (Figure 5.8 C and D and 5.9 A-E). The expression was upregulated 
in the combined bpv(HOpic) and rapamycin group compared to bpv(HOpic) alone, 
both in oocytes (77.3 r 14.7) and granulosa cells (14.7 r 1.5%) (p < 0.05). While 
rapamycin on its own did not alter the expression in oocytes (69.4 r 13.9, p > 0.05), it 
decreased significantly in granulosa cells (15.7 r 1.5) compared to bpv(HOpic) group 
p < 0.05) (Figure 5.8 C, D and 5.9 A-E).  
 
The JH2AX to ATM ratio was calculated to further analyse whether DNA damage 
occurred concurrently with ATM expression. Oocyte JH2AX to ATM ratio was 
defined as oocyte mean gray value of JH2AX divided by ATM. Whilst in granulosa 
cells, the ratio was obtained by dividing the proportion of JH2AX expression by ATM. 
The ratio was markedly increased in oocytes of bpv(HOpic) (1.99 r 0.27) group 
compared to control (1.04 r 0.2, p < 0.05). No significant differences were observed 
either in the rapamycin (1.2 r 0.3) or in combined bpv(HOpic) and rapamycin groups 
(1.06 r 0.15) (p > 0.05) compared to control, but significant differences were observed 
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when these two groups were compared to the bpv(HOpic) group (p < 0.05). On the 
other hand, the ratio in granulosa cells was higher in bpv(HOpic) ( 1.5 r 0.2) (p < 0.05) 
and there were no significant changes in combined bpv(HOpic) and rapamycin or 





Figure 5.8. γH2AX and ATM localisation by immunofluorescence in the control and treatment 
groups. (A) JH2AX expression in the nucleus within oocytes and (B) granulosa cells did not reveal 
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significant differences across the groups. While DNA repair protein, ATM, was downregulated in (C) 
oocytes and (D) granulosa cells in bpv(HOpic) group. (E) The ratio of JH2AX to ATM indicated an 
increase in bpv(HOpic) compared to control in oocytes and (F) granulosa cells. Kruskal Wallis test. 
Asterisk (***): p ≤ 0.001, (**): p ≤ 0.01, (*): p < 0.05. Analysis of 62 follicles. 
 
Figure 5.9. Photomicrographs of immunofluorescence microscopy of γH2AX and ATM 
expression in all groups. (A) Negative control, (B) Control, with positive γH2AX and ATM expression 
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both in oocytes and granulosa cells, (C) γH2AX and less ATM expression within oocytes and granulosa 
cells in bpv(HOpic) group, (D) Positive γH2AX and ATM expression in bpv(HOpic) and rapamycin, 
and (E) Negative γH2AX and ATM expression in oocytes with limited expression in granulosa cells in 
rapamycin group. Negative staining of γH2AX and ATM in oocyte and minimal staining in granulosa 
cells in rapamycin group could reflect minimal effect of rapamycin on DNA damage. In this context, 
both γH2AX and ATM were not upregulated. Scale bar = 50 Pm. 
 
Follicular capacity to repair damage was assessed by analysing Rad51. It was shown 
that Rad51 expression in oocytes was downregulated in bpv(HOpic) (22.2%) 
compared to control (58.3%) (p = 0.008). The addition of rapamycin either in 
combination with bpv(HOpic) (46.4%, p = 0.059) or rapamycin alone (28.6%, p = 
0.166) did not significantly alter the expression (Figure 5.10 A). Rad51 expression 
within granulosa cells was similar across groups (p > 0.05) (Figure 5.10 B).  
 
Figure 5.10. Immunohistochemistry analysis of Rad51 expression in oocytes and granulosa cells. 
(A) The proportion of Rad51 in oocytes showing a decline in the oocyte of bpv(HOpic) group. (B) 
Granulosa cells expression of Rad51 showing a similar Rad51 expression across the groups. Error bars 
show mean percentage ± SEM. Kruskal Wallis test. Asterisk (***) ≤ 0.001, (**) ≤ 0.01, (*) < 0.05. p-
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value was assigned at < 0.05. Adjacent photomicrographs of Rad51 expression within oocytes and 
granulosa cells of isolated follicles in (1) control, antral follicle with positive staining in oocytes, (2) 
Negative staining in oocytes in bpv(HOpic) group, (3) bpv(HOpic) and rapamycin and (4) rapamycin 
group. Scale bar = 50 Pm. 
 
5.3.3. Effects of the Treatment on Cx43, Laminin and GDF9 Expression 
 
Cx43, GDF9 and laminin expression was determined within the follicles after 6 to 8 
days of the culture period. Cx43 expression was assessed in isolated follicles after 6 
days of culture to determine whether culture condition affected cell communication. 
Cx43 and laminin were only expressed within the granulosa cell area, while GDF9 
protein was also detected in the granulosa cells area (Figure 5.11 B, C, D. E). GDF9 
expression was similar across the groups (p > 0.05) (Figure 5.11 A). Cx43 and laminin 
were calculated as an area in the granulosa cell compartment that expressed Cx43 and 
laminin above the threshold set at the same level across the follicle (before the 
analysis) to a total granulosa cells area per follicles. Depending on the follicle size, 
173 sections from 57 follicles were included in the analysis. Cx43 expression in 
granulosa cells was markedly decreased in bpv(HOpic) (14.8 r 0.9%) compared to 
control (17.01 r 0.70%) (p = 0.006), and no significant alterations were found either 
in rapamycin or combined bpv(HOpic) and rapamycin group (p ! 0.05) (Figure 5.12 
B). Laminin expression was determined to assess basal lamina expansion and whether 
the culture conditions were able to preserve membrana granulosa throughout the 
culture period. There was no significant effect of either the treatment or the isolation 
techniques on laminin expression (Figure 5.12 C, 5.13 A-E).  
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Figure 5.11. The localisation of GDF9 (red) and Cx43 (green) protein within ovarian follicles 
following six days of the culture period. (A) Negative control (B) GDF9 (red) and Cx43 (green) 
expression within primary follicles indicate a limited Cx43 expression within granulosa cells 
compartment and intense GDF9 expression within the oocyte. (C) GDF9 and Cx43 expression in 
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control. (D) bpv(HOpic) group shows a weak Cx43 expression within granulosa cells with GDF9 
expressed in the oocyte. (E) bpv(HOpic) and rapamycin and (F) rapamycin group. GDF9 is not detected 
in granulosa cells of the primary follicle. GDF9 expression seems to be low both in oocyte and granulosa 
cells in control and bpv(HOpic) groups. However, quantitative analysis showed no significant 
difference in GDF9 expression across the groups. Scale bar = 50 Pm. 
 
 
Figure 5.12. Oocytes of in vitro grown follicles expression of GDF9, granulosa cells expression of 
Cx43 and follicular expression of laminin. (A) Oocytes expression of GDF9 indicates no significant 
differences observed among the groups. (B) Cx43 expression was lower in bpv(HOpic) group  (C) 
Laminin expressed in a similar fashion across the groups. Kruskal Wallis test. Asterisk (***) ≤ 0.001, 
(**) ≤ 0.01, (*) < 0.05. Data shows mean percentage r SEM. 
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Figure 5.13. Photomicrographs of immunofluorescence microscopy of laminin and Cx43 within 
the granulosa cells compartment. (A) Freshly fixed tissue used as a negative control, (B) Control, 
with positive Cx43 (green) and laminin (red) expression in granulosa cells, (C) bpv(HOpic) group, (D) 
bpv(HOpic) and rapamycin, and (E) rapamycin group. Scale bar = 50 Pm.  
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5.4. Discussion 
In this chapter, the investigation on whether isolated preantral follicles from the tissue 
fragments treated with rapamycin or bpv(HOPic) could restore DDR following 6 days 
of culture was extended. The results demonstrated that the addition of bpv(HOpic) 
alone in culture media decreased preantral follicle growth compared to control in 
agreement with our previous published findings (McLaughlin et al., 2014). It appeared 
that culture of preantral follicles isolated from either rapamycin on its own or in 
combination with bpv(HOpic) did not alter the proportion of morphologically healthy 
follicles. It is interesting to note that, overall morphological health in the control group 
was considerably lower compared to our previous study in bovine (McLaughlin and 
Telfer, 2010) and human (McLaughlin et al., 2018). The primary features of 
morphologically unhealthy follicles in all groups were disorganised or granulosa cell 
loss, loopy basal lamina and shrunken oocytes (Abdel-Khalek et al., 2010). 
Eventually, the growth of preantral follicles throughout the culture period only reached 
the antral stage in control and rapamycin group and all antral follicles obtained were 
morphologically unhealthy. 
 
In this chapter, we investigated further whether the treatment in ovarian cortical 
fragments was sufficient to obviate DNA damage and restore DNA repair functions in 
isolated preantral follicles cultured for another 6 to 8 days. Despite a significant 
increase in morphologically unhealthy follicles in bpv(HOpic) group, JH2AX 
expression did not differ across the group. In contrast, at the same time point, DNA 
repair protein expression of ATM and Rad51 in bpv(HOpic) group was attenuated 
compared to control suggesting a lack of DNA repair protein interaction. Likewise, 
both the rapamycin and combined bpv(HOpic) and rapamycin groups did not show a 
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significantly enhanced ATM expression. However, morphologically healthy follicles 
in these groups did not differ from control and bpv(HOpic) group. Whilst there 
appeared to be a trend that morphologically healthy follicles were more evident in 
rapamycin compared to the bpv(HOpic) group, it did not reach statistical significance. 
These findings indicated that DNA damage occurrence in all treatment groups was 
either severe with limited repair or DNA repair mechanism did not function 
appropriately that might trigger the pro-apoptotic gene activation and subsequently 
apoptosis (Livera et al., 2008, Suh et al., 2006).  
 
ATM phosphorylation has been reported as the first step in the G2 checkpoint 
activation in the DNA damage repair pathway (Carroll and Marangos, 2013). We 
demonstrated that ATM was downregulated in bpv(HOpic) group. As was shown in 
chapter 4, granulosa cells of secondary follicles exhibited a low DNA damage in all 
groups and generally DNA repair capacity was not affected. However, it seemed likely 
that follicles in bpv(HOpic) group were not able to survive as the highest 
morphologically unhealthy follicle were observed in this group. In line with this 
finding, widespread granulosa cells of secondary follicle apoptosis have been reported 
following cisplatin exposure and is associated with upregulation of PI3K/Akt signaling 
pathway (Chang et al., 2015). In surviving follicles, DNA repair protein activity was 
able to repair DNA damage as was shown by Rad51 activity in response to doxorubicin 
induced DNA damage in mouse oocytes (Kujjo et al., 2010). 
 
During preantral follicle development, increased expression of GFD9 is observed but 
this was not found in this study. Despite an increase in follicle growth, in control group, 
GDF9 expression did not differ across the group. Photomicrographs in Figure 5.11 C 
and D show that GDF9 expression appears to be low both in oocyte and granulosa 
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cells in control and bpv(HOpic) groups. However, the images used in the 
photomicrographs have been randomly selected and any perceived differences are not 
necessarily reflected in the quantitative analysis. Indeed, the analysis showed no 
significant difference in GDF9 expression across the groups. GDF9 protein was 
detected within oocytes and granulosa cells as previously reported in a range of species 
(Fernandez et al., 2016, Kona et al., 2016, Palomino and De Los Reyes, 2016), 
including in bovine (Hosoe et al., 2011) and human cumulus cells (Li et al., 2014). 
Increases in GDF9 expression can be an indication of oocyte growth and granulosa 
cells differentiation. It is well established that maintenance of oocyte-granulosa cell 
connections is fundamental for healthy follicle development (Albertini et al., 2001, 
Eppig, 2001, McLaughlin et al., 2010a). However, in the present study no significant 
changes in GDF9 and Cx43 expression in the treatment groups compared to control.  
 
Granulosa cell interaction appeared well preserved in control group but a decline in 
Cx43 expression was observed in the bpv(HOpic) group. It is worth noting that in vitro 
culture may interfere with the intercellular interactions as evident by the existence of 
granulosa cell loosening and intercellular spaces (Nottola et al., 2011) suggesting the 
similar situation possibly applied in granulosa cells of control group as only 7% of the 
follicles in this group exhibited morphologically healthy after 6 days of culture. 
However, more evidence is required to support this outcome, including the presence 
of uncultured preantral and antral follicles as a comparison. The investigation of Cx37 
or other markers such as rhodamine-phalloidin expression could also provide 
comprehensive information pertaining to follicles grown in vitro. 
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It has been reported that the formation of an antral cavity is commonly established 
when the diameter of the follicle reaches 200 Pm (McLaughlin et al., 2010a). We 
previously demonstrated that the presence of activin in media during the multi-step 
IVG system was associated with an increased number of antral follicles compared to 
medium without activin (McLaughlin et al., 2010a). In contrast, in the present study, 
despite the mean follicle diameter in control group being able to reach 200 Pm or larger 
after 6 days of culture, only 1.7% of follicles in the control group formed antral 
cavities. These outcomes reflect variation between cultures and perhaps with more 
experience and a greater number of replicates, a higher proportion of follicles would 
be achieved. 
 
The use of mechanical isolation has been established in our group as the most 
appropriate method to isolate preantral follicles from cattle and human as the use of 
enzymes can be deleterious. However, this method is laborious and is associated with 
low follicle yield (Kim et al., 2018). In domestic animals or human, these techniques 
become more time consuming and difficult to achieve since the ovary is more fibrous 
than the mouse ovary. The time needed for isolation might influence follicular health 
and survival and this of course is operator dependent (Kim et al., 2018). Nonetheless, 
outcomes are significantly poorer after enzyme digestion as the basement membrane 
and thecal cell layer are affected resulting in poor follicle morphology (Demeestere et 
al., 2002, Kim et al., 2018, Telfer et al., 2000, Telfer and Zelinski, 2013). The presence 
of adequate theca layers is required in growing follicles to retain the 3D structure of 
the isolated follicle. Collagenase treatment may lead to destruction of theca layers, 
though this damage can be eluded by the addition of new purified enzyme such as 
liberase (reviewed by (Telfer and Zelinski, 2013)). 
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Mechanical isolation has an advantage in that the theca cells can be conserved, and 
this may support follicle growth and development through steroid biosynthesis and the 
production of matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) that are critical for tissue remodelling and basal lamina 
turnover (Thomas et al., 2001). However, follicular growth is hampered by a large 
number of stromal cells, therefore it is essential to ensure a balance to preserve 
adequate theca cells that support follicle development but does not prevent growth. In 
this respect, technical skill is essential to achieve this condition. Insufficient and 
ineffective isolation techniques may lead to the presence of a large amount of stroma 
and theca cells leading to poor morphological health of follicles in this experiment..  
 
Basal lamina expansion is used as a marker of follicular growth (Hatzirodos et al., 
2014, Hummitzsch et al., 2013a, Irving-Rodgers et al., 2009). Expansion of basal 
lamina could not be analysed in the present study since the methodology used in this 
study involved permeabilisation during immunohistochemistry. Therefore, this is not 
a reflection of the basal lamina morphology as most of the laminin expression was 
observed in membrana granulosa cells rather than in basal lamina. In this context, 
laminin expression might not be useful in determining the impact of technical isolation 
on isolated preantral follicles. 
 
Recent findings analysing the ultrastructure of ovarian follicles isolated from tissue 
exposed to mTOR inhibitor suggested that granulosa cell intercellular spaces and 
vacuolisation were more noticeable in the control group compared to the mTOR 
inhibitor group (Grosbois et al., 2019). The defects were more likely as a consequence 
of culture conditions as they were more common following six days of culture period 
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both in control and mTOR inhibitor group (Grosbois et al., 2019). It is intriguing that, 
despite more follicles showing morphologically poor health, the effects of mTOR 
inhibitor in isolated follicle culture was still present after 6 days of culture, which 
might be due to a higher dose of mTOR inhibitor compared to that used in our present 
study. Although there was a trend for more morphologically healthy follicles to be 
present in the rapamycin group in the experiments of this chapter, it did not achieve 
significance. This observation could be due to there being fewer follicles sized t 100 
µm in this group. Alternatively, the low dose rapamycin used in this study was perhaps 
not sufficient to deliver continuous effects on the isolated follicle growth. We were 
not able to identify whether rapamycin could provide a better follicle growth outcome 
compared to control as was shown in another recent study (Grosbois et al., 2019). 
 
Our investigations have not been able to definitively demonstrate the effects of 
treatment on isolated preantral follicles. The low sample size and poor survival rate 
are principal limitations of this study. For these reasons LSD was used as a post-hoc 
test following ANOVA rather than Bonferroni that was used in previous chapters. The 
aim of changing the post hoc analysis type was that in Bonferroni there is an increased 
risk of having a type 2 error (false negative) when sample size is low. Given the low 
sample size compared to the data presented in chapter 3 and 4, type 2 errors are less 
likely using LSD. However, the risk of having type 1 errors (false positive) become 
more likely (Williams and Abdi, 2010). Whilst the use of LSD analysis might not be 
ideal, it provides information on the trend of the results. If the number of follicles in 
each group can be increased, then Bonferroni’s would be used with greater confidence 
to ensure the validity of the results.  
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In conclusion, preantral follicles isolated from bpv(HOpic) exposed tissue displayed  
decreased morphological health in parallel with diminished DNA repair protein. The 
effect of rapamycin administration in culture media during ovarian fragments culture 
did not significantly increase preantral follicle survival. Likewise, Cx43 expression as 
the main connexins forming gap junctions between granulosa cells did not 








































6.1. General Discussion 
Developing culture systems to support the earliest stage of follicle/oocyte development 
to maturity in women is an optimistic but challenging strategy to preserve fertility 
when ovarian tissue transplantation is contraindicated. Each cell component that 
makes up the follicle (oocyte, granulosa cells and stromal cells) makes significant 
contributions to regulating follicle growth and in regulating the quality of follicles at 
all stages. Given that the majority of follicles within the ovarian cortex are at the 
dormant, primordial follicle stage, any IVG system must begin with the activation of 
this stage (Telfer and Zelinski, 2013). However, uninhibited growth in vitro at this 
stage has become a significant concern as it could lead to perturbation of tightly 
regulated growth patterns and possibly intercellular communication throughout the 
culture period and ultimately the development of poor-quality oocytes.  
 
The process of follicle development is species-specific with each having a specific 
timescale in vivo (Smitz and Cortvrindt, 2002). The approximate length of follicular 
growth from primordial to primary follicle is at least 120 days in the human, and it 
takes about 65 days for primary follicles to reach the early antral stage (Gougeon, 
1986) although it is not known if this is continuous growth or a start-stop process. 
Meanwhile, it requires several months in large domestic animals (Smitz and 
Cortvrindt, 2002). Despite the risk of precocious growth during in vitro follicle culture, 
a multi-step IVG system established in our group has demonstrated the capacity to 
produce mature human oocytes developed from primordial follicles entirely in vitro 
(McLaughlin et al., 2018). This has provided proof of principle, but the outcomes need 
to be improved in terms of optimising oocyte quality and yield. The work presented in 
this thesis focused on the first two stages of the IVG system which are 1) primordial 
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follicle activation and 2) preantral follicle isolation with growth to antral stage of 
development. Experiments were designed to alter the rate of activation and to 
determine how this affected subsequent development. The overall aim of this thesis 
was to further investigate and determine the effects of pharmacological activation 
utilising the PI3K/Akt/mTOR signalling pathway on follicle growth and DDR of both 
oocytes and granulosa cells in vitro. A primary focus was to explore the DDR function 
in oocytes and granulosa cells with the aim of gaining a better understanding of follicle 
quality and to provide indications on how to improve the IVG system. The bovine 
ovary shares the same characteristics as humans, in term of morphology and function 
(Adams et al., 2012). In addition, because the bovine tissue was more readily available, 
it was used in all of the experiments carried out in this thesis.  
 
6.1.1. The Impact of PI3K/Akt Pathway Modulation on Follicular Growth, 
Survival and DDR 
The PI3K/Akt/mTOR pathway within the oocyte is the primary pathway controlling 
primordial follicle activation. The activation rate is an accumulative effect of all 
substrates involved in this pathway and determined by the delicate balance between 
stimulatory and inhibitory signals (Adhikari and Liu, 2009). The work reported in this 
thesis has revealed that bovine ovarian cortical strips exposed to an inhibitor of PTEN 
(bpv(HOpic)) leads to increased primordial follicle activation but that this is associated 
with increased DNA damage and attenuated DNA repair capacity of both oocytes and 
granulosa cells in vitro. PTEN is an essential factor in normal cell growth in oocytes 
and in proliferation of granulosa cells (Jagarlamudi et al., 2009, Reddy et al., 2008). 
An excessive increase of Akt, caused by PTEN inhibition, may compromise HR 
activity leading to genomic instability. This condition also plays a pivotal role in the 
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pathology of cancer as Akt inhibits apoptosis and increases cell proliferation (Plo et 
al., 2008). 
 
The role of the Hippo signalling pathway was not directly investigated in this study, 
nevertheless, the way the tissue was prepared by cutting the cortex into pieces of 1 mm 
thick, removing excess stroma and then gently stretching fragments would be expected 
to induce Hippo pathway activity within the tissue, as has been previously 
demonstrated in the mouse and human ovary (Kawamura et al., 2013). Disrupting the 
Hippo pathway may be the underlying mechanism of primordial follicle activation in 
the absence of PTEN inhibition (control group) as was shown by increased the 
proportion of activated follicles more than 50% after 6 days of culture. This finding 
confirmed that the culture system is capable of supporting primordial follicle 
activation. The presence of PTEN inhibition in the culture media further augments the 
activation. Ultimately, an increase in primordial follicle activation in the PTEN 
inhibition group is an accumulative consequence of both PI3K modulation and Hippo 
pathway disruption (Grosbois and Demeestere, 2018, Kawamura et al., 2013, Li et al., 
2010a). However, it should be pointed out that disrupting the Hippo pathway has also 
been linked to cancer pathology (Fan et al., 2017a). Inactivation of the Hippo pathway 
has been delineated to confine cancer cells transformation in response to DNA 
damage. In response to DNA damage, the Hippo pathway may trigger either cell death 
or preserved genome integrity (Pefani and O'Neill, 2016). 
 
The involvement of PI3K/Akt activation in our experiments could be the cause of 
impaired DDR in oocytes and granulosa cells. Excessive PI3K/Akt activity leads to an 
increase in DNA damage with limited DNA repair. This increase in activity has been 
connected to the rapid loss of the primordial follicle pool and accelerated ovarian 
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ageing (Reddy et al., 2008, Reddy et al., 2009), whether it be age related (Govindaraj 
et al., 2015, Oktay et al., 2015, Titus et al., 2013, Zhang et al., 2015) or following 
genotoxic insults to DNA(Chang et al., 2015, Kerr et al., 2012b, Lin et al., 2017, 
Nguyen et al., 2018, Rinaldi et al., 2017, Wang et al., 2019b).  
 
Likewise, there are some interesting data showing an association between increased 
PI3K/Akt activity and endometriosis (Barra et al., 2018, Govatati et al., 2014, 
Madanes et al., 2019, Makker et al., 2012, Takeuchi et al., 2019, Yin et al., 2012). 
Primordial follicle loss in endometriosis has been hypothesised as a cause of PI3K/Akt 
upregulation in mice and human (Takeuchi et al., 2019) and is suggested to be 
responsible for ovarian ageing in women with endometriosis (Kitajima et al., 2014). 
Diminished ovarian reserved in endometriosis patients occurs concomitantly with 
compromised DSB repair mechanism (Choi et al., 2018).  
 
Considering that PI3K/Akt signalling pathway upregulation enhances resting follicle 
growth in vitro, but with increased DNA damage and impaired DNA repair, we 
extended the investigation by lowering the activation rate. Rapamycin, an mTOR 
inhibitor, has been shown to prolong cell lifespan and enhance metabolic function 
(Kennedy and Lamming, 2016). The use of an mTOR inhibitor has been beneficial to 
prevent excessive primordial follicle activation and maintain the primordial follicle 
pool (Zhou et al., 2017). A series of publications have investigated the impact of 
chemotherapy on DDR of both oocytes and granulosa cells in a range of species. The 
fact that rapamycin prevents primordial follicle loss against chemotherapy is due to its 
mechanism to inhibit PI3K/Akt/mTOR activation (Goldman et al., 2017, Zhou et al., 
2017), supporting utilisation of this substrate to lower the activation rate as was 
designed in the experiments in chapter 4. We tested the hypothesis that the presence 
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of rapamycin in the culture media could ameliorate the effects of PI3K induced 
excessive activation and improve DDR of both oocytes and granulosa cells during 
ovarian fragment culture. We further investigated whether rapamycin alone, by 
reducing follicle activation, might promote similar effects on DDR as the control group 
or even better. 
 
The results presented in chapter 4 demonstrated that the addition of rapamycin in 
culture media combined with a low dose of bpv(HOpic) enhanced follicle activation 
but at a significantly lower rate compared to PTEN inhibition alone. However, DNA 
damage decreased, with increased expression of the DNA repair proteins MRE11, 
ATM and Rad51 in mainly non-growing and primary follicles. DNA damage was 
significantly lower in granulosa cells of primary follicles in the presence of rapamycin 
either on its own or in combination with bpv(Hopic) compared to the PTEN inhibition 
group. In parallel with our findings, the administration of rapamycin as a co-treatment 
with CP was able to amend the follicle loss and decreased AMH level caused by CP 
in a mouse model (Zhou et al., 2017). Similarly, everolimus, another mTOR inhibitor, 
has been shown to be capable of preventing follicle loss following cisplatin treatment. 
Similar outcomes are also revealed when both mTORC1 and 2 are inhibited in mice 
(Goldman et al., 2017).  
 
The efficacy of mTOR inhibition to attenuate PI3K/Akt activity has been implicated 
in preclinical studies to reduce the growth of endometriosis implants (Kacan et al., 
2017, Lee and Kim, 2014, Matsuzaki et al., 2018). Recently, a study in mice 
demonstrated that PI3K/Akt inhibition was sufficient to reduce follicle loss caused by 
endometriosis (Takeuchi et al., 2019). It is known that both of these situations have 
been associated with increased DNA damage and compromised DSB repair 
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mechanism (Choi et al., 2018, Kim and Suh, 2014, Kujjo et al., 2010, Kujjo et al., 
2012, Nguyen et al., 2019, Soleimani et al., 2011) suggesting that rapamycin might be 
beneficial to mitigate the negative impact of PI3K/Akt activation on DDR of follicular 
growth in vitro. This is consistent with our findings. It has been reported that JH2AX 
expression is upregulated both in endometrium and ovarian tissue of patients with 
endometriosis. DNA repair proteins ATM, Rad51 and BRCA1 are significantly 
attenuated in parallel with decreased ovarian reserve indicated by low AMH serum 
concentration (Choi et al., 2018). Hence, the mechanism underpinning follicle loss, 
ovarian ageing and DNA damage in endometriosis may be similar to chemotherapy-
induced damage to oocytes. It is intriguing to note that oocytes and granulosa cells 
within the follicles in endometriotic ovarian tissue may be more vulnerable to 
genotoxic exposure, as is shown by increased DNA damage propensity (Choi et al., 
2018). 
 
6.1.2. The Impact of PI3K/Akt Pathway Modulation on Preantral Follicle 
Growth and DDR 
In contrast to primordial follicles that can be grown within ovarian cortical fragments, 
growth beyond the preantral stage is inhibited within the dense human and bovine 
ovarian stromal. In this respect, preantral follicles must be removed and then cultured 
individually in V-bottom 96 well plates (McLaughlin et al., 2010a, McLaughlin et al., 
2010b, McLaughlin et al., 2018). Human (Telfer et al., 2008) and bovine (McLaughlin 
and Telfer, 2010) primordial follicle activation and development to secondary stage 
follicles within ovarian cortical fragments has been achieved by utilising the first 2 
stages of this IVG system. In chapter 5, the impact of the treatments on growth, 
survival, and DDR response of isolated follicles cultured for another 6 to 8 days 
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following primordial follicle activation was explored. The results demonstrated that 
the overall morphological health of follicles was reduced, and a low number of antral 
follicles was obtained, suggesting the ability of follicles to grow beyond 6 days in 
culture merits further study. The observed antral follicle formation is an indication that 
the isolated follicles can be grown in vitro. However, the presence of PTEN inhibition 
during culture of ovarian cortex is associated with impaired growth of isolated 
preantral follicles, which is in line with the observed compromised DNA repair 
proteins ATM and Rad51.  
 
The impact of treatments on granulosa cell communication was further studied by 
monitoring Cx43 expression. This study demonstrated that Cx43 expression was 
significantly increased in the control group, concomitant with a higher proportion of 
follicles surviving in this group. Loss of cellular connections has been a recurring 
feature in IVG systems and is linked to accelerated follicular growth in vitro (Smitz 
and Cortvrindt, 2002). Cx43 plays an essential role in granulosa cell communication 
as has been highlighted in a null mouse model. Cx43 ablation in mice delayed oocyte 
development (Ackert et al., 2001). Follicles lacking Cx43 fail to become multilaminar 
with reduced intercellular connections (Ackert et al., 2001). 
 
6.3. Concluding Remarks 
The work in this thesis has demonstrated that increased primordial follicle activation 
due to PI3K/Akt signalling activity induces DNA damage and compromises DNA 
repair proteins within both oocytes and granulosa cells in vitro. The outcomes 
presented in this thesis also provide some new insights into the effect of 
downregulating the PI3K/Akt pathway and its impact on follicular development as 
well as on DDR of oocytes and granulosa cells in vitro. It has been identified that 
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increased DNA damage with limited DNA repair in oocytes and granulosa cells is 
ameliorated by the presence of rapamycin in culture media. Data presented here 
suggests the interaction between substrates involved in the PI3K/Akt/mTOR pathway 
affects follicular growth in vitro. The presence of rapamycin in ovarian cortical strip 
culture reduces the adverse effects of PI3K/Akt on DDR of both oocytes and granulosa 
cells in vitro. Nevertheless, cumulative effects of interactions between all DNA 
damage and DNA repair proteins in the presence of rapamycin, do not mitigate the 
negative impacts of PI3K/Akt on DDR in isolated preantral follicle growth cultured 
individually for another 6 days. The overall findings in this thesis suggest that an 
mTORC1 inhibitor can be a functional pharmacological agent to reduce the activation 
rate and may be beneficial to improve follicle growth and survival. This positive effect 
at step 1 was not maintained in isolated growing follicles. Before the use of these 
factors can be applied clinically, further research on human tissue is required.  
 
6.4. Future Direction 
The outcomes presented in this thesis could form the basis of a new approach to 
improve IVG systems. These findings raised issues that remain to be addressed and 
should be further investigated, including the long-term impacts and implication of 
manipulating the PI3K/Akt/mTOR and the Hippo signalling pathways. Given that the 
canonical PI3K/Akt signalling pathway controls a myriad of cellular functions, further 
studies on how PI3K/Akt triggers DNA damage are required. 
 
From a clinical perspective, the development of IVG systems for endometriosis 
patients is another intriguing direction for future research. An increase in growing 
follicles alongside reduced primordial follicles in endometriosis may represent a 
persistent process of follicle activation and loss leading to a global decrease in ovarian 
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reserve (Carrillo et al., 2016). The use of agents to limit activation may be constructive 
to improve DDR in endometriosis patients. Since the study has been limited to mice 
(Takeuchi et al., 2019), IVG system in endometriosis patients with mTOR inhibition 
treatments could be considered to counteract impaired DDR associated PI3K/Akt 
activation. This approach in developing IVG systems in endometriosis patients could 
provide a new opportunity for fertility enhancement or preservation for these patients.  
 
IVA methods have raised controversy regarding efficacy and safety with in vitro 
studies indicating that manipulating activation by pharmacological methods has an 
impact on subsequent quality of oocytes (Grosbois and Demeestere, 2018, Lerer-
Serfaty et al., 2013, McLaughlin et al., 2014). It should be pointed out that the 
PI3K/Akt signalling pathway has also been linked to primordial follicle loss following 
ovarian tissue transplantation. Attempts to prevent follicle loss following tissue 
transplantation have been considered. It has been shown recently that an IVA protocol 
utilising both PI3K/Akt and Hippo signalling pathways prior to ovarian tissue 
transplantation may have disastrous consequences on follicle health (Dolmans et al., 
2007, Gavish et al., 2018, Roness et al., 2013). It remains uncertain whether IVA 
procedure prior to ovarian tissue transplantation was truly effective emphasising the 
necessity for further in-depth investigations focused on clinical implication, technical 
improvement, long term safety, and efficacy. Future research on whether the 
administration of a substrate to limit follicle activation prior to ovarian tissue 
transplantation will be more beneficial to counteract follicle loss after transplantation. 
 
Many studies have been carried out by targeting DNA damage and DNA damage 
repair capacity of oocytes and granulosa cells, including prevention of ovarian damage 
against chemotherapy, radiation or environmental toxicants. The future direction 
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should be focused on whether it is feasible to increase DNA repair capacity in oocytes. 
DNA repair mechanisms targeting ATM have been used to protect the ovary against 
Phosphoramide mustard (PM). ATM inhibition increases the number of large primary 
follicles following exposure to PM, suggesting the potential use of ATM inhibition to 
increase the viability and maturation of ovarian follicles exposed to PM (Ganesan and 
Keating, 2016a).  
 
It is worth considering that DNA damage heralds apoptotic events and may exist 
without any significant morphological alterations. Moreover, the cell’s aptitude to 
mend the damage determines the balance between cell survival and apoptosis. In this 
perspective, attempts to optimise the DDR efficiency may be beneficial to improve 
oocyte quality either in vivo or in vitro. However, all of these studies have been 
conducted experimentally and merit further investigation prior to considering any 
clinical application. In this context, further research emphasising either the most 
appropriate timing or the dose of mTOR administration are required. 
 
The work presented in this thesis demonstrates that the presence of rapamycin in the 
culture media is not sufficient to improve the growth and survival of isolated preantral 
follicles. Interestingly, the overall follicle survival is low. Future studies are required 
to investigate all aspects involved in the culture system that might influence outcomes, 
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STUDY QUESTION: Does ovarian follicle activation by phosphatase homologue of chromosome-10 (PTEN) inhibition affect DNA dam-
age and repair in bovine oocytes and granulosa cells?
SUMMARY ANSWER: PTEN inhibition promotes bovine non-growing follicle activation but results in increased DNA damage and
impaired DNA repair capacity in ovarian follicles in vitro.
WHAT IS KNOWN ALREADY: Inhibition of PTEN is known to activate primordial follicles but may compromise further developmental
potential. In breast cancer cells, PTEN inhibition represses nuclear translocation of breast cancer susceptibility 1 (BRCA1) and Rad51; this
impairs DNA repair resulting in an accumulation of damaged DNA, which contributes to cell senescence.
STUDY DESIGN, SIZE, DURATION: Bovine ovarian tissue fragments were exposed to control medium alone or containing either 1 or
10 μM bpv(HOpic), a pharmacological inhibitor of PTEN, in vitro for 24 h. A sub-group of tissue fragments were collected for Western blot
analysis after bpv(HOpic) exposure. The remainder were incubated in control medium for a further 5 days and then analysed histologically
and by immunohistochemistry to detect DNA damage and repair pathways.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Bovine ovaries were obtained from abattoir-slaughtered heifers. Tissue frag-
ments were exposed to either control medium alone or medium containing either 1 μM or 10 μM bpv(HOpic) for 24 h. Tissue fragments col-
lected after 24 h were subjected to Akt quantification by Western blotting (six to nine fragments per group per experiment). Follicle stage
and morphology were classified in remaining fragments. Immunohistochemical analysis included nuclear exclusion of FOXO3 as a marker of
follicle activation, γH2AX as a marker of DNA damage, meiotic recombination 11 (MRE11), ataxia telangiectasia mutated (ATM), Rad51,
breast cancer susceptibility 1 (BRCA1) and breast cancer susceptibility 2 (BRCA2) as DNA repair factors. A total of 29 550 follicles from
three independent experiments were analysed.
MAIN RESULTS AND THE ROLE OF CHANCE: Tissue fragments exposed to bpv(HOpic) had increased Akt phosphorylation at ser-
ine 473 (pAkt/Akt ratio, 2.25- and 6.23-fold higher in 1 and 10 μM bpv(HOpic) respectively compared to control, P < 0.05). These tissue
fragments contained a significantly higher proportion of growing follicles compared to control (78.6% in 1 μM and 88.7% in 10 μM versus
70.5% in control; P < 0.001). The proportion of morphologically healthy follicles did not differ significantly between 1 μM bpv(HOpic) and
control (P < 0.001) but follicle health was lower in 10 μM compared to 1 μM and control in all follicle types (P < 0.05). DNA damage in
oocytes, indicated by expression of γH2AX, increased following exposure to 1 μM bpv(HOpic) (non-growing, 83%; primary follicles, 76%)
and 10 μM (non-growing, 77%; primary, 84%) compared to control (non-growing, 30% and primary, 59%) (P < 0.05 for all groups). A signifi-
cant reduction in expression of DNA repair proteins MRE11, ATM and Rad51 was observed in oocytes of non-growing and primary follicles
of treatment groups (primary follicles in controls versus 10 μM bpv(HOpic): MRE, 68% versus 47%; ATM, 47% versus 18%; Rad51, 48%
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
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versus 24%), P < 0.05 for all groups. Higher dose bpv(HOpic) also resulted in lower expression of BRCA1 compared to control and 1 μM
bpv(HOpic) (P < 0.001) in non-growing and primary follicles. BRCA2 expression was increased in oocytes of primary follicles in 1 μM bpv
(HOpic) (36%) compared to control (20%, P = 0.010) with a marked decrease in 10 μM (1%, P ≤ 0.001). Granulosa cells of primary and sec-
ondary follicles in bpv(HOpic) groups showed more DNA damage compared to control (P < 0.05). However, bpv(HOpic) did not impact
granulosa cell DNA repair capacity in secondary follicles, but BRCA1 declined significantly in higher dose bpv(HOpic).
LARGE-SCALE DATA: N/A.
LIMITATIONS, REASONS FOR CAUTION: This study focuses on non-growing follicle activation after 6 days culture and may not
reflect DNA damage and repair capacity in later stages of oocyte and follicle growth.
WIDER IMPLICATIONS OF THE FINDINGS: In vitro activation of follicle growth may compromise the bidirectional signalling between
oocyte and granulosa cells necessary for optimal oocyte and follicle health. This large animal model may be useful in optimising follicle activa-
tion protocols with a view to transfer for clinical application.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Indonesia endowment fund for education. No compet-
ing interest.
TRIAL REGISTRATION NUMBER: Not applicable.
Key words: PTEN inhibition / non-growing follicle activation / DNA damage / DNA repair / bovine ovarian follicles / in vitro
Introduction
The phosphatidylinositol 3-kinase (PI3K) signalling pathway appears to
be the primary non-gonadotrophic growth factor signalling pathway
that regulates the growth and differentiation of ovarian follicles
(Dupont and Scaramuzzi, 2016). The balance between PI3K/Akt sub-
strates determines follicle growth acceleration, deceleration, survival
and apoptosis (Liu et al., 2006; Zhou et al., 2017), and phosphatase
homologue of chromosome-10 (PTEN) is a negative regulator of this
pathway. Excessive PI3K activation in mice has been hypothesised to
contribute to premature activation of primordial follicles which in turn
results in depletion of the primordial follicle pool and ovarian aging
(Reddy et al., 2008; Sobinoff et al., 2012). Inhibition of PTEN in cul-
tured human ovarian cortex results in increased activation of primor-
dial follicles and more secondary follicles, however the subsequent
growth and survival of those apparently healthy isolated secondary fol-
licles is compromised (McLaughlin et al., 2014; Grosbois and
Demeestere, 2018).
This finding might be related to the role of PTEN in maintaining gen-
omic integrity (Shen et al., 2007), promoting and regulating cell growth
and survival (Reddy et al., 2008; Jagarlamudi et al., 2009). Akt activa-
tion during cell cycles in normal cell proliferation upregulates numer-
ous substrates at the G1/S and G2/M transition, some of which are
involved in DNA damage repair pathway. DNA damage is the starting
event of apoptosis and can be detected even in the absence of mor-
phological changes. It is suggested that the PI3K/Akt pathway initiates
checkpoint kinase 1 (Chk1) phosphorylation during DNA damage
response cascade at G2 arrest (Xu et al., 2010), thus allowing time for
DNA repair processing.
Effects of PTEN inhibition on DNA damage response have been
reported in many different types of cancer (Altiok et al., 1999; Plo
et al., 2008; Golding et al., 2009; Fraser et al., 2012) with varying out-
comes. Endogenously high levels of Akt decreases homologous recom-
bination repair capacity of DNA double-strand breaks (DSBs) (Brunet
et al., 1999; Thacker, 2005; Plo et al., 2008; Jia et al., 2013). In addition,
a study using a breast cancer cell line showed that high intracellular
levels of Akt repressed nuclear translocation of breast cancer suscepti-
bility 1 (BRCA1) and Rad51, resulting in the lack of homologous
recombination of DNA DSB repair (Plo et al., 2008). Upregulation of
the PI3K/Akt pathway can also generate spontaneous DNA breaks
and pose a significant threat to genome stability by inhibition of Chk1
(Puc and Parsons, 2005). On the other hand, low protein kinase B
(Akt) activity has been shown to impair the DNA damage repair
mechanism by non-homologous end joining in human glioma cells (Kao
et al., 2007; Golding et al., 2009).
Taken together, these findings support the idea that oocytes lacking
PTEN may accumulate DNA damage, with reduced DNA damage
repair capacity. DNA DSBs are the most detrimental type of damage,
but they do not occur as frequently as other lesions. Persistent unre-
paired DNA DSBs may lead to genomic instability (Khanna and
Jackson, 2001; Jackson and Bartek, 2009; Menezo et al., 2010; Titus
et al., 2013) and the capacity of the cell to repair the damage will influ-
ence the balance between cell survival and apoptosis (Bzymek et al.,
2010; Torgovnick and Schumacher, 2015). In oocytes and granulosa
cells, unrepaired DNA DSBs may potentially impact upon the quality
of oocytes (Carroll and Marangos, 2013; Oktay et al., 2015; Winship
et al., 2018). In this study, our aim was to determine whether PTEN
inhibition affected DNA damage and repair mechanisms in bovine
ovarian follicles activated in vitro, using a serum-free culture system.
We have shown that this system is able to maintain follicular growth
and support oocyte development in vitro using bovine and human ovar-
ies (Telfer et al., 2008; McLaughlin and Telfer, 2010).
Materials andMethods
Ovarian cortical tissue collection,
preparation
Bovine ovaries were obtained from the abattoir and collected in pre-
warmed culture medium M199 (HEPES buffered) (Gibco BRL, Life
Technologies Ltd., Paisley, Renfrewshire, UK) supplemented with sodium
pyruvate (2mM), glutamine (2mM), bovine serum albumin (BSA) (3mg/ml),
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penicillin G (75 μg/ml), streptomycin (50 μg/ml) and amphotericin B (2.5 μg/
ml) (all chemicals from Sigma-Aldrich Chemicals, Poole, Dorset, UK). At the
laboratory, thin slices of ovarian cortex were removed from the ovaries using
a scalpel blade no. 24 and then transferred into fresh dissection medium com-
prising preheated Leibovitz medium (Gibco BRL) supplemented with sodium
pyruvate (2mM), glutamine (2mM), BSA (Fraction V. 3mg/ml), penicillin G
(75 μg/ml) and streptomycin (50 μg/ml). Excess stromal tissue was trimmed
using forceps and a scalpel blade. The tissue was gently stretched using the
blunt edge of a scalpel blade with the cortex uppermost and cut into small
strips sized 4mm× 2mm× 1mm. Any follicles measuring >40 μm were
excised from the tissue fragments.
Ovarian tissue fragments culture
Basic culture medium was prepared from McCoy’s 5a medium with bicarbon-
ate and HEPES (20mM) (GIbco BRL) supplemented with BSA (1mg/ml), glu-
tamine (3mM), penicillin G (0.1 mg/ml), streptomycin (0.1mg/ml),
transferrin (2.5 μg/ml), sodium selenite (4 ng/ml), insulin (l0 ng/ml), hFSH
(1 ng/ml) and ascorbic acid (50 μg/ml) (all obtained from Sigma-Aldrich
Chemicals). Before use, the medium was equilibrated at 37°C in humidified
air with 5% CO2.
Following tissue preparation and cutting, 10–12 fragments per culture
were randomly selected as 0 h controls for histological examination. The
remaining tissue fragments were cultured in flat-bottomed 24-well culture
plates (Corning Costar Europe, Badhoevedorp, The Netherlands) contain-
ing 300 μl of basic culture medium or culture medium supplemented with
the PTEN inhibitor dipotassium bisperoxo(5-hydroxypyridine-2-carboxyl)
oxovanadate (V) (bpv(HOpic) (Merck Millipore Chemicals Ltd, UK) at 1
or 10 μM at 37°C in humidified air with 5% CO2. After 24 h, all media was
removed from tissue fragments and replaced with fresh basic culture
medium. At this point, 6–9 tissue fragments from each group were snap-
frozen and stored at −80°C for Western blot analysis of Akt
phosphorylation.
Remaining tissue fragments were incubated for a further 5 days, with half
the media removed and replaced with fresh on alternate days. On comple-
tion of the culture period, all remaining tissue fragments were fixed in 10%
normal buffered formalin (NBF) for histological examination to determine
the effect of PTEN inhibitor on follicle and oocyte development.
Histological methods and tissue analysis
After fixation in NBF for 24 h, tissues were further processed and embed-
ded individually into paraffin wax blocks and serially sectioned at 5 μm
thickness. Sections were mounted on Super Frost Plus slides (VWR
International Ltd., Leicestershire, UK). For all morphological and numerical
analyses, the examiner was blinded to the treatment groups. Analysis of
follicles within tissue fragments was performed on every section under the
light microscope with a crossed micrometre under 40× magnification.
Follicle developmental stage was categorised using a modification of an
established system (Pedersen and Peters, 1968). Primordial and transitory
follicles were classified as non-growing due to the evidence suggesting that
in the bovine ovary these follicles are in quiescence (van Wezel and
Rodgers, 1996). The number of follicles within each stage of development
was recorded, for Day 0 and Day 6 of each treatment. The classification of
healthy follicles was based on the same criteria as in Telfer et al. with modi-
fications (Telfer et al., 2008). For follicles to be categorised as morpho-
logically normal the oocyte must be grossly circular, surrounded by a zona
pellucida, have a visible germinal vesicle and defined nucleolus and have
<10% of pyknotic granulosa cells present. The proportion of follicles at dif-
ferent developmental stages was defined as a percentage of morphologic-
ally healthy follicles over the total follicle count (Brunet et al., 1999).
Immunohistochemistry
Quantitative analysis of DNA damage was performed using immunofluor-
escence. DNA damage repair proteins were localised in tissue sections
using antibodies against Rad51 (137323; 1:500; Abcam), meiotic recom-
bination (MRE) 11 (NB100-142; 1:1000; Novusbio), BRCA1 (Ab16781;
1:200; Abcam), ATM (ab78; 1:500; Abcam) and BRCA2 (Ab27976; 1:200;
Abcam). Nuclear exclusion of FOXO3 was detected using immunohisto-
chemistry (NBP2-24579; 1:500; Novusbio).
Tissue sections mounted on slides were dewaxed in xylene and rehy-
drated through decreasing concentrations of alcohol before being
immersed in tris-buffered saline with 0.05% (v/v) Tween 20 (TBST).
Antigen retrieval was performed by microwaving the slides in 10 mM
sodium citrate (pH 6.0) at simmer setting for 20 min. Following antigen
retrieval, the slides were washed in TBST (2 × 5 min) and then immersed
in 3% (v/v) hydrogen peroxide to quench endogenous peroxidase activity.
After 2 × 5 min washes in TBST, sections were incubated with appropriate
blocking solution for 1 h (150 μl goat serum or horse serum in 10 ml TBST
followed by overnight incubation with the diluted primary antibodies at
4°C. Primary antibody was replaced with blocking solution for negative
controls.
Primary antibody was washed off, and sections were incubated for
30 min with biotinylated secondary antibody at room temperature
(Vectastain Elite ABC kit; Vector Laboratories, Peterborough, UK) and
then washed in TBST (2 × 5 min). Slides were then incubated with
Streptavidin Horseradish Peroxidase (Streptavidin horse-radish peroxid-
ase; HRP) for 30 min at room temperature. Following a TBST wash DAB
(3,3′-diaminobenzidine) peroxidase substrate kit (Vector Laboratories)
solution was added to the sections for between 2 and 5 min and counter-
stained with haematoxylin for 20 s, dehydrated in graded alcohol, cleared
and then mounted with dibutylphthalate polystyrene xylene (DPX).
Immunofluorescence
Localisation of γH2AX (a marker of DNA damage) was detected by
immunofluorescence. As previously described mounted tissue sections
were deparaffinised and rehydrated and then washed in PBS with 0.1% (v/v)
Triton X-100 (PBST) (pH 7.2–7.4) for 2× 5 min. Then, the slides were sub-
jected to high temperature antigen retrieval as described earlier and incu-
bated for 1 h at RT with blocking solution (5%, v/v, goat serum in PBST).
Tissue sections were then probed with primary antibody (1:1000) against
γH2AX (NB100-384; Novusbio) overnight at 4°C. Blocking solution without
primary antibody served as negative control. After washing with PBST (4×
10min), sections were incubated with appropriate secondary antibodies
(Cy3-conjugated affinity pure donkey anti rabbit IgG [H + L], 1:250; Jackson
Laboratories) for 2 hours and then washed for 2× 10min. The slides were
then mounted in Vectashield hardset with 4′-6-diamidino-2-phenylindole
(DAPI) (H-1500; Vector Laboratories).
Images were analysed using ImageJ and γH2AX expression in oocytes
and granulosa cells determined. The number of oocytes with γH2AX foci
per total number of follicles was calculated. The γH2AX expression in
granulosa cells was quantitatively analysed by calculating the proportion of
γH2AX positive granulosa cells per total number of granulosa cells per fol-
licle. Images were captured using a Zeiss LSM 800 confocal microscope
with X20 magnification in the IMPACT imaging facility (Centre for
Discovery Brain Sciences, The University of Edinburgh).
Western blotting
Ovarian cortical strips (6–9 per group per experiment) were suspended in
radio immunoprecipitation assay buffer (RIPA) extraction buffer (Fisher
Scientific, Loughborough, UK) supplemented with 1% v/v Halt Protease
and Phosphatase Inhibitor Cocktail (PI) (Thermo Scientific, Loughborough,
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UK). The tissue was cut with scissors and homogenised. Proteins were
detected using a slightly modified protocol as previously described
(Clarkson et al., 2018). In brief, the sample was centrifuged at 3400 × g for
5 min and protein was purified using Vivaspin tubes (Sartorius
Mechatronics Ltd, Epsom, UK) with 50 kDa filters. Protein concentration
was measured using Coomassie-Plus Reagent (Thermo Scientific Pierce,
Northumberland, UK). Protein samples were denatured at 100°C for
10 min, 20 μg was loaded onto 4–20% gradient gels (Life Technologies,
Paisley, UK) in Tris-glycine/SDS running buffer (25 mM Tris-HCl, 52 mM
glycine, 0.1% SDS) and run at 125 V for 1 h. Proteins were transferred to
nitrocellulose membranes (Amersham Pharmacia). Bovine serum albumin
(BSA) (5%, w/v) in TBST was used to block the nitrocellulose membranes
for 1 h at room temperature with gentle agitation. Blots were then incu-
bated, with a rabbit monoclonal antibody against Akt (9272, 1:5000; Cell
Signaling) or rabbit polyclonal antibody against Akt phosphorylated at ser-
ine 473 (ab81283, 1:500; Abcam) and with a mouse monoclonal antibody
against alpha tubulin (ab7291, 1:5000; Abcam) as a loading control, over-
night at 4°C with gentle agitation. Blots were washed in 0.1% TBST and
then incubated with appropriate secondary antibodies, a goat polyclonal
antibody raised against mouse IgG (heavy and light chain) (115-035-146;
Jackson Laboratory) or rabbit IgG (H + L) (111-035-003) 1:5000 in 5%
BSA for 1 h at room temperature. To enhance chemiluminescence detec-
tion, nitrocellulose membranes were placed in Amersham (ECL) prime
Western blotting detection reagent (GE Health Care) for 1 min and
exposed to autoradiographic film. Western blots were digitally scanned
and analysed using ImageJ. All analysis was normalised to alpha tubulin.
Statistical analyses
All data were analysed using the SPSS statistical software version 22 (SPSS,
Inc., Chicago, USA) and GraphPad Software version 7 (GraphPad
Software Inc., San Diego, CA, USA). Quantitative data are presented as
mean ± SEM. Chi-squared test was used to analyse the percentage of
healthy and unhealthy follicles, the distribution of follicle stages and the
proportion of oocytes expressing proteins related to DNA damage and
DNA DSB repair. Granulosa cell expression of γH2AX, MRE11, ATM,
Rad51, BRCA1 and BRCA2 was determined using one-way ANOVA test
followed by Bonferroni post hoc test. Statistical significance was assigned at
P ≤ 0.05.
Results
Analysis of follicle distribution
A total of 32 ovarian cortical fragments were obtained on Day 0 from
three culture replicates, and a total of 8833 follicles were analysed.
Non-growing follicles were the most prevalent on Day 0, constituting
79.6% of total follicle number. The majority of the remaining follicles
were at the primary stage (19.0%) and a small percentage were at sec-
ondary stage (1.4%) (Table I). More than 80% of all follicles at Day 0
were healthy (Fig. 1). No antral follicles were observed at Day 0 (D0)
in any tissue fragments.
Assessment of follicle activation and survival
Analysis of 20 717 follicles from a total of 147 ovarian cortical tissue
fragments (n = 15–18 fragments per group per culture) after 6 days of
culture showed that the proportion of non-growing follicles declined
significantly in all groups compared to D0 (Table I). This decline was
balanced by a significant increase in the percentage of growing follicles
(primary and secondary follicles in D0: 20.4%, control: 70.5%, 1 μM
bpv(HOpic): 78.6% and 10 μM bpv(HOpic): 88.7%) (P < 0.001 for all
groups). A greater proportion of growing follicles was observed in
10 μM bpv(HOpic) compared to control and 1 μM bpv(HOpic) (P <
0.001 for all groups). Secondary follicles were the most mature grow-
ing follicle stage observed in all groups. The proportion of follicles pro-
gressing to the secondary stage in the presence of bpv(HOpic) was
significantly higher compared to control (1 μM: 9.7%, 10 μM: 10.6%,
control: 6.2%) (P < 0.05). No significant difference was observed
between 1 and 10 μM bpv(HOpic) (P = 0.530). The higher concentration
of bpv(HOpic) resulted in a reduction in the proportion of morphologic-
ally healthy follicles at all stages. This was seen for both non-growing (P <
0.05 for all groups) and growing follicles (P < 0.001 for primary and sec-
ondary follicles) compared to control and 1 μM bpv(HOpic) (Fig. 1).
The effects of bpv(HOpic) on PI3K
downstream pathway activation
To assess the nuclear exclusion of FOXO3 as an effect of PTEN inhibi-
tor on the PI3K pathway, FOXO3 localisation was determined by
immunohistochemistry (Fig. 2A–D). A total of 1704 follicles were ana-
lysed over three separate cultures and the mean percentage ± SEM of
oocytes showing nuclear exclusion of FOXO3 was calculated (Fig. 2A).
A significant increase in nuclear exclusion of FOXO3 was observed in
oocytes contained within tissue exposed to bpv(HOpic) 1 μM (69.1 ±
11.7%; P = 0.008) and 10 μM (81.2 ± 12.4%; P = 0.003) compared to
controls (38.3 ± 9.2%). Furthermore, the proportion of follicles with
nuclear exclusion of FOXO3 was significantly higher in 10 μM compared
to 1 μM (P = 0.020) (Fig. 2A).
Western blot analysis showed an increase in the ratio of pAkt
(Ser473) to Akt in bpv(HOpic) exposed tissue compared to control
(2.25- and 6.23-fold higher in 1 and 10 μM bpv(HOpic) respectively,
P < 0.05) (Fig. 2E and F). A significant increase was observed in the
higher concentration of bpv(HOpic) compared to 1 μM (P = 0.030)
(Fig. 2F).
The effects of PTEN inhibitor on DNA
damage and DNADSB repair capacity in
follicles
γH2AX binds at DNA strand breaks and is a marker of DNA damage.
Localisation of γH2AX in each of the groups was analysed in oocytes
(Fig. 3A–E) and granulosa cells (Fig. 3F–H). After 6 days of culture,
γH2AX expression was reduced from 79% (D0) to 30 and 59% in
non-growing and primary follicles respectively (P < 0.001) (Fig. 3I).
Culture did not significantly affect γH2AX expression in oocytes of
secondary follicles. However, bpv(HOpic) increased γH2AX expres-
sion in oocytes of all follicle types at both concentrations of bpv(HO)
pic (1 μM: non-growing, 83%; primary, 76%; secondary, 77%; 10 μM:
non-growing, 77%; primary, 84%; secondary, 89%) (P < 0.05), with no
difference between doses (Fig. 3I).
In granulosa cells, γH2AX expression in non-growing follicles did
not significantly differ between groups (Fig. 3J). Similarly, no significant
differences were observed between D0, control and the lower con-
centration of bpv(HOpic) in primary follicles (Fig. 3J). A significant
increase in expression in primary follicles was observed in the higher
(36.9 ± 4.2) compared to the lower concentration (11.8 ± 3.39) and
control (16.9 ± 2.9) (P ≤ 0.001) (Fig. 3J). No differences in γH2AX
expression in granulosa cells of secondary follicles were observed
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between D0 and control; however, significant increases were
observed in both bpv(HOpic) treatment groups (1 μM: 76.9 ± 12.2,
P = 0.024; 10 μM bpv[HOpic]: 77.8 ± 14.0, P = 0.011) compared to
control (16.7 ± 16.7) (Fig. 3F–J). There was no significant difference
between the two concentrations.
Expression of the DNA DSBs repair proteins MRE11 (Fig. 4A1–5)
and ATM (Fig. 4B1–5) was observed in all stages of follicle develop-
ment after 6 days of culture (Fig. 4A and B). MRE11 was decreased in
oocytes in 1 μM (42%) and 10 μM bpv(HOpic) (47%) of primary folli-
cles compared to control (68%) (P < 0.001) (Fig. 4 A6). Similarly, the
expression of MRE11 in granulosa cells declined significantly in the
presence of bpv(HOpic) in non-growing (1 μM: 41.2 ± 2.9%; 10 μM:
52.3 ± 3.9%) and primary follicles (1 μM: 56.2 ± 1.9%; 10 μM: 58.3 ±
2.5%), compared to control (non-growing: 75.9 ± 1.4% and primary
follicles: 79.0 ± 1.8%) (P < 0.05 for all groups). No significant reduction
was observed in secondary follicles with either dose (Fig. 4A7).
ATM, a regulator of the DNA repair downstream pathway, declined
significantly in all types of follicles in bpv(HOpic) groups at Day 6 of
culture. bpv(HOpic) reduced ATM expression in oocytes of primary
follicles from 26% in 1 μM to 18% in 10 μM bpv(HOpic) (P ≤ 0.001)
(Fig. 4B6). In granulosa cells, ATM expression in bpv(HOpic) groups of
non-growing and primary follicles was significantly lower compared to
control (P < 0.05) (Fig. 4B7).
BRCA1, BRCA2 and RAD51 were localised within oocytes and
granulosa cells (Fig. 5A–C). Analysis of 1315 follicles revealed that the
proportion of BRCA1 positive oocytes of non-growing and primary
follicles decreased significantly after 6 days of culture in control group
(19 versus 13% and 22 versus 14% in non-growing and primary folli-
cles, respectively) (P < 0.05) (Fig. 5A6). BRCA1 expression in all fol-
licle types treated with 1 μM bpv(HOpic) did not change significantly
compared to control (P > 0.05). However, there was very low expres-
sion of BRCA1 in all follicle groups treated with 10 μM bpv(HOpic)
(P < 0.001) (Fig. 5A6). Similarly, low expression of BRCA1 was seen in
granulosa cells of growing follicles treated with 10 μM bpv(HOpic)
although granulosa cells of non-growing follicles showed a high level of
expression (Fig. 5A7). BRCA2 expression in oocytes was markedly
increased in 1 μM bpv(HOpic) in primary follicles (36%) compared to
control (20%, P = 0.010) (Fig. 5B6). There was no significant difference
in expression within granulosa cells among all the groups in primary
and secondary follicles (Fig. 5B7).
In contrast, Rad51 expression in oocytes was significantly reduced in
both bpv(HOpic) groups in primary follicles (control versus 1 and
10 μM bpv[HOpic]: 48 versus 34 versus 24%) (P < 0.05), without sig-
nificant changes in secondary follicles (Fig. 5C6). Rad51 expression
was observed infrequently (<10%) in granulosa cells, mainly in second-
ary follicles with no significant changes observed among the groups
(P > 0.05) (Fig. 5C7).
Discussion
Consistent with our previous finding using human tissue (McLaughlin
et al., 2014), bovine ovarian tissue fragments exposed to 1 and 10 μM
bpv(HOpic) for 24 h showed increased primordial follicle activation.
The culture system used in this study supports significant primordial
follicle activation in the control group: recent studies indicate that this
is as a result of disrupting the Hippo signaling pathway during the prep-
aration of the tissue (Kawamura et al., 2013; Hsueh et al., 2015).
Hippo disruption increases expression of downstream growth factors
but manipulation of the PI3K pathway results in further activation
(Kawamura et al., 2013; McLaughlin et al., 2014; Hsueh et al., 2015;
Grosbois and Demeestere, 2018). PI3K pathway activation resulting
from PTEN inhibition was confirmed by increased phosphorylated Akt
expression and nuclear exclusion of FOXO3. However, a deleterious
.............................................................................................................................................................................................
Table I Total number of follicles in each treatment group, at Day 0 and after 6 days of culture. (a), (b), (c) and (d) denote a
significant difference between treatment groups. A significantly greater proportion of primary and secondary follicles were observed in
treatment groups compared to control (P < 0.05).
Group Non-growing follicle n (%) Primary follicle n (%) Secondary follicle n (%) Total
Day-0 7029 (79.6)a 1681 (19.0)a 123 (1.4)a 8833




1 M bpv HOpic
10 M bpv HOpic
6 days of culture
1400 (21.4)c 4513 (68.9)c 633 (9.7)c 6546
880 (11.4)d 6047 (78.1)d 818 (10.6)c 7745
Total 29,550
Figure 1 Proportion of morphologically healthy follicles at
each stage of development. Day 0 (yellow), control medium
(green), 1 μM bpv(HOpic) (red) and 10 μM bpv(HOpic) (blue).
***≤0.001, **≤0.01 and *≤0.05. The total number of follicles analysed
for each stage and treatment is shown in Table I. Data here represent
the proportion that were classified as healthy.
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effect on follicle morphological health was observed with the higher
dose bpv(HOpic), in agreement with data from human ovary (Lerer-
Serfaty et al., 2013; McLaughlin et al., 2014). The present data extend
this by demonstrating that increased activation is associated with
increased DNA damage and reduced DNA repair in ovarian follicles
and, particularly, in oocytes.
Figure 2 Expression of nuclear export of FOXO3 and ratio of phosphorylated Akt and Akt in control and bpv(HOpic) treated tis-
sue. (A) Comparison of oocyte nuclear export of FOXO3 in control and bpv(HOpic) groups. Histogram shows mean percentage ± SEM (from three
cultures per treatment with a minimum of 100 follicles analysed per group) of oocytes showing non-nuclear detection of FOXO3. B-D:
Photomicrographs showing localisation of FOXO3 in bovine follicles. Negative control (B). Non-growing follicles with brown staining in the nucleus
indicating inactivated FOXO3 (red arrow, C), nuclear export of FOXO3 from the nucleus of the activated primary follicles in bpv(HOpic) group indi-
cated by brown staining in the ooplasm and negative staining in the nucleus (black arrow, D). Scale bar = 20 μm. (E) Western blot showing Akt and
phosphorylated Akt (pAkt) expression in all groups. (F) pAkt/Akt ratio following 24 h exposure cultured control (green), 1 μM bpv(HOpic) (red),
10 μM bpv(HOpic) (blue). Lines represent significant differences between groups with a P value of ≤0.05 *.
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The findings in this study support the view that the PTEN/Akt/PI3K
pathway involves other intracellular pathways (Blanco-Aparicio et al.,
2007) that may have negative impacts on follicle growth. PTEN/PI3K/
Akt activity impacts on DNA damage and repair (Hunt et al., 2012;
Ming and He, 2012) and has a central role in coordinating the apop-
tosis cascade activity (Weng et al., 2001; Lu et al., 2016). As DNA
damage precedes the apoptotic process and can be present without
any significant morphological changes, we investigated the effect of
PTEN inhibition on DNA damage and DNA repair capacity of oocytes
and granulosa cells. The bpv(HOpic) concentrations used in this study
were low with a short-term incubation compared to other studies in
human (Novella-Maestre et al., 2015). However, these low concentra-
tions clearly increased DNA damage and compromised DNA repair
capacity of the follicles.
The DNA damage repair pathway involves γH2AX, and this binds
specifically to the location of damage and controls recruitment of
DNA repair proteins. Phosphorylation of γH2AX initiates the down-
stream pathway that leads to DNA repair or cell cycle arrest (Oktay
et al., 2015). We found that γH2AX expression was significantly higher
in uncultured D0 tissue compared to control. However, the high
γH2AX expression level in the D0 group was associated with
increased expression of the DNA DSBs repair proteins MRE11, ATM
Figure 3 Representative images showing localisation by immunofluorescence of γH2AX bovine ovarian tissue in each treatment
group. γH2AX (red) and DAPI (blue) staining in oocyte and granulosa cells (A–H). γH2AX staining appeared as bright points (foci) within nuclei
(white arrows) in oocytes (A-E). The green arrows indicate areas where there is no γH2AX expression (B,C). Negative control (A), γH2AX positive
and negative in the oocytes of day zero (D0) (B) positive and negative staining in cultured control (C); positive staining in 1 μM bpv(HOpic) (D) and
10 μM bpv(HOpic) (E). Localisation of γH2AX expression (white arrows) in granulosa cells (F–H) in control (F), 1 μM (G) and 10 μM bpv(HOpic) (H).
Scale bar = 20 μm. Comparison of proportion of follicles showing γH2AX positive staining in the oocytes (I) and granulosa cells (J) of all groups.
Analysis of 567 follicles from three independent experiments (I and J). The proportion of γH2AX positive oocytes per total number of follicles in each
stage of follicle development (I); expression of γH2AX in granulosa cells (J), mean ± SEM. ***P ≤ 0.001, **P ≤ 0.01 and *P ≤ 0.05. Yellow, D0; green,
cultured control; red,1 μM bpv(HOpic) and blue, 10 μM bpv(HOpic).
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and Rad51 at all stages of follicle development. These breaks could
reflect latent damage due to mild injury during tissue preparation and
transport that appear to be rapidly resolved and may not cause serious
consequences. This type of damage can be repaired directly without
cell cycle arrest (Menezo et al., 2010), as was indicated by the reduc-
tion in γH2AX expression following tissue culture and there being few-
er morphologically unhealthy follicles in the cultured control tissue. All
types of follicles in control cultures generated adequate DNA repair
Figure 4 Immunohistochemical detection of MRE11 and ATM in oocytes and granulosa cells of follicles in all groups.
Photomicrographs of MRE11 localisation (A1–5) and ATM (B1–5) expression in oocytes and granulosa cells. Negative control (1); positive staining
(brown) in the oocytes and granulosa cells of day zero (D0; 2), control (3); 1 μM (4) and 10 μM bpv(HOpic) (5). Scale bar = 20 μm. The proportion of
MRE11 and ATM in oocytes (A6, B6) and granulosa cells (A7, B7) shown as mean percentage ± SEM. Yellow bars, D0; green bars, cultured control;
red bars, bpv(HOpic) 1 μM and blue bars, bpv(HOpic) 10 μM. Total number of follicles analysed: 4659 (MRE) and 5309 (ATM). ***≤0.001, **≤0.01,
*≤0.05. P value was assigned at ≤0.05.
Figure 5 Immunohistochemical detection of BRCA1, BRCA2 and Rad51. Photomicrographs of BRCA1 (A1–5), BRCA2 (B1–5) and
Rad51 (C1–5) expression in oocytes and granulosa cells. Negative control (A1, B1 and C1); positive staining (brown) in the oocytes and granulosa cells
of day zero (D0; A2,B2,C2), control cultures (A3, B3 and C3); 1 μM (A4, B4 and C4) and 10 μM bpv(HOpic) (A5, B and B6). Scale bar = 20 μm. The
proportion of oocytes (A6, B6 and C6) and granulosa cells (A7, B7 and C7) expressing BRCA1, BRCA2 and Rad51 in each treatment group (yellow
bars, D0; green bars, cultured control; red bars, bpv(HOpic) 1 μM and blue bars, bpv(HOpic) 10 μM). Analysis of 1315 (BRCA1), 1134 (BRCA2) and
4148 (Rad51) follicles. ***≤0.001, **≤0.01, *≤0.05. P value was assigned at ≤0.05.
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capacity compared to treatment groups, which may reflect a culture
medium with a nutrient-rich environment that is beneficial to cell
metabolism (Paynter et al., 1999).
DNA damage persisted or increased in the oocytes of both bpv
(HOpic) treatment groups and was not associated with increasing
DNA repair protein expression. In the DNA damage repair pathway,
BRCA2 is indispensable in regulating the activity of Rad51. Increased
BRCA2 expression in oocytes was consistent with the expression of
Rad51 except in the higher dose of bpv(HOpic) of non-growing folli-
cles wherein low level of BRCA2 did not affect Rad51 expression. In
contrast, BRCA2 expression was high in 1 μM bpv(HOpic) exposed
primary follicles but was not associated with increased Rad51 expres-
sion. This may indicate compromised homologous recombination.
This finding may describe the association between Akt activation by
bpv(HOpic) and defects in DNA damage repair protein interactions.
Deficiencies in these interactions have previously been reported in
human and mouse ovarian studies and associated with ageing (Titus
et al., 2013). DNA DSB repair capacity as reflected in BRCA1, BRCA2
and Rad51 was markedly reduced in oocytes exposed to the higher
dose of bpv(HOpic). Activation of Akt has been shown to abolish the
G2 cell cycle checkpoint by delaying nuclear translocation of BRCA1
during DNA DSB repair in a breast cancer cell line. This leads to
deactivation of Chk1 following DNA damage process (Tonic et al.,
2010; Wu et al., 2010). Although we did not quantitatively measure
the intensity of DNA damage indicated by γH2AX expression in this
study, our findings suggest that the DNA damage in the presence of
bpV(HOpic) might be severe with limited repair, which may result in
permanent cell cycle arrest.
Increased expression of γH2AX was observed in granulosa cells of
growing follicles in the bpv(HOpic) treated groups. DNA DSB repair
capacity of secondary follicles was not compromised in all groups,
except BRCA1, which was apparently decreased with higher dose bpv
(HOpic). Interestingly, the lower dose bpv(HOpic) did not affect
expression of BRCA1 in all follicle types. Most of the follicles in higher
dose bpv(HOpic) showed apoptosis after 6 days of culture. One pos-
sible explanation of these findings is that as actively dividing cells, such
as granulosa cells, demonstrate a high metabolic activity and prolifer-
ation rate that will increase with the activation of Akt. In this context,
granulosa cells of secondary follicles are more vulnerable to DNA
induced damage. It seems likely that a decline in the capacity of DNA
repair in granulosa cells happens more slowly than DNA damage, simi-
lar to the process that occurs with ageing (Zhang et al., 2015). The
proportion of morphologically normal follicles did not vary between
1 μM bpv(HOpic) and control group regardless of the presence of
DNA damage and lack of DNA repair capacity. This may reflect a bet-
ter response to DNA damage in low-dose compared to high-dose
group but a study on human tissue has shown that the growth of
apparently healthy preantral follicles isolated after treatment with
1 μM bpv(HOpic) was compromised after a further six days of culture
(McLaughlin et al., 2014). It has been reported that different factors
affect the time period between the occurrence of DNA damage and
apoptotic events (Xiao et al., 2017). This study indicates that the dose
of bpv(HOpic) could also affect this time frame.
It is worth considering the broader significance of these findings
since PTEN inhibition has been used to activate primordial follicles in
POI patients by activating follicles in tissue that is subsequently grafted
back to patients (Suzuki et al., 2015). The present data suggest that
this strategy may be associated with increased DNA breaks and
reduced DNA repair capacity. The impact of DNA damage on
oocytes may range from meiotic dysfunction to cell death (Oktay
et al., 2015), possibly leading to reduced fertility (Kirk and Lyon, 1982;
Meirow et al., 2001; Menezo et al., 2007; Adriaens et al., 2009). More
than 50% of oocytes with severe DNA DSBs can escape apoptosis and
eventually achieve resumption of meiosis to the germinal vesicle break-
down stage in mice, but none of these oocytes develop to metaphase
II (Lin et al., 2014). This indicates that intact DNA DSB repair capacity
in oocytes is pivotal to achieving mature and competent oocytes cap-
able of fertilisation. This study is limited to primordial follicle activation
and implications for later stages of follicle development have not been
assessed. Impairment of human preantral follicle growth has been
demonstrated after bpv(HOpic) treatment in vitro (McLaughlin et al.,
2014), but the implications for mature oocyte development are unex-
plored. We have recently demonstrated that a human in vitro growth
(IVG) system (whose first stage is as used here) can support complete
follicle development resulting in metaphase II oocytes (McLaughlin
et al., 2018). This methodology may be useful to provide additional
insights into DNA damage and DNA repair of oocytes and granulosa
cells, which may subsequently lead to improved IVG systems.
In summary, this study demonstrates that increasing activity of the
PI3AKT pathway by a short exposure of bovine ovarian tissue frag-
ments to bpV(HOpic) results in increased primordial follicle activation.
However, this was accompanied by increased DNA damage and com-
promised DNA DSB repair capacity, in both oocytes and granulosa
cells. These findings highlight the complexities and interactions
between the regulation of initiation of follicle growth and the mainten-
ance of follicle health and indicate the need for caution in developing
pharmacological approaches to manipulation of this pathway for clin-
ical use.
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Abstract: The preservation of genome integrity in the mammalian female germline from primordial
follicle arrest to activation of growth to oocyte maturation is fundamental to ensure reproductive
success. As oocytes are formed before birth and may remain dormant for many years, it is essential
that defence mechanisms are monitored and well maintained. The phosphatase and tensin homolog
of chromosome 10 (PTEN)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB, Akt) is a
major signalling pathway governing primordial follicle recruitment and growth. This pathway also
contributes to cell growth, survival and metabolism, and to the maintenance of genomic integrity.
Accelerated primordial follicle activation through this pathway may result in a compromised DNA
damage response (DDR). Additionally, the distinct DDR mechanisms in oocytes may become less
e cient with ageing. This review considers DNA damage surveillance mechanisms and their links to
the PTEN/PI3K/Akt signalling pathway, impacting on the DDR during growth activation of primordial
follicles, and in ovarian ageing. Targeting DDR mechanisms within oocytes may be of value in
developing techniques to protect ovaries against chemotherapy and in advancing clinical approaches
to regulate primordial follicle activation.
Keywords: PTEN/PI3K/Akt; follicle activation; DNA damage response (DDR); ageing
1. Introduction
In mammalian females, oocytes are formed before birth and are surrounded by somatic cells
(granulosa cells) to form structures known as follicles. Oocytes have entered meiosis and are arrested
at the dictyate stage of prophase I with the most immature stage (primordial follicles) forming the
store of female germ cells that will be utilised throughout reproductive life (reviewed in [1]). The pool
of primordial follicles is progressively reduced with age leading to reproductive senescence [2–4].
Follicles are gradually lost from the pool either through death or by activation of the growth pathway.
Therefore the rates of activation and degeneration determine the size of the pool and the time to onset
of menopause [5]. Once follicles are recruited into the growing pool, pre-granulosa cells di↵erentiate
to form a single layer of cuboidal cells surrounding the oocyte. In parallel, the oocyte increases in
size and undergoes further growth and maturation whilst still being maintained in meiotic arrest.
These processes are referred to as primordial follicle activation [6]. Primordial follicles may be quiescent
for many years and in humans for several decades, highlighting the importance of potential DNA
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damage accumulation [7] that may threaten genomic integrity. In this context, a robust surveillance
mechanism is essential to ensure that oocytes with DNA damage have it repaired or are eliminated
with prevention of further growth and development [8,9], thus maintaining the quality of oocyte and
any resulting embryo throughout the reproductive lifespan [10].
The phosphatase and tensin homolog of chromosome 10 (PTEN)/phosphatidylinositol 3-kinase
(PI3K)/protein kinase B (PKB, Akt) pathway is one of the major non-gonadotropic insulin signalling
pathways that coordinates the activation, growth and di↵erentiation of follicles [6,11]. The pathway
functions to control a myriad of cellular functions involving cell metabolism, proliferation and
survival [12,13]. There is evidence to support the existence of crosstalk between the PI3K/Akt signalling
pathway and the DNA damage response (DDR) in cells [14–16], indicating the importance of the
consequences of interference with one of these pathways on the other. High PI3K/Akt activity is
linked to a decline in the number of primordial follicles and ovarian ageing [17,18]. Ovarian ageing is
associated with impaired DDR within oocytes [19–22] and this can also be induced following exposure
to DNA damaging agents [23–28]. Nevertheless, taking advantage of PI3K/Akt signalling pathway
e↵ects on follicular recruitment, PTEN inhibition, as a central negative regulator of the pathway, has
been widely used to activate primordial follicles in a range of species [18,29–33]. Most importantly,
pregnancies have been achieved in women following transplantation of small fragments of ovarian
cortex after exposure to pharmacological inhibitors of PTEN [34]. Recent studies suggest that activation
of follicles by these methods may be damaging to subsequent growth and survival of follicles [35–37],
indicating that further investigation is required to fully understand the impact and implications of
follicle activation using pharmacological manipulation of this pathway.
A great deal of evidence, discussed below, suggests that the PI3K/PTEN/Akt pathway is essential
in regulating cell-cycle checkpoint initiation and DNA repair and that the lack of PTEN in cells may
cause genomic instability [38,39]. The ability to respond to such damage is crucial to ensure primordial
follicle survival and to support the production of mature oocytes with a minimised risk of meiotic
abnormalities against the adverse effects of age (reviewed in [40]) and ultimately to maintain reproductive
lifespan. Surveillance mechanisms within oocytes to ameliorate DNA damage are essential as, during
reproductive life, oocytes (and granulosa cells) can be subjected to DNA damage: this mainly occurs in
the long-lived primordial follicles as a consequence of external and internal insults [21]. DNA double
strand-breaks (DSBs) do not occur as frequently as other lesions, but persistent unrepaired DNA DSBs are
the most severe type of damage and may lead to genomic instability [21,41–43].
In this review, we will limit the discussion to the DNA damage/DSBs repair pathway, and primarily
focus on the mechanisms used by oocytes within primordial follicles to protect themselves against
DNA damage throughout their lifespan. The DDR mechanism in granulosa cells will be discussed
where relevant. Crosstalk between the PI3K/PTEN/Akt pathway and DDR has been linked to increased
DNA damage and impaired DNA repair protein interactions in ovarian follicles activated in vitro [29].
Such findings will be important in elucidating the impact of pharmacological activation of primordial
follicles by manipulation of the PI3K/PTEN/Akt pathway and its impact on DDR.
2. Methods
Published articles including original research, peer-reviewed and reviews were searched
systematically in PubMed (Medline) database using specific terms such as ‘DNA damage’, ‘oocytes’,
‘primordial follicle activation’, ‘PI3K/Akt’, ‘ovarian ageing’ and ‘chemotherapy’. Abstracts and
conferences proceeding were not included. The search yielded 757 relevant references of English
language literature. Article selection was conducted using Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [44]. The references in these articles were searched
manually to retrieve additional articles, and an additional 19 articles were included. These were
then screened for duplication, to ensure only articles related to DNA damage repair mechanism in
primordial follicles were included. Only original research articles meeting the following eligibility
criteria were included in the final search results: original research articles published from 1990 to 2019,
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full articles available, articles in English and not symposia proceeding. Manuscripts were selected
concerning primordial follicle activation in association with PI3K signalling pathway, ovarian ageing
and DDR in oocytes of immature follicles. A total of 52 published full-text articles were included after
cross-referencing, and 40 articles were analysed qualitatively (Figure 1).
Figure 1. Flow chart following Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines to determine the study included into qualitative analysis.
3. DNA Damage Repair Pathway within Primordial Follicles
The DNA of a cell is continuously threatened by various types of damage that may cause a
reduction in cellular function, cell cycle progression and DNA repair [45]. Exogenous sources of DNA
damage include environmental agents such as ultraviolet, radiation and chemotherapeutic drugs [24].
Reactive oxygen species (ROS) are also an endogenous source of damage within somatic cells [46] and
oocytes [20,47]. DNA damage constitutes a significant issue in non-dividing or slowly dividing cells as
a large amount of DNA damage may accumulate over time. Any damage that does not cause cell cycle
arrest will tend to induce replication errors leading to mutations [20]. However, all cells are endowed
with the capacity to ameliorate the threats to DNA, which occurs mainly at the G1/S and G2/M-phase
transition. Cells with DNA damage respond in various ways to activate an appropriate DDR pathway.
A mild injury may not result in serious consequences as it can be repaired directly without cell cycle
arrest. While severe DNA damage may result in cell cycle arrest, allowing su cient time to repair
DNA damage. During this time, a sequence of DDR proteins is activated and the cell’s fate depends on
its capacity to repair the damage [48].
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DNA DSBs can be repaired by two main mechanisms: non-homologous end-joining (NHEJ) [49],
and homologous recombination (HR) [20,50]. NHEJ is error-prone since it mediates the direct re-ligation
of the two ends of broken DNA and is not based on a complementary DNA template. Given its
error-prone nature, NHEJ is commonly accompanied by deletion or insertion of base pairs [51,52].
NHEJ primarily occurs at the G0/G1 phase [53] and can be independent of the cell cycle [54]. NHEJ is
the most common type of DNA damage repair in mitotic cells. In contrast, HR is largely error-free and
is functionally dominant at S and G2/M phases of the cell cycle when sister chromatids are available as a
template for accurate DNA repair [55]. In this context, HR is the primary mode of DNA DSBs repair in
meiotic cells. Both pathways are evident and can be functionally active in mammalian oocytes [56,57],
although HR predominates in oocytes at all stages of development [10,48,58–62]. Given that primordial
follicles are arrested at G2/M and accurate repair is a prerequisite to conserve genetic information [63],
HR appears to be the pathway of choice for oocytes within primordial (immature) follicles [10,48,58,59].
While NHEJ can occur in the late stage of oocyte development [49,60,64].
HR requires the recognition of the DNA DSBs by the meiotic recombination 11 (MRE11)-Rad50-nijmegen
breakage syndrome 1 (NBS1) (MRN) complex. The binding of MRN complex to DSB free ends
allows the NBS1 protein to interact with ataxia telangiectasia mutated (ATM) dimers leading to
autophosphorylation of ATM at a serine residue (367, 1893 and 1981) [65]. Detection of DNA damage
attracts ATM kinase to the DNA DSB sites, through direct interaction between ATM and the C-terminal
region of NBS1 [66]. It has been reported that ovaries from MRE11 mutant mice showed a marked
increase in unrepaired DSBs, with primordial follicle loss and infertility although the number of mature
follicles did not di↵er between wild type and mutant mice [67]. However, meiotic progression in
mutant mice was delayed with only 5% of oocytes being able to complete synapsis [67], suggesting a
key role of MRE11 in oocyte DDR.
ATM in turn phosphorylates a specific histone protein, H2AX, at the C-terminal serine 139 to
generate  H2AX, which binds specifically to the DNA damage sites and controls the recruitment
of DNA repair proteins. The critical role of ATM in DDR is demonstrated by a study using mouse
ovaries in culture exposed to phosphoramide mustard (PM), a metabolite of cyclophosphamide (CP).
Increased  H2AX in oocytes occurred 24 h after exposure and consequently induced substantial follicle
loss. Interestingly, the administration of the ATM inhibitor KU55933, reduced the adverse impact
of PM on follicle depletion, emphasising the importance of ATM in the DDR [68]. Phosphorylation
of  H2AX initiates a downstream pathway resulting in DNA repair or cell cycle arrest (reviewed
in [20]).  H2AX is extensively phosphorylated from minutes to hours following the detection of DNA
breaks, quantitatively reflecting the severity of the damage [69–71]. Mediator DNA damage checkpoint
protein (MDC1) is then activated and bound to  H2AX, mediated by breast cancer susceptibility gene
1 (BRCA1; Figure 2A). MDC1 forms foci that co-localise with  H2AX within minutes after the damage
occurs and provides positive feedback, recruiting additional MRN complexes and thus leading to
propagation of  H2AX at sites of DNA breaks [72].
Phosphorylation of ATM is the first step in the initiation of G2 checkpoint activation in the
DNA damage repair pathway [73]. Activation of ATM upregulates downstream pathways leading to
e↵ective DNA repair through HR/NHEJ (HR in oocytes of primordial follicle, Figure 2A), initiation of
checkpoint kinase 2 (Chk2, Figure 2A) or apoptosis (through activation of TAp63↵, Figure 2B,C, and
discussed in detail below) [20,74]. Activation of HR generates single-strand DNA (ssDNA) at multiple
steps and requires a specific factor, replication protein A (RPA). In oocytes, the ssDNA binding protein
complex RPA is replaced by Rad51 and meiotic cDNA1 (Dmc1). BRCA2 mediates the interaction
between Rad51, Dmc1 and ssDNA to form the meiotic presynaptic nucleofilament, resulting in the
initiation of HR (Figure 2A). Dmc1 deficiency in mouse oocytes leads to synapsis failure, which is
HR-dependent and ultimately reduces follicle survival [75].
The role of Rad51 is of paramount importance in the final step of HR and in preventing oocyte
death, as is evident from studies in mouse and bovine [48,62,76]. Inhibition of Rad51 prior to irradiation
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exposure increases damage to DNA, whereas enhancing Rad51 expression by injecting recombinant
Rad51 is su cient to prevent DNA damage [48,76].
In the presence of DSBs, Chk2 activation delays the cell cycle transiently to provide su cient
time for DNA repair [77]. DNA damage checkpoints are primarily expressed when oocytes are in
meiotic arrest. Their expression persists at this stage leading to increased sensitivity of oocytes in
primordial follicles to DNA damage-inducing agents [75]. Activation of Chk2 simultaneously inhibits
cell division cycle (Cdc) phosphatases including Cdc25a, Cdc25b and Cdc25c. This in turn activates
cyclin-dependent kinase (Cdk) and consequently blocks the cell cycle progressing from G1 to S and
G2/M phase (reviewed in [50]). The activation of p53 family members is another downstream target of
ATM and functions to maintain checkpoint activation at G1/S of the cell cycle [53,78]. Inhibition of
ATM in mouse oocytes exposed to irradiation results in a failure to activate p63, which then blocks the
apoptosis pathway and prevents oocyte death [79].
4. A Unique p63 Pathway Links DNA Damage and Apoptosis in Oocytes within Primordial Follicles
In conditions resulting in severe DNA damage or with ine↵ective DNA repair, DNA DSBs
accumulation is more likely to initiate the activity of p53 family members. This process is critical to
abolish oocytes with unrepaired DNA damage and safeguard against germline mutations. The apoptosis
process of oocytes within primordial follicles is mediated by a distinct cell surveillance mechanism involving
N-terminal transactivation domain p63 (TAp63↵) [24,80–82], a p53 family member [83]. TAp63↵ functions
to respond to DNA damage primarily after prophase 1 of meiosis and is constitutively active only in female
germ cells once DNA breaks occur [81]. The essential role of TAp63↵ in the apoptosis process makes it
an essential regulator in follicle loss during chemotherapy, which may result in a reduced primordial
follicular pool. Oocytes in the quiescent state demonstrate a high TAp63↵ expression. Wild-type mice
exposed to radiation show primordial follicle loss (without loss of growing preantral follicles), whilst
TAp63-deficient mice are insensitive to irradiation-induced apoptosis, confirming the indispensable role
of TAp63↵ in the DDR of the oocyte within primordial follicles [80].
The p63 gene encodes two major isoforms of TAp63, one with the transactivation (TA) domain
and the other, DN-p63 (N-terminal truncated), lacking the TA domain [84]. TAp63↵ is the main p63
isoform expressed in the nuclei of oocytes within primordial follicles [80,81,83]. TAp63↵ is maintained
in inactive dimeric form by the transcriptional inhibitory domain (TID) and further stabilised by the
interaction of N-terminal transactivation (TAD) with TID and the oligomerization domain. In the
dimeric state, the transactivation of TAp63↵ is suppressed by decreasing its DNA binding a nity
and repressing the activity of the domain responsible for the transcriptional process [85]. Exposure to
genotoxic agents such as radiation trigger a conformation change in TAp63↵ to its active tetrameric
state, which in turn increases its DNA binding a nity and may ultimately cause apoptosis [85–87] and
elimination of damaged oocytes (Figure 2C). The presence of TAp63↵ in oocytes of immature follicles
highlights the need for adequate surveillance mechanism to ensure only oocytes with complete DNA
damage repair are recruited to ovulation [80,81,84].
Mouse oocytes within primordial follicles also express all necessary kinases required to trigger
p63 activation. Once DNA damage ensues, it may activate p63 directly, resulting in enhanced oocyte
sensitivity to DNA damage compared to granulosa cells [88]. This vulnerability of oocytes to DNA
damage is confirmed by a study using a low dose irradiation treatment in mice that is su cient to
induce oocyte death while the surrounding cells of the ovaries are not a↵ected [79]. TAp63↵ is also
expressed in oocytes within primary and preantral follicles, but expression is downregulated with
oocyte growth [80,81], resulting in growing oocytes being less sensitive to DNA damage. The sensitivity
to DNA damage diminishes once follicles reach the antral stage owing to complete loss of TAp63↵
expression at this stage [88].
TAp63 activation in oocytes within primordial follicles requires consecutive phosphorylation by
Chk2 at serine 582 [89]. TAp63↵ is not phosphorylated in Chk2 deficient mice following exposure
to irradiation [75] with ine↵ective oocyte elimination, whereas the entire primordial follicle pool
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in wild type mouse ovary is eradicated [75]. Transcriptional activation of BH3-only pro-apoptotic
BCL-2 family members PUMA (p53 upregulated modulator of apoptosis) and NOXA [24] are critical
downstream targets of oocytes apoptosis mediated by TAp63 [82]. PUMA and NOXA trigger apoptosis
by binding and suppressing the pro-survival B-cell lymphoma 2 (Bcl2) activity, an anti-apoptotic protein
implicated in repairing mitochondrial permeability. PUMA and NOXA binding to Bcl-2 unleashes the
pro-apoptotic protein B-cell lymphoma (Bcl)-associated X (BAX), precipitating an imbalance between
BAX and Bcl2, which then activates apoptosis [90] (Figure 2B). It has been reported that oocytes of
PUMA and NOXA deficient mice are not a↵ected by  -irradiation and are capable of producing healthy
o↵spring [24]. Primordial follicle loss is also much reduced in PUMA knockout mice treated with CP
and cisplatin [26]. Alternatively, upregulation of p53 elicits p21 transcription that directly prevents
Cdk2 and Cdk4 transcription and eventually induces cycle arrest (reviewed in [50,91]), thus allowing
DNA repair [90].
Figure 2. DNA double-strand breaks (DSBs) response pathway. (A) Homologous recombination
(HR) repair pathway to combat DNA DSBs. Detection and recognition of DNA DSBs by the meiotic
recombination 11-Rad50-nijmegen breakage syndrome 1 (MRN) complex (MRE11-RAD50-NBS1)
triggers phosphorylation of ataxia telangiectasia mutated (ATM). Activation of ATM results in the
phosphorylation of several DNA damage response (DDR) kinases such as histone protein, H2A
variant, H2AX, at Serine 139 to generate  H2AX, checkpoint kinase 2 (Chk2) and p53 (TAp63↵ in
primordial oocytes), mediating the e↵ects of ATM on DNA damage repair, cell-cycle arrest and
apoptosis. p63 induces cell-cycle arrest by activating the transcription of p21, which may hinder cell
cycle progression through inhibition of cyclin-dependent kinase 2 (Cdk2) and Cdk 4 activity. Mediator
DNA damage checkpoint protein 1 (MDC1) binds to  H2AX via breast cancer susceptibility gene 1
(BRCA1) and forms foci that co-localise with  H2AX. In oocytes, the DNA strand resection is activated
and leads to homologous recombination (HR). Activation of HR generates single-strand DNA (ssDNA)
at multiple steps and requires a specific factor, replication protein A (RPA). The ssDNA binding
protein complex RPA in oocytes is replaced by Rad51 and meiotic cDNA1 (Dmc1). (B) Activated Chk2
promotes degradation of cell division cycle (Cdc25) and ultimately provokes cell cycle arrest through
phosphorylation of Cdk2 and 4. Alternatively, in response to excessive or irreparable DNA damage,
p63 may induce a cascade of apoptotic signalling pathway that requires transcriptional induction of p53
upregulated modulator of apoptosis (PUMA) and NOXA [24,92]. Apoptosis is controlled by the balance
between pro-apoptosis B-cell lymphoma 2 (Bcl2) and anti-apoptosis B-cell lymphoma (Bcl)-associated
X (BAX) activity. (C) An interplay of dimeric to the tetrameric formation of TAp63↵. Phosphorylation
of TAp63↵ ultimately transforms the inactive dimeric form of TAp63↵ to the active tetrameric form
(figure adapted from [84,85,87]).
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5. The PI3K/Akt Pathway Links Primordial Follicle Growth and the DDR
The regulation of recruitment of primordial follicles to grow is strictly controlled by a delicate
balance between inhibitory and stimulatory factors to preserve the primordial follicle pool from
premature exhaustion. Evidence from genetically modified mice supports the central role of the
PTEN/PI3K/Akt signalling pathway in controlling the initiation of primordial follicle growth [93]. Thus,
the size of the primordial follicle pool is determined by the dynamic activity of this pathway [17,18].
Accordingly, many studies involving pharmacological and non-pharmacological manipulation of
this pathway have been conducted to investigate the activation of primordial follicles in vitro and
in vivo [18,31,33,36,94–99].
Upregulation of the PI3K/Akt signalling pathway within the oocyte triggers a cascade of reactions
that ultimately initiates activation of primordial follicles [6]. PI3K is comprised of a heterodimer of
the p85 regulatory subunit and p110 catalytic subunit. In response to growth factors, all regulatory
subunits of PI3K interact with the insulin receptor substrate, and thereby activate the catalytic
subunit. The interaction induces the phosphorylation of membrane phospholipid phosphatidylinositol
4,5-biphosphonate (PIP2). PIP2 is converted to phosphatidylinositol 3,4,5-trisphosphate (PIP3), which
then serves as a second messenger to enable phosphoinositide-dependent kinase 1 (PDK1) activation.
PTEN, expressed by the oocyte, reverses this process by converting PIP3 to PIP2. PIP3 binds to
Pleckstrin homology (PH) domain of PDK1 and Akt and recruits these two kinases to the subcortical
area. This in turn activates PDK1 and subsequent Akt phosphorylation at threonine 308. Akt is further
phosphorylated by mammalian target of rapamycin complex 2 (mTORC2) at serine 473 for its full
activation, which then regulates a number of downstream targets [6].
PDK1 is indispensable in maintaining primordial follicle survival and preserving reproductive
lifespan. It seems likely that both PTEN and PDK1 loss leads to premature ovarian failure (POF) but
through di↵erent mechanisms. PTEN loss is associated with excessive primordial follicle activation and
subsequent follicular atresia, whereas PDK1 deficiency instigates accelerated clearance of primordial
follicles straight from their quiescent state [17]. Both types of primordial follicle loss are suggested
to underlie ovarian ageing [17]. However, PTEN deletion in oocytes of primary and late stages of
growing follicles does not reveal any significant e↵ects on follicular growth [18].
mTORC1 is a further downstream substrate of Akt. mTORC1 is upregulated by the destabilisation
of the heterodimeric complex of tuberous sclerosis complex 1 (TSC1) and 2 (TSC2). mTORC1
phosphorylates S6 protein kinase (S6K1), which promotes cell growth and proliferation and activates
ribosomal protein S6 (rpS6), which increases protein translation [6] (Figure 3). The lack of TSC1
and TSC2 in mouse oocytes instigates massive primordial follicle activation, leading to POF [100].
Forkhead transcription factor FOXO3 (forkhead box O3) is a key target of the PTEN/PI3K/Akt pathway.
Once activated, FOXO3 is shuttled from the nucleus to the cytoplasm, which then suppresses its
transcriptional function leading to primordial follicle activation [93,101]. The FOXO3 deleted mouse
model displays global primordial follicle activation at the neonatal stage leading to primordial follicle
loss and POF [102,103]. Conversely, overexpression of constitutively active FOXO3 in the nucleus
of mouse oocytes preserves them in a dormant state [104]. FOXO3 can thus be considered as a
guardian of the primordial follicle pool, enhancing the ovarian reserve and maintaining reproductive
capacity [102–104].
PI3K-related protein kinases (PIKKs) are considered to be the main regulators of DNA damage
repair capacity of cells. Akt activation implicates the cell cycle checkpoint kinase 1 (Chk1), which
has an important role in the DNA damage repair mechanism as it delays the cell cycle progression
in S and G2 phase to correct an error of DNA damage before cell division [105]. PTEN is a tumour
suppressor gene and is an essential factor in promoting normal cell proliferation and coordinating
oocyte growth alongside granulosa cell proliferation [18,30]. Oocyte-specific PTEN deletion increases
primordial follicle activation and prevents follicles from undergoing apoptosis but may be associated
with accelerated clearance of follicles leading to primordial follicle pool exhaustion and POF [17,18].
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Figure 3. Crosstalk between primordial follicle activation and DDR pathway. Receptor protein tyrosine
kinase (RPTK) Kit and its ligand activate phosphoinositide 3-kinase (PI3K) and as a response to
this activation, the catalytic subunits of PI3K, p85 and p110, will be activated. In turn, it converts
phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-bisphosphate (PIP3), which
then serves as the second messenger to enable phosphoinositide-dependent kinase-1 (PDK1) activation.
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reverses this process and increases
PIP2 expression. PDK1 and Akt are recruited through binding of their pleckstrin homology (PH) domains
to PIP3, leading to phosphorylation of protein kinase B (Akt) by PDK1. Akt activation consequently
triggers phosphorylation of forkhead box O3 (FOXO3) resulting in cytoplasmic localisation of this
transcription factor. Increased in Akt activity also induces phosphorylation of mammalian target of
rapamycin complex I (mTORC1) through inactivation of tuberous sclerosis complex 1 and 2 (TSC 1, 2).
S6 protein kinase (S6K) activity is then upregulated and simultaneously triggers phosphorylation
of ribosomal protein S6 (rpS6). Meanwhile, high intracellular levels of Akt have been reported to
increase DNA damage, repress nuclear translocation of breast cancer susceptibility gene 1 (BRCA1) and
compromise homologous recombination (HR) in breast cancer cells.
Hyperactivation of Akt due to PTEN inhibition may impair HR activity leading to genomic
instability. Notably, a high endogenous level of Akt may be of significant importance in the pathology
of cancer as Akt inhibits apoptosis and increases cell proliferation [15]. In cancer cells, excessive
Akt activation has also been linked to suppressed NHEJ and DNA DSB repair [106]. PI3K/Akt
signalling compromises DNA DSB repair by inactivating the G2 checkpoint [107], with increased Chk1
phosphorylation [108] or cytoplasmic sequestration of BRCA1 [15]. In addition, lack of PTEN in the
cell leads to deficient DNA DSBs repair capacity and high incidence of spontaneous DNA breaks [16].
A study using a mouse model has shown that the expression of  H2AX was upregulated by seven-fold
in PTEN-null mouse embryonic fibroblasts [109]. Furthermore, PTEN deletion is su cient to markedly
reduce the level of Rad51 that in turn leads to chromosomal instability [110,111]. In normal cells,
increased Akt and DNA damage accumulation due to ine cient DNA repair are associated with
Ras-induced senescence [112]. Crosstalk between PTEN/PI3K/Akt signalling pathway and DNA
damage repair interactions is summarised in Figure 3.
Despite the role of PI3K/Akt in the pathology of cancer, the modulation of this pathway has been
adopted as a potential approach for women with premature ovarian insu ciency (POI) and pregnancies
have been achieved [34,113]. However, it has become increasingly evident that this pharmacological
approach may be detrimental to oocyte/follicle development [29,35–37]. We have demonstrated that
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dipotassium bisperoxo (5-hydroxypyridine-2-carboxyl) oxovanadate (bpv(HOpic)), a potent PTEN
inhibitor, compromises the growth of apparently healthy human preantral follicles [36]. Likewise, the
use of alginate sca↵old and polyethylene glycol (PEG)-fibrinogen to culture human ovarian cortical
strips in the presence of 100 µM bpv(HOpic) did not support follicular development [35]. Furthermore,
constitutive PI3K activation in the perinatal period in transgenic mouse oocytes leads to lack of
co-ordination between oocyte and granulosa cell growth, leading to enlarged oocytes surrounded
by immature pre-granulosa cells. These mice are anovulatory, but follicles develop, and oocytes
are meiotically competent. The inability to ovulate is likely the result of endocrine factors due to
unregulated follicle growth [114]. PI3K over-activation in mouse oocytes has also been associated with
granulosa cell tumour (GCT), characterised by excessive granulosa cell proliferation [115].
A recent finding from our lab utilising bovine ovarian cortical fragments exposed to the PTEN
inhibitor bpv(HOpic) for 24 h showed increased primordial follicle activation after six days of culture.
However,  H2AX expression in oocytes was upregulated and not associated with increased expression
of the DNA repair enzymes ATM and Rad51. A low dose of bpv(HOpic) did not a↵ect BRCA1 and
2 expression and more follicles in this group survived after six days of culture compared to high
doses of bpv(HOpic). Nevertheless, a marked decrease in BRCA1 and 2 expression was observed
after exposure to high doses suggesting a compromised DDR. Interestingly, despite high  H2AX
expression being observed in granulosa cells of secondary stage follicles, DNA repair capacity of these
cells was not significantly a↵ected, as indicated by increased MRE11, ATM and Rad51 expression
and a non-significant decline of BRCA1 and 2 [29] (Figure 4). Although the mechanism by which
PI3K/Akt upregulation induces DNA damage in oocytes has not been elucidated, accelerated primordial
follicle growth has been linked to decreased estradiol production indicating impaired granulosa cell
function, whilst lowering the activation rate results in normal estradiol production [37]. This suggests
that the rapid growth may be associated with a disordered intrafollicular oocyte and somatic cell
relationship [116]. This condition may lead to uncoordinated oocyte and granulosa cell growth, as
reported in mice [114].
Figure 4. Potential e↵ects of phosphoinositide 3-kinase /protein kinase B (PI3K/Akt) activation
on DNA damage and DNA repair response of oocytes in vitro. Inhibition of PTEN by low dose
Dipotassium bisperoxo(5-hydroxypyridine-2-carboxyl) oxovanadate (V) (bpv(HOpic)) is su cient to
induce primordial follicle activation. However, gamma H2AX ( H2AX) increases and DNA repair
proteins meiotic recombination 11 (MRE11), ataxia telangiectasia mutated (ATM) and Rad51 are
downregulated, as are breast cancer susceptibility gene 1 (BRCA1) and breast cancer susceptibility gene
2 (BRCA2).
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Several publications utilising mouse models have provided evidence that oocytes within
resting follicles may be directly targeted by chemotherapy treatments, including CP, cisplatin and
doxorubicin [24,26,117,118]. It has also been proposed that primordial follicle depletion following
chemotherapy may be induced by the loss of growing follicles with an increase in primordial follicle
activation [119,120]. A study investigating the mechanism by which cisplatin induced ovarian failure
showed that cisplatin reduced PTEN expression in oocytes leading to primordial follicle activation.
Once follicles were activated to grow, they became more vulnerable to apoptosis with a loss of
luteinising hormone (LH) receptor expression resulting in decreased oocyte meiotic competence and
ovulation failure [23]. These direct and indirect e↵ects of chemotherapy treatments on primordial
follicles can form the basis to develop potential methods to protect ovaries against the adverse impacts
of chemotherapy [121].
In addition to chemotherapy, another clinical problem that is linked to DNA damage, PI3K/Akt
signalling pathway and ovarian ageing is endometriosis. Increased PI3K/Akt activity has been
suggested in endometriosis [122–127], with loss of nuclear PTEN [128]. Primordial follicle loss in
endometriosis has been associated with PI3K/Akt upregulation in mice and human [125] and is
suggested to be responsible for ovarian ageing [129]. A diminished ovarian reserve in endometriosis
occurs concomitantly with increased DNA damage and compromised DSB repair mechanism, indicated
by low Rad51 and BRCA1 expression [130]. Experimental studies in rats indicate that an mTOR
inhibitor is e↵ective to suppress the growth of endometriotic implants, supporting the engagement of
this pathway [131].
The e↵ects of PI3K/Akt/mTOR on primordial follicle activation following chemotherapy treatment
have led to research utilising this mechanism to reduce the adverse impact of chemotherapy on
the ovary. In human, as mTOR hyperactivation is a common feature of cancers, mTOR inhibitors
are becoming a therapeutic target in certain type of cancers. In a study utilising mouse embryonic
fibroblast cell lines, constitutive mTOR activation enhanced apoptosis triggered by chemotherapy
through persistent DNA damage as was shown by the upregulation of  H2AX. In parallel, the absence
of both PTEN and TSC2 upregulates  H2AX expression. Intriguingly, mTOR inhibition prior to
treatment is able to protect cells from etoposide-induced apoptotic cell death [132]. Substrates that
inhibit mTOR have been shown to reduce excessive primordial activation and maintain the primordial
follicle pool [133–135]. This positive e↵ect is due to mTOR downregulation during chemotherapy and
subsequently reduced Akt and S6K phosphorylation resulting in decreased primordial follicle loss and
maintenance of the ovarian reserve and fertility [136]. Studies investigating the PI3K/Akt pathway are
detailed in Table 1.
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Table 1. Recent studies investigating the impact of phosphatase and tensin homolog deleted on chromosome 10/phosphoinositide 3-kinase/protein kinase B/mammalian
target of rapamycin complex (PTEN/PI3K/Akt/mTORC) pathway either as a part of genetic modification/pharmacological activation, chemotherapy treatment or
ovotoxicity exposure on primordial follicle activation, follicular growth and survival.
Agents Used/Compounds/Concentration Mechanism of Action Species/Methods E↵ects on Follicular Growth/Survival
Specific E↵ects on Granulosa
Cells/Oocyte
Study
1 and 10 µM Dipotassium bisperoxo
(5-hydroxypyridine-2-carboxyl) oxovanadate (V)
(bpv(HOpic)) for 24 h/ PTEN inhibitors.
Increase PI3K/Akt Bovine/ovarian cortical fragmentscultured. Decreases in higher dose.
Compromises DNA damage
response (DDR). [29]
20, 40, 60, 80, 120 and 140 µM diazinon (DZN) Inhibit PI3K/Akt Porcine isolated granulosa cells. Granulosa cells death
Increase DNA damage, mRNA level
of Ataxia telangiectasia mutated
(ATM), Rad51 and breast cancer
susceptibility gene1 (BRCA1) increase
p53 leading to granulosa cell death.
[137]
30 µM bpv (HOpic) + 150 µg/mL 740Y-P for 24






Lowering the rate of activation improves
follicular growth.
PTEN inhibition compromises
granulosa cell estradiol production. [37]
Cyclophosphamide (CP) 75 mg, 100 mg, 150 mg
per kg body weight and 5 mg/kg body weight
per day 1 week before and after CP
administration.
PI3K/Akt activation Mice, in vivo
CP induces non-growing and growing
follicle loss. Rapamycin prevents CP
induced primordial follicle activation.
Anti-mullerian hormone (AMH)
expression decreases after CP
exposure.
[133]
Transgenic mouse model Increase PI3K activationin transgenic mice, Cre+ Transgenic mice, Cre+ and Cre 
Normal secondary follicles, granulosa
cell tumour (GCT) in primordial and
primary follicles.
Bilateral GCT due to increased
activin A. [115]
440 µM bisphenol A(BPA). Increases PI3K/Aktactivation
Rat ovarian fragment culture
exposed to BPA.
BPA induces DNA damage both in
oocytes and granulosa cells. PI3K
signalling pathway involved in
BPA-induced DNA damage.
Primordial follicle is activated to
replace the larger follicle depletion. [138]
Transgenic mouse model Increase PI3K activationin transgenic mice, Cre+ Transgenic mice, Cre+ and Cre  Increases follicles survival
Asynchronous oocytes and granulosa
cells growth. [114]
100 µM bpv(HOpic) for 25 h Increase PI3K/Aktactivation
Human ovarian cortical
fragments cultured. No damage to the follicular growth.
Enhance estradiol production
without any damage to follicles
compared to control group.
[33]
200 µM phosphatidic acid (PA) and 50 µM
propranolol (PRO) for 24 h in mice;
bpv(HOpic)(100 µM) /740Y-P (250 µM /mL) for
24 h, 740Y-P (250 µM /mL) only for another 24 h;
PA (100 mM)/740Y-P (200 µM)/PRO (50 µM) for
24 h in human.
Increase PI3K/Akt /mTOR
activation.
Mice and human ovaries
transiently incubated in mTOR
activators followed by grafting
into female mice.
No damage to the follicular growth. NA [139]
30 µM of bpv(HOpic), and 150 µM /mL of 740YP
for 24 h followed by incubation with 740YP





following in vitro activation
(IVA).
Autografting of ovarian fragments
following in vitro activation (IVA)
procedure to infertility related primary
ovarian insu ciency (POI) patients.
NA [34]
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Table 1. Cont.
Agents Used/Compounds/Concentration Mechanism of Action Species/Methods E↵ects on Follicular Growth/Survival
Specific E↵ects on Granulosa
Cells/Oocyte
Study





fragments and isolated preantral
follicle culture.
Higher dose compromises follicular
growth. The lower dose is associated
with deleterious e↵ects on subsequent
growth of preantral follicles.
NA [36]
Cisplatin, once daily at doses of 0.5, 1.0, 1.5 and
2.0 mg/ kg for 5 to 14 days Activation of PI3K/Akt
Intraperitoneal injection of
cisplatin in mice
Increases the proportion of growing
follicles. Induces ovarian failure. [23]
100 µM bpv(HOpic) and 500 µM /mL 740Y-P for







Compromises follicle survival. NA [35]
30 µM bpv(HOpic) and 150 µg/mL
740YP for 24 h
Increase PI3K/Akt
activation.
Mice ovarian transplantation and
human ovarian fragments
transplantation following IVA.
Promotes primordial follicle activation
both in mice and human. NA [113]
Female mice deficient in PTEN Increase PI3K/Aktactivation PTEN knockout mice
Rapamycin reduces the primordial




induced by the absence of PTEN.
[134]
1 µM bpv(HOpic) for 24 h Increase PI3K/Akt activity.
Mice cortical fragments IVA
followed by transplantation and
bpv(HOpic) directly injected to
female mice.
Does not compromise follicular health. More mature and fertilised oocytes inPTEN inhibition group. [32]
100 µM bpv(HOpic) and/or 500 µg/mL 740Y-P
for 48 h or bpv(HOpic) plus 740Y-P together
with the Akt inhibitor SH-550 µM or the PI3K




Mice and human cortical
fragments incubated in Akt
activators followed by
xenografting.
Increases in the number of secondary
and antral stage follicles following
xenografting and does not a↵ect
follicular health.
No malignancy observed after long
term ovarian transplantation. [140]
Mice lacking Tuberous sclerosis complex 1
(TSC1), PTEN; TSC1 and PTEN;
Phosphatidylinositol-dependent kinase 1 (PDK1)
and PDK1 and TSC1 in oocytes.
Enhances mTOR
activation. Mutant female mice
Degenerated activated primordial
follicles (short term), diminished
follicular health (long term).
Rapamycin prevents global
primordial follicle activation.
Activation does not cause tumour
development.
[100]
Homozygous mutant female mice deficient
Tuberous sclerosis complex 2 ( TSC2) in oocytes.
Enhances mTOR
activation. Mutant female mice. Massive primordial follicle activation. Depletion of follicle reserve. [93]
Female mice lacking PTEN, PDK1 and r
ibosomal protein S6 kinase (rpS6) Increases PI3K/Akt Mutant female mice.
Follicles with degenerating oocytes in
PDK1 deletion and enlarged oocytes in
PTEN deletion.
The absence of PTEN causes Primary
Ovarian Insu ciency (POI) that can
be reversed by PDK1 deletion.
[17]
PTEN deletion in mice. Increases PI3K/Akt PTEN mutant mice
Tends to be normal follicle morphology
but with enlarged oocytes and flattened
granulosa cells.
PTEN deletion leads to excessive
primordial follicle activation. [18]
NA: Not available.
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6. DNA Damage Associated with Ovarian Ageing, a Crosstalk between PI3K/Akt/PTEN
Signalling, Ageing and DNA Damage Response
Ovarian ageing as a physiological process varies substantially among women depending on the
number of primordial follicles and the rate of follicle loss [141,142]. It is also very closely associated with
reduced oocyte quality [143]. A link between these is suggested by the increasing rate of primordial
follicle activation with age [144] with PI3K/Akt signalling pathway being a key regulator of this growth
activation [17,18]. Compromised DNA repair protein interactions as a consequence of ovarian ageing
has been connected to increase PI3K/Akt activity [19–22].
There is increasing evidence of an association between DNA damage and repair capacity of
oocytes and maternal age, with DNA repair becoming less e cient with ageing [19–21,58]. A study in
non-human primates confirmed a lack of DNA repair e ciency with advancing age, with cytoplasmic
sequestration of BRCA1 in oocytes [22]. Although DNA damage and repair mechanisms in granulosa
cells are not the main focus of this review, it is worth mentioning that  H2AX expression in granulosa
cells of growing follicles was not di↵erent between old and young mice [22]. This finding may suggest
less e↵ective DNA repair in oocytes within primordial follicles compared to surrounding somatic cells.
Accordingly, mouse oocytes of all follicle types exhibit high expression of  H2AX with increasing age.
At the same time, the oocyte appears to have an ine↵ective DNA repair mechanism as was shown by
a profound drop in BRCA1, MRE11 and ATM but not BRCA2. Mutations in BRCA1 but not BRCA2
perturb ovarian stimulation leading to smaller litter size. Interestingly, DNA damage was not evident
in pre-granulosa cells within primordial follicles [21]. In line with these findings, the mRNA level
of BRCA1, Rad51 and H2AX were reduced in aged female rat and bu↵alo oocytes within primordial
follicles [19,58].
Women with BRCA2 mutations do not show a reduced response to ovarian stimulation [145].
However, BRCA2 deficient mice are able to produce competent and fertilised oocytes but more
abnormal embryos are observed [146], indicating an important role of BRCA2 in the oocyte. In women,
complete loss of BRCA2 function leads to ovarian dysgenesis resulting in primary amenorrhea, with
reduced Rad51 function in HR indicated by low Rad51 expression at the site of DNA damage [147].
A genome-wide association study (GWAS) analysis also shows association between DNA damage
repair and age at menopause [148], particularly highlighting links with BRCA1. Likewise, a diminished
ovarian reserve mirrored by low AMH levels in women with BRCA1 but not BRCA2 mutations [149]
supports findings from a transgenic mouse model [21]. In addition, primordial follicles with BRCA1
mutations are more susceptible to DNA damage accumulation, as shown by high  H2AX expression
in primordial follicles [25].
As ageing is thus associated with a reduction in DNA repair capacity, oocytes from older women
may be more susceptible to genotoxic insults with increased primordial follicle loss due to apoptosis [10].
It is evident that the degree of doxorubicin induced DNA damage is independent of age, but apoptotic
events are more apparent in oocytes of old mice. This may be related to the finding that oocytes from
young mice have a greater DNA repair capacity [48]. Qualitative analysis of recent findings of studies
in DNA damage and ovarian ageing are summarised in Table 2.
ROS accumulation in mitochondria can be an underlying factor in ageing, by increasing oxidative
damage leading to a gradual decrease in follicle quality [150]. Increased ROS activity due to
senescence parallels diminished activity of the oxidative defence system and may lead to increased lipid
peroxidation, oxidative stress and damage to macromolecules including DNA with either single-strand
breaks (SSBs) or DSBs [151]. High ROS expression in follicular fluid of patients undergoing in vitro
fertilisation (IVF) has been linked to reduced oocyte fertilisation and poor embryo quality [152].
Mitochondria have been hypothesised to be the first organelle a↵ected by ROS since they are the source
of oxygen radical production; ageing is also associated with increased mitochondrial DNA (mtDNA)
deletions [153,154]. PTEN upregulation, through modulation of the PI3K/Akt pathway, decreases ROS
production in cells (reviewed in [155,156]). Increased ROS concentration in mitochondria due to ageing
may inhibit PTEN leading to accumulation of PIP3, which then increases Akt activation and further
Cells 2020, 9, 200 14 of 25
increases ROS production. This pathway suggests a positive feedback loop between PTEN, PIP3 and
ROS [157]. The impact of ageing on the PI3k/Akt signalling pathway, DDR and resting pool depletion
is summarised in Figure 5.
Figure 5. Molecular relationship between phosphoinositide 3-kinase/protein kinase (PTEN/Akt)
activation, DNA damage and decreased ovarian reserve. Breast cancer susceptibility gene 1 (BRCA1)
mutation may lead to compromised DNA repair pathway and eventually primordial follicle apoptosis
leading to follicle loss and decreased ovarian reserve. In addition, mitochondria can be one of the
major sources of DNA damage. Excessive reactive oxygen species (ROS) production may harm
macromolecules in the cells including DNA leading to single-stand breaks (SSBs) or double-strand
breaks (DSBs). High ROS expression in mitochondria may lead to PTEN inhibition and increase Akt
activation. This may eventually further increase ROS production due to inactivation of forkhead box
O3 (FOXO3).
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Table 2. Summary of recent clinical and experimental studies providing evidence linking DNA damage response (DDR), ovarian ageing and ovarian reserve.
Study Focus Study Type DDR Pathway A↵ected Main Outcomes References
Oocyte maturation rate of breast cancer patient with breast cancer
susceptibility gene 1 (BRCA1) and Breast cancer 2 (BRCA2) mutation.
Retrospective
cohort study. BRCA1 and BRCA2
The number of mature oocytes resulted from in vitro maturation (IVM)
procedure is not di↵erent between women with BRCA1 and without
BRCA mutation.
[158]
Ovarian reserve of patients with BRCA mutation carriers and
non-carriers with or without malignancy.
Retrospective
cohort study. BRCA1 and BRCA2
Patients with BRCA mutation carriers and noncarriers show comparable
ovarian reserve and number of oocytes yield following ovarian stimulation. [159]
The role of BRCA2 in ovarian development and puberty onset. A case controlstudy in human. BRCA2 and Rad51
Lack of BRCA2 reduces Rad51 recruitment during
homologous recombination. [147]
Ovarian reserve in patients with BRCA1 mutation. Case-controlstudy.  H2AX, BRCA1 and BRCA2
DNA double-strand breaks (DSBs) increase in BRCA1 mutation group but
not BRCA2. DNA damage increases with age in BRCA1/2 mutation. [25]
Oocyte yield following ovarian stimulation in patients with
BRCA1/2 mutation.
Retrospective
cohort study. BRCA1 and BRCA2
The number of oocytes produced by women with BRCA mutation is lower
than without BRCA1 mutation. [160]




BRCA1,  H2AX, MRE11, Rad51
and ATM
mRNA expression of BRCA1, meiotic recombination 11 (MRE11), Rad51 and
ataxia telangiectasia mutated (ATM) decline significantly in aged
bu↵alo ovaries.
[58]
The e↵ects of BRCA mutation on anti-Mullerian hormone (AMH)
serum level.
Prospective
cohort study BRCA1 and BRCA2
Patients with BRCA2 mutations exhibit a lower AMH level compare to
low-risk control patients. [161]
Anti-mullerian hormone (AMH) serum level in patients with
BRCA1/2 mutation.
Cross-sectional
study BRCA1 and BRCA2
AMH serum level of patients with BRCA1/2 mutation carriers does not
significantly di↵erent from non-carriers. [162]
AMH serum level in women with BRCA1 and BRCA2 mutation. Cross-sectionalstudy BRCA1 and BRCA2 BRCA1 but not in BRCA2 mutation carriers have a lower AMH level. [149]
Ovarian ageing e↵ects on DNA damage repair response in rat ovaries. Experimental  H2AX, BRCA1, MRE11, Rad51,ATM, BRCA1 and BRCA2
DNA repair proteins BRCA1, Rad51, ATM and  H2AX in aged rat
primordial follicles declined compared to immature rats. [19]
Comparison of proteins profile of primordial follicles isolated from
immature rat and aged rat. Experimental
Heat shock cognate 71kDa
(Hsp71C), calreticulin, Bcl-2-related
ovarian killer protein (BOK)
Protein expression for DSBs response decreases significantly in aged rats. [59]
The association between DNA DSBs in granulosa cells and ageing. Experimental  H2AX, BRCA1, Telomeric repeatbinding factor (TRF2)
Increased  H2AX and decreased BRCA1 expression in all follicle types
with age. [22]
The association between AMH serum level and BRCA mutation. Cross-sectionalstudy BRCA1 and BRCA2
AMH serum level of patients with a BRCA1 mutation is lower than without
BRCA1 mutation. [163]
The e↵ect of ovarian ageing on DNA DSBs of oocytes and
granulosa cells. Experimental
 H2AX, BRCA1, MRE11, Rad51,
ATM, BRCA1 and BRCA2 Increased DNA damage and decreased DDR capacity with advancing age. [21]
Time to menopause in BRCA1 and 2 mutations carriers. Case controlstudy. BRCA1 and BRCA2
Both BRCA1 and 2 mutation patients experience menopause earlier
than control. [164]
Doxorubicin e↵ects on ovarian ageing. Experimental  H2AX, ATM and activatedcaspase 3
 H2AX expression is higher in ovarian tissue exposed to doxorubicin
in vitro. [118]
Transactivation p73 (TAp73) expression in young and aged
female oocytes. Experimental TAp73 TAp73 is downregulated in older women’s oocytes. [165]
The e↵ects of age on the occurrence of aneuploidy in mouse oocytes. Experimental BRCA1 BRCA1 expression is decreased in oocytes of aged mice. Aneuploidyincreases in aged oocytes. [166]
The role of BRCA2 in male and female gametogenesis. Experimental BRCA2 BRCA2 deficiency in mice leads to infertility. [146]
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7. Conclusions and Future Directions
It is clear that mammalian oocytes have distinct DNA damage surveillance mechanisms. There is
evidence linking the regulation of primordial follicle growth activation through the PI3K pathway
with increased DNA damage/reduced repair, and this provides a model for the development of new
approaches to the investigation and potentially therapeutic intervention in both these key aspects of
oocyte biology. Evidence from both genetic mouse models and the culture of mammalian ovarian
cortical fragments supports the contention that imbalance in signalling events between oocytes
and granulosa cells may contribute to impaired follicle function after aberrant primordial follicle
growth activation.
Data reviewed here explore the links between the regulation of primordial follicle growth activation
and DNA damage repair pathways. The primordial follicle and particularly the oocyte within it
has unique physiological challenges, being required to maintain genomic integrity and quality from
birth over several decades without cell growth or replication. Thus, the opportunity for repeated
DNA surveillance during cell division is absent, and oocyte-specific pathways from DNA damage to
apoptosis exist. There is increasing research activity linking follicle growth regulation with oocyte
DNA damage and repair capacity in the context of potential prevention of ovarian damage against
chemotherapy, radiation or environmental toxicants. The elucidation of the possibility to confer
resistance against chemotherapy through identification of key factors in the oocyte apoptotic pathway
may lead to clinical trials building on the di↵erences in these pathways between the oocyte and
somatic cells.
Rad51, a critical protein involved in oocyte resilience to apoptosis, is a feasible candidate to
promote DNA repair capacity in oocytes and ultimately conserve fertility in women undergoing
cancer treatment. Administration of recombinant Rad51 into mouse oocytes has been demonstrated to
increase DDR, prevent apoptosis, improve the defective DNA repair capacity in oocyte and restore
embryo development [48,76]. Future investigation into the safety and e cacy of modulating Rad51
as a clinical application to preserve functional germ cells may be beneficial to improve oocyte and
embryo development following chemotherapy exposure and in ageing.
Targeting the PI3K/PTEN/Akt/mTOR pathway, mTOR inhibition with rapamycin [133] and
everolimus [136] have also been investigated as a means to protect ovaries during exposure to
chemotherapy in mice. Melatonin and ghrelin have also been proposed to protect the ovaries against
cisplatin and may also a↵ect this pathway, though perhaps indirectly. Both ghrelin and melatonin
suppress cisplatin-mediated PI3K/Akt pathway upregulation and inhibit FOXO3 nuclear shuttling,
thus preserving the primordial follicle pool [167]. This is a promising avenue, though it will be essential
to ensure that the e↵ects of chemotherapy on cancer cells are not compromised [10].
It has been shown that either complete loss of PUMA or partial loss of TAp63 in mice oocytes
could retain the primordial follicle pool following CP and cisplatin exposure. This is a promising
approach to reduce the negative e↵ects of chemotherapy on the ovaries [26,117] as the salvage process
exclusively occurs within the oocyte without interfering with the cancer treatments [10].
An intriguing novel approach to the protection of ovaries against chemotherapy has been
suggested by a recent study introducing microRNAs (miRNAs) [168]. It is reported that miRNAs
are di↵erentially expressed in mouse postnatal ovaries exposed to 4-hydroperoxy-cyclophosphamide
(4-HC), some of which have been implicated in DDR and apoptosis and a↵ect cellular susceptibility to
DNA damaging agents [169]. MiRNAs can be e↵ective techniques as their expression can be adjusted
with their microenvironment during chemotherapy treatment, thus minimising o↵-target toxicity.
Lethal 7 (let-7a) mimic is an example of a new miRNA based therapeutic to minimise follicle injury
following chemotherapy treatment [170]. However, this work is at an early stage, with challenges
including how to deliver miRNAs to a specific target organ with minimum side e↵ects.
In vitro activation (IVA) methods have generated controversy regarding e cacy and safety with
in vitro studies indicating that manipulating activation by pharmacological methods has an impact on
subsequent quality of oocytes [35–37]. Pharmacological primordial activation utilising a PTEN inhibitor
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has been associated with increased DNA damage and impaired DNA repair capacity particularly in
oocytes [29]. While an IVA protocol utilising both PI3K/Akt and Hippo signalling pathways prior to
ovarian tissue transplantation may have major negative consequences on follicle health [119,171,172],
the PI3K/Akt signalling pathway may also be a potential target to prevent follicle activation and
loss following ovarian tissue transplantation, maximising the longevity of the transplanted tissue.
A recent study showed that short exposure to a specific inhibitor of mTORC1 partially hindered
follicular activation while improving follicle survival and steroidogenesis [37]. Since precocious
follicular growth in vitro has been a major constraint in developing in vitro follicle growth systems,
lowering the activation rate by using an mTORC inhibitor may have additional value as a promising
strategy for the derivation of mature oocytes in vitro. Finally as the canonical PI3K/Akt signalling
pathway is interconnected with many feedback loops that are essential for optimal cell function during
ageing [157], future research investigating the potential of manipulation of PTEN and PI3K to reduce
ROS accumulation and thus damage in ageing oocytes will be essential.
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